PKCA
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0A2R8Y4L2 | S95 | Sugiyama | HNRNPA1L3 HNRNPA1P48 | RPHKVDGRVVEPKRAVSREDsQRPDAHLTVKKIFVGGIKED |
| A5A3E0 | S1068 | Sugiyama | POTEF A26C1B | SLSTFQQMWISKQEyDEsGPsIVHRKCL_____________ |
| A5A3E0 | Y940 | Sugiyama | POTEF A26C1B | ALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPEA |
| A6NMY6 | S26 | Sugiyama | ANXA2P2 ANX2L2 ANX2P2 LPC2B | EILCKLsLEGDHstPPsAyGsVKAytNFDAERDALNIEtAI |
| B6ZGS9 | S135 | GPS6 | NR1H4 hCG_20893 | GASAGRIKGDELCVVCGDRAsGYHYNALTCEGCKGFFRRsI |
| B6ZGS9 | S154 | GPS6 | NR1H4 hCG_20893 | AsGYHYNALTCEGCKGFFRRsITKNAVYKCKNGGNCVMDMY |
| O00161 | S161 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | SNAP23 | KRItNDAREDEMEENLtQVGsILGNLKDMALNIGNEIDAQN |
| O00161 | S23 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | SNAP23 | NLssEEIQQRAHQITDEsLEstRRILGLAIEsQDAGIKtIt |
| O00161 | T24 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | SNAP23 | LssEEIQQRAHQITDEsLEstRRILGLAIEsQDAGIKtItM |
| O00168 | S88 | EPSD|PSP | FXYD1 PLM | QRTGEPDEEEGtFRssIRRLstRRR________________ |
| O00571 | S82 | Sugiyama | DDX3X DBX DDX3 | ssKDKDAyssFGsRsDsRGKssFFsDRGsGsRGRFDDRGRs |
| O14493 | S194 | EPSD|PSP | CLDN4 CPER CPETR1 WBSCR8 | LLLGGGLLCCNCPPRtDKPYsAKYSAARsAAAsNyV_____ |
| O14745 | S162 | GPS6|ELM|EPSD|PSP | NHERF1 NHERF SLC9A3R1 | KSHPEQRELRPRLCtMKKGPsGYGFNLHSDKSKPGQFIRsV |
| O14745 | S339 | EPSD|PSP | NHERF1 NHERF SLC9A3R1 | PILDFNISLAMAKERAHQKRssKRAPQMDWSKKNELFSNL_ |
| O14745 | S340 | EPSD|PSP | NHERF1 NHERF SLC9A3R1 | ILDFNISLAMAKERAHQKRssKRAPQMDWSKKNELFSNL__ |
| O14745 | S77 | EPSD|PSP | NHERF1 NHERF SLC9A3R1 | DRLVEVNGENVEKETHQQVVsRIRAALNAVRLLVVDPEtDE |
| O14920 | S177 | EPSD|PSP | IKBKB IKKB | EQRLIHKIIDLGYAKELDQGsLCTsFVGTLQyLAPELLEQQ |
| O14920 | S181 | EPSD|PSP | IKBKB IKKB | IHKIIDLGYAKELDQGsLCTsFVGTLQyLAPELLEQQKyTV |
| O14939 | S243 | GPS6|SIGNOR|ELM|EPSD|PSP | PLD2 | CCGRDQVCYRWSKRWLVVKDsFLLYMCLEtGAISFVQLFDP |
| O14939 | T252 | GPS6|SIGNOR|ELM|EPSD|PSP | PLD2 | RWSKRWLVVKDsFLLYMCLEtGAISFVQLFDPGFEVQVGKR |
| O14974 | S910 | Sugiyama | PPP1R12A MBS MYPT1 | yETssTsAGDRyDsLLGRsGsysYLEERKPYSSRLEKDDST |
| O14986 | S413 | SIGNOR | PIP5K1B STM7 | SRVFKKIQALKASPSKKRCNsIAALKATSQEIVSSISQEWK |
| O15217 | T193 | SIGNOR|EPSD|PSP | GSTA4 | NILSAFPFLQEYTVKLsNIPtIKRFLEPGSKKKPPPDEIYV |
| O15350 | S388 | SIGNOR|EPSD|PSP | TP73 P73 | LMKLKESLELMELVPQPLVDsYRQQQQLLQRPSHLQPPSYG |
| O15371 | T49 | Sugiyama | EIF3D EIF3S7 | PyQPFsKGDRLGKVADWtGAtyQDKRYTNKYSSQFGGGSQY |
| O15446 | S64 | Sugiyama | POLR1G ASE1 CAST CD3EAP PAF49 | LIQAPADFAPECFNGRHVPLsGsQIVKGKLAGKRHRyRVLS |
| O15519 | S193 | SIGNOR|EPSD|PSP | CFLAR CASH CASP8AP1 CLARP MRIT | QSVQGAGTSYRNVLQAAIQKsLKDPSNNFRLHNGRSKEQRL |
| O43526 | S551 | SIGNOR|iPTMNet|EPSD | KCNQ2 | DLTPGLKVSIRAVCVMRFLVsKRKFKEsLRPYDVMDVIEQY |
| O43526 | S558 | SIGNOR|iPTMNet|EPSD | KCNQ2 | VSIRAVCVMRFLVsKRKFKEsLRPYDVMDVIEQYSAGHLDM |
| O43526 | T217 | PSP | KCNQ2 | LRSLRFLQILRMIRMDRRGGtWKLLGSVVYAHSKELVTAWY |
| O43823 | S323 | Sugiyama | AKAP8 AKAP95 | RKRKQFQLyEEPDtKLARVDsEGDFsENDDAAGDFRsGDEE |
| O60220 | S94 | Sugiyama | TIMM8A DDP DDP1 TIM8A | SQFILNRLEQTQKSKPVFSEsLsD_________________ |
| O60479 | S137 | iPTMNet|EPSD | DLX3 | AEVRMVNGKPKKVRKPRtIYssYQLAALQRRFQKAQYLALP |
| O60479 | S138 | SIGNOR|iPTMNet|EPSD | DLX3 | EVRMVNGKPKKVRKPRtIYssYQLAALQRRFQKAQYLALPE |
| O60479 | S182 | iPTMNet|EPSD | DLX3 | LAAQLGLTQTQVKIWFQNRRsKFKKLYKNGEVPLEHSPNNS |
| O60479 | T134 | SIGNOR|iPTMNet|EPSD | DLX3 | EPEAEVRMVNGKPKKVRKPRtIYssYQLAALQRRFQKAQYL |
| O60500 | T1120 | SIGNOR|EPSD|PSP | NPHS1 NPHN | KTEAGSEEDRVRNEYEESQWtGERDtQSSTVSTTEAEPYYR |
| O60500 | T1125 | SIGNOR|EPSD|PSP | NPHS1 NPHN | SEEDRVRNEYEESQWtGERDtQSSTVSTTEAEPYYRSLRDF |
| O60674 | S518 | SIGNOR|PSP | JAK2 | CCPPKPKDKSNLLVFRTNGVsDVPtsPTLQRPTHMNQMVFH |
| O60674 | T174 | SIGNOR|PSP | JAK2 | FAQWRHDFVHGWIKVPVTHEtQEECLGMAVLDMMRIAKEND |
| O60716 | S879 | EPSD|PSP | CTNND1 KIAA0384 | sQssHsyDDstLPLIDRNQKsDKKPDREEIQMSNMGsNtKs |
| O60825 | T475 | SIGNOR|iPTMNet|EPSD | PFKFB2 | KNQTPVRMRRNsFtPLsssNtIRRPRNYsVGsRPLKPLsPL |
| O60841 | S196 | Sugiyama | EIF5B IF2 KIAA0741 | ERsRINssGEsGDEsDEFLQsRKGQKKNQKNKPGPNIEsGN |
| O60841 | S222 | Sugiyama | EIF5B IF2 KIAA0741 | KNQKNKPGPNIEsGNEDDDAsFKIKTVAQKKAEKKERERKK |
| O60869 | T91 | SIGNOR|iPTMNet|EPSD | EDF1 | DRVTLEVGKVIQQGRQSKGLtQKDLATKINEKPQVIADyES |
| O60928 | S201 | SIGNOR|EPSD|PSP | KCNJ13 | MDGKPNLIFQVANTRPSPLTsVRVSAVLYQERENGKLYQTS |
| O60941 | T179 | EPSD|PSP | DTNB | NGLMIFSKFDQFLKEVLKLPtAVFEGPSFGYTEHSVRTCFP |
| O60941 | T212 | EPSD|PSP | DTNB | HSVRTCFPQQRKIMLNMFLDtMMADPPPQCLVWLPLMHRLA |
| O60941 | T69 | EPSD|PSP | DTNB | NLHLVDIWNMIEAFRDNGLNtLDHTTEISVSRLETVISSIY |
| O75144 | S285 | SIGNOR|PSP | ICOSLG B7H2 B7RP1 ICOSL KIAA0653 | LLVVVAVAIGWVCRDRCLQHsYAGAWAVsPETELTGHV___ |
| O75376 | S70 | EPSD|PSP | NCOR1 KIAA1047 | VSQASQLLQQQQQQQLRRRPsLLSEFHPGSDRPQERRtsyE |
| O75385 | S423 | SIGNOR | ULK1 KIAA0722 | sPsPPCsssPsPsGRAGPFSsSRCGASVPIPVPTQVQNYQR |
| O75400 | T948 | Sugiyama | PRPF40A FBP11 FLAF1 FNBP3 HIP10 HYPA HSPC225 | GNWDtsGsELsEGELEKRRRtLLEQLDDDQ___________ |
| O75469 | T408 | EPSD|PSP | NR1I2 PXR | FLFLKIMAMLTELRSINAQHtQRLLRIQDIHPFAtPLMQEL |
| O75643 | S26 | Sugiyama | SNRNP200 ASCC3L1 BRR2 HELIC2 KIAA0788 | ARsLQYEYKANsNLVLQADRsLIDRTRRDEPTGEVLsLVGK |
| O75689 | S87 | SIGNOR|iPTMNet|EPSD|PSP | ADAP1 CENTA1 | EAQVEFMASHGNDAARARFEsKVPSFYYRPTPSDCQLLREQ |
| O75689 | T276 | SIGNOR|iPTMNet|EPSD|PSP | ADAP1 CENTA1 | EGYMEKTGPKQTEGFRKRWFtMDDRRLMYFKDPLDAFARGE |
| O75955 | S315 | PSP | FLOT1 | ERLAEAEKSQLIMQAEAEAAsVRMRGEAEAFAIGARARAEA |
| O76090 | S358 | EPSD|PSP | BEST1 VMD2 | WNKPEPQPPYTAASAQFRRAsFMGSTFNISLNKEEMEFQPN |
| O94759 | S39 | PSP | TRPM2 EREG1 KNP3 LTRPC2 TRPC7 | GLPRRVTDLGMVSNLRRSNssLFKSWRLQCPFGNNDKQESL |
| O94806 | S731 | EPSD|PSP | PRKD3 EPK2 PRKCN | EPFPQVKLCDFGFARIIGEKsFRRsVVGtPAyLAPEVLRSK |
| O94901 | S113 | SIGNOR | SUN1 KIAA0810 UNC84A | QRRSTNKSAFSINHVSRQVTsSGVSHGGTVSLQDAVTRRPP |
| O94901 | S55 | EPSD|PSP | SUN1 KIAA0810 UNC84A | DFETEHKLDPVFDsPRMSRRsLRLATTACTLGDGEAVGADS |
| O94992 | S158 | EPSD | HEXIM1 CLP1 EDG1 HIS1 MAQ1 | EEEWGQQQRQLGKKKHRRRPsKKKRHWKPYYKLTWEEKKKF |
| O95243 | S165 | SIGNOR|EPSD|PSP | MBD4 MED1 | VLSKRGIKSRYKDCSMAALTsHLQNQSNNSNWNLRTRSKCK |
| O95243 | S262 | SIGNOR|EPSD|PSP | MBD4 MED1 | PIKKTKKGCRKsCSGFVQSDsKRESVCNKADAESEPVAQKS |
| O95471 | S204 | EPSD|PSP | CLDN7 CEPTRL2 CPETRL2 | CSCPGNESKAGYRVPRSYPKsNssKEYV_____________ |
| O95644 | S245 | EPSD | NFATC1 NFAT2 NFATC | LGACtLLGsPRHsPstsPRAsVTEESWLGARssRPAsPCNK |
| O95644 | S256 | iPTMNet|EPSD | NFATC1 NFAT2 NFATC | HsPstsPRAsVTEESWLGARssRPAsPCNKRKYsLNGRQPP |
| O95644 | S269 | EPSD | NFATC1 NFAT2 NFATC | ESWLGARssRPAsPCNKRKYsLNGRQPPysPHHsPtPSPHG |
| O95644 | S294 | SIGNOR|EPSD | NFATC1 NFAT2 NFATC | QPPysPHHsPtPSPHGsPRVsVTDDSWLGNTTQYTSSAIVA |
| O95678 | S162 | Sugiyama | KRT75 K6HF KB18 | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWA |
| O95714 | S2928 | Sugiyama | HERC2 | ILLGRIRAEEEDLAAVPFLAsDNEEEEDEKGNSGsLIRKKA |
| O95757 | S587 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | RLNQTLKKGKVKsIDLPIQssLCRQLGQDLLNsyIENEGKM |
| O95786 | S8 | EPSD|PSP | RIGI DDX58 | _____________MTTEQRRsLQAFQDYIRKTLDPTYILSY |
| O95786 | T170 | EPSD|PSP | RIGI DDX58 | AGAEKLVECLLRSDKENWPKtLKLALEKERNKFSELWIVEK |
| O95832 | T191 | PSP | CLDN1 CLD1 SEMP1 UNQ481/PRO944 | AASLCLLGGALLCCSCPRKTtSYPTPRPYPKPAPSSGKDyV |
| O96004 | S109 | SIGNOR|ELM|iPTMNet|EPSD | HAND1 BHLHA27 EHAND | GGRLGRRKGsGPKKERRRtEsINSAFAELRECIPNVPADTK |
| O96004 | S98 | SIGNOR|ELM|iPTMNet|EPSD | HAND1 BHLHA27 EHAND | PGQSPGRLEALGGRLGRRKGsGPKKERRRtEsINSAFAELR |
| O96004 | T107 | SIGNOR|ELM|iPTMNet|EPSD | HAND1 BHLHA27 EHAND | ALGGRLGRRKGsGPKKERRRtEsINSAFAELRECIPNVPAD |
| P00338 | S161 | Sugiyama | LDHA PIG19 | DILTYVAWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVH |
| P00338 | S167 | Sugiyama | LDHA PIG19 | AWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVHPLSCHG |
| P00491 | S176 | Sugiyama | PNP NP | GDRFPAMsDAyDRtMRQRALstWKQMGEQRELQEGTYVMVA |
| P00533 | T678 | GPS6|SIGNOR|ELM|EPSD|PSP | EGFR ERBB ERBB1 HER1 | LVVALGIGLFMRRRHIVRKRtLRRLLQERELVEPLtPsGEA |
| P00558 | S415 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | GGGAsLELLEGKVLPGVDALsNI__________________ |
| P00749 | S158 | GPS6|ELM|EPSD|PSP | PLAU | GLKLLVQECMVHDCADGKKPsSPPEELKFQCGQKTLRPRFK |
| P00749 | S323 | GPS6|ELM|EPSD|PSP | PLAU | MYNDPQFGTSCEITGFGKENsTDYLYPEQLKMTVVKLISHR |
| P01589 | S268 | SIGNOR|ELM|EPSD|PSP | IL2RA | FLLISVLLLSGLTWQRRQRKsRRtI________________ |
| P01589 | T271 | SIGNOR|ELM|EPSD|PSP | IL2RA | ISVLLLSGLTWQRRQRKsRRtI___________________ |
| P01730 | S433 | EPSD|PSP | CD4 | GLGIFFCVRCRHRRRQAERMsQIKRLLsEKKTCQCPHRFQK |
| P01730 | S440 | EPSD|PSP | CD4 | VRCRHRRRQAERMsQIKRLLsEKKTCQCPHRFQKTCSPI__ |
| P02538 | S176 | Sugiyama | KRT6A K6A KRT6D | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWT |
| P02545 | S403 | SIGNOR|ELM|iPTMNet|EPSD | LMNA LMN1 | EEERLRLsPsPtsQRsRGRAssHssQtQGGGsVtKKRKLEs |
| P02545 | S404 | SIGNOR|ELM|iPTMNet|EPSD | LMNA LMN1 | EERLRLsPsPtsQRsRGRAssHssQtQGGGsVtKKRKLEst |
| P02545 | S437 | Sugiyama | LMNA LMN1 | KKRKLEstEsRssFsQHARtsGRVAVEEVDEEGKFVRLRNK |
| P02545 | S5 | ELM | LMNA LMN1 | ________________METPsQRRAtRsGAQAsstPLsPtR |
| P02545 | S525 | SIGNOR|iPTMNet|EPSD | LMNA LMN1 | tHsPPTDLVWKAQNtWGCGNsLRtALINstGEEVAMRKLVR |
| P02545 | S625 | ELM | LMNA LMN1 | AQVGGPIssGssAssVtVtRsYRsVGGsGGGsFGDNLVtRS |
| P02545 | T19 | iPTMNet|EPSD | LMNA LMN1 | __METPsQRRAtRsGAQAsstPLsPtRItRLQEKEDLQELN |
| P02545 | T199 | ELM | LMNA LMN1 | AKKQLQDEMLRRVDAENRLQtMKEELDFQKNIysEELREtK |
| P02545 | T416 | ELM | LMNA LMN1 | QRsRGRAssHssQtQGGGsVtKKRKLEstEsRssFsQHARt |
| P02545 | T480 | ELM | LMNA LMN1 | EDQsMGNWQIKRQNGDDPLLtYRFPPKFTLKAGQVVTIWAA |
| P02671 | S576 | ELM | FGA | NtKEsssHHPGIAEFPsRGKsssYSKQFTssTSYNRGDstF |
| P02671 | S577 | ELM | FGA | tKEsssHHPGIAEFPsRGKsssYSKQFTssTSYNRGDstFE |
| P02671 | S578 | ELM | FGA | KEsssHHPGIAEFPsRGKsssYSKQFTssTSYNRGDstFES |
| P02671 | S618 | ELM | FGA | SKSYKMADEAGsEADHEGTHsTKRGHAKSRPVRDCDDVLQT |
| P02686 | S141 | SIGNOR|EPSD | MBP | QEDSAATSESLDVMASQKRPsQRHGsKyLATAstMDHARHG |
| P02686 | S146 | SIGNOR|EPSD | MBP | ATSESLDVMASQKRPsQRHGsKyLATAstMDHARHGFLPRH |
| P02686 | S190 | SIGNOR|EPSD | MBP | GILDsIGRFFGGDRGAPKRGsGKDSHHPARTAHyGsLPQKS |
| P02686 | S249 | SIGNOR|EPSD | MBP | tPRtPPPSQGKGRGLSLSRFsWGAEGQRPGFGYGGRAsDYK |
| P02686 | S266 | SIGNOR|EPSD | MBP | SRFsWGAEGQRPGFGYGGRAsDYKSAHKGFKGVDAQGtLsK |
| P02686 | S285 | SIGNOR|EPSD | MBP | AsDYKSAHKGFKGVDAQGtLsKIFKLGGRDsRSGsPMARR_ |
| P02686 | S295 | SIGNOR|EPSD | MBP | FKGVDAQGtLsKIFKLGGRDsRSGsPMARR___________ |
| P02786 | S159 | Sugiyama | TFRC | DFTGtIKLLNENsyVPREAGsQKDENLALyVENQFREFKLS |
| P02786 | S24 | GPS6|ELM|EPSD|PSP | TFRC | QARsAFsNLFGGEPLsytRFsLARQVDGDNsHVEMKLAVDE |
| P02786 | S361 | Sugiyama | TFRC | AAEKLFGNMEGDCPSDWKTDstCRMVTSESKNVKLTVSNVL |
| P02786 | T143 | Sugiyama | TFRC | yWDDLKRKLsEKLDstDFTGtIKLLNENsyVPREAGsQKDE |
| P04004 | S381 | SIGNOR|iPTMNet|EPSD|PSP | VTN | PRPsLAKKQRFRHRNRKGYRsQRGHsRGRNQNsRRPsRAtW |
| P04004 | S386 | EPSD|PSP | VTN | AKKQRFRHRNRKGYRsQRGHsRGRNQNsRRPsRAtWLsLFs |
| P04004 | S393 | EPSD|PSP | VTN | HRNRKGYRsQRGHsRGRNQNsRRPsRAtWLsLFssEEsNLG |
| P04004 | S397 | EPSD|PSP | VTN | KGYRsQRGHsRGRNQNsRRPsRAtWLsLFssEEsNLGANNY |
| P04049 | S233 | SIGNOR | RAF1 RAF | TMRRMRESVSRMPVssQHRystPHAFtFNtssPSSEGSLSQ |
| P04049 | S43 | SIGNOR|EPSD|PSP | RAF1 RAF | DGssCIsPtIVQQFGYQRRAsDDGKLtDPSKTSNTIRVFLP |
| P04049 | S497 | SIGNOR | RAF1 RAF | HEGLtVKIGDFGLAtVKsRWsGsQQVEQPTGSVLWMAPEVI |
| P04049 | S499 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | RAF1 RAF | GLtVKIGDFGLAtVKsRWsGsQQVEQPTGSVLWMAPEVIRM |
| P04049 | S619 | SIGNOR | RAF1 RAF | FPQILssIELLQHsLPKINRsAsEPsLHRAAHtEDINACtL |
| P04075 | S336 | Sugiyama | ALDOA ALDA | GKKENLKAAQEEYVKRALANsLACQGKytPsGQAGAAAsEs |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04083 | S27 | GPS6|SIGNOR|ELM|EPSD|PSP | ANXA1 ANX1 LPC1 | FLKQAWFIENEEQEyVQtVKssKGGPGsAVsPyPtFNPssD |
| P04083 | S28 | ELM|EPSD|PSP | ANXA1 ANX1 LPC1 | LKQAWFIENEEQEyVQtVKssKGGPGsAVsPyPtFNPssDV |
| P04083 | T24 | ELM | ANXA1 ANX1 LPC1 | VsEFLKQAWFIENEEQEyVQtVKssKGGPGsAVsPyPtFNP |
| P04259 | S176 | Sugiyama | KRT6B K6B KRTL1 | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04439 | S359 | SIGNOR|ELM|EPSD | HLA-A HLAA | RKGGsyTQAASSDSAQGSDVsLTACKV______________ |
| P04626 | T686 | EPSD|PSP | ERBB2 HER2 MLN19 NEU NGL | VLGVVFGILIKRRQQKIRKYtMRRLLQETELVEPLtPsGAM |
| P04637 | S371 | SIGNOR|iPTMNet|EPSD|PSP | TP53 P53 | KDAQAGKEPGGSRAHssHLKsKKGQstsRHKKLMFKtEGPD |
| P04637 | S376 | EPSD|PSP | TP53 P53 | GKEPGGSRAHssHLKsKKGQstsRHKKLMFKtEGPDsD___ |
| P04637 | S378 | iPTMNet|EPSD|PSP | TP53 P53 | EPGGSRAHssHLKsKKGQstsRHKKLMFKtEGPDsD_____ |
| P04637 | T377 | EPSD|PSP | TP53 P53 | KEPGGSRAHssHLKsKKGQstsRHKKLMFKtEGPDsD____ |
| P04792 | S15 | PSP | HSPB1 HSP27 HSP28 | ______MTERRVPFsLLRGPsWDPFRDWyPHsRLFDQAFGL |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P04792 | S86 | Sugiyama | HSPB1 HSP27 HSP28 | PAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVNHFAP |
| P05023 | S16 | SIGNOR | ATP1A1 | _____MGKGVGRDKyEPAAVsEQGDKKGKKGKKDRDMDELK |
| P05107 | S745 | GPS6|ELM|EPSD|PSP | ITGB2 CD18 MFI7 | ALIHLSDLREyRRFEKEKLKsQWNNDNPLFKsAtttVMNPK |
| P05107 | S756 | ELM | ITGB2 CD18 MFI7 | RRFEKEKLKsQWNNDNPLFKsAtttVMNPKFAES_______ |
| P05107 | T758 | GPS6|SIGNOR|ELM|EPSD|PSP | ITGB2 CD18 MFI7 | FEKEKLKsQWNNDNPLFKsAtttVMNPKFAES_________ |
| P05107 | T760 | GPS6|SIGNOR|ELM|EPSD|PSP | ITGB2 CD18 MFI7 | KEKLKsQWNNDNPLFKsAtttVMNPKFAES___________ |
| P05114 | S21 | SIGNOR|ELM|iPTMNet|EPSD | HMGN1 HMG14 | MPKRKVssAEGAAKEEPKRRsARLsAKPPAKVEAKPKKAAA |
| P05114 | S25 | SIGNOR|ELM|iPTMNet|EPSD | HMGN1 HMG14 | KVssAEGAAKEEPKRRsARLsAKPPAKVEAKPKKAAAKDKS |
| P05114 | S7 | iPTMNet|EPSD | HMGN1 HMG14 | ______________MPKRKVssAEGAAKEEPKRRsARLsAK |
| P05204 | S25 | SIGNOR|iPTMNet|EPSD | HMGN2 HMG17 | KAEGDAKGDKAKVKDEPQRRsARLsAKPAPPKPEPKPKKAP |
| P05204 | S29 | SIGNOR|iPTMNet|EPSD | HMGN2 HMG17 | DAKGDKAKVKDEPQRRsARLsAKPAPPKPEPKPKKAPAKKG |
| P05455 | S325 | Sugiyama | SSB | VLEGEVEKEALKKIIEDQQEsLNKWKSKGRRFKGKGKGNKA |
| P05455 | S94 | Sugiyama | SSB | KSKAELMEIsEDKTKIRRsPsKPLPEVTDEyKNDVKNRsVY |
| P05556 | S785 | EPSD|PSP | ITGB1 FNRB MDF2 MSK12 | KFEKEKMNAKWDtGENPIyKsAVttVVNPKyEGK_______ |
| P05783 | S53 | SIGNOR|ELM|iPTMNet|EPSD | KRT18 CYK18 PIG46 | AsVyAGAGGsGsRIsVsRstsFRGGMGsGGLAtGIAGGLAG |
| P05783 | S93 | Sugiyama | KRT18 CYK18 PIG46 | GMGGIQNEKETMQsLNDRLAsyLDRVRSLETENRRLESKIR |
| P05787 | S104 | Sugiyama | KRT8 CYK8 | IQAVRTQEKEQIKTLNNKFAsFIDKVRFLEQQNKMLETKWS |
| P05787 | S410 | Sugiyama | KRT8 CYK8 | TYRKLLEGEESRLEsGMQNMsIHtKTTSGYAGGLSSAYGGL |
| P06127 | T434 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | CD5 LEU1 | QRQWIGPTGMNQNMsFHRNHtAtVRsHAENPtASHVDNEys |
| P06127 | T436 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | CD5 LEU1 | QWIGPTGMNQNMsFHRNHtAtVRsHAENPtASHVDNEysQP |
| P06213 | S1062 | GPS6|SIGNOR|ELM|EPSD|PSP | INSR | ARDIIKGEAETRVAVKTVNEsAsLRERIEFLNEAsVMKGFT |
| P06213 | S1064 | GPS6|SIGNOR|ELM|EPSD|PSP | INSR | DIIKGEAETRVAVKTVNEsAsLRERIEFLNEAsVMKGFTCH |
| P06213 | T1362 | SIGNOR|EPSD | INSR | GRDGGSsLGFKRsyEEHIPytHMNGGKKNGRILtLPRSNPS |
| P06213 | T1375 | GPS6|ELM|EPSD | INSR | yEEHIPytHMNGGKKNGRILtLPRSNPS_____________ |
| P06239 | S42 | SIGNOR|iPTMNet|EPSD|PSP | LCK | NCHYPIVPLDGKGTLLIRNGsEVRDPLVTYEGsNPPAsPLQ |
| P06401 | S400 | PSP | PGR NR3C3 | FQPPALKIKEEEEGAEASARsPRSYLVAGANPAAFPDFPLG |
| P06730 | S209 | SIGNOR|iPTMNet|EPSD | EIF4E EIF4EL1 EIF4F | LPPKIVIGyQsHADTAtKsGsttKNRFVV____________ |
| P06748 | S227 | ELM | NPM1 NPM | SNQNGKDsKPsstPRsKGQEsFKKQEKtPKtPKGPssVEDI |
| P07195 | S162 | Sugiyama | LDHB | DILTYVTWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIH |
| P07195 | S168 | Sugiyama | LDHB | TWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIHPSSCHG |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07307 | S12 | ELM | ASGR2 CLEC4H2 | _________MAKDFQDIQQLsSEENDHPFHQGEGPGTRRLN |
| P07355 | S12 | EPSD|PSP | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | _________MstVHEILCKLsLEGDHstPPsAyGsVKAytN |
| P07355 | S26 | GPS6|SIGNOR|ELM|EPSD|PSP|Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | EILCKLsLEGDHstPPsAyGsVKAytNFDAERDALNIEtAI |
| P07437 | S75 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | tGGKyVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| P07737 | T65 | Sugiyama | PFN1 | PAEVGVLVGKDRssFyVNGLtLGGQKCsVIRDsLLQDGEFs |
| P07737 | Y60 | Sugiyama | PFN1 | FVNITPAEVGVLVGKDRssFyVNGLtLGGQKCsVIRDsLLQ |
| P07814 | S330 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | KHRKNPIEKNLQMWEEMKKGsQFGQsCCLRAKIDMSSNNGC |
| P07814 | S739 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | TKVEATKNETSAPFKERPtPsLNNNCttsEDsLVLyNRVAV |
| P07864 | S161 | Sugiyama | LDHC LDH3 LDHX | DILTYIVWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVH |
| P07864 | S167 | Sugiyama | LDHC LDH3 LDHX | VWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVHPTSCHG |
| P07949 | T675 | EPSD|PSP | RET CDHF12 CDHR16 PTC | FCIHCYHKFAHKPPISSAEMtFRRPAQAFPVsysssGARRP |
| P08034 | S229 | SIGNOR|ELM|iPTMNet|EPSD | GJB1 CX32 | VVYLIIRACARRAQRRSNPPsRKGsGFGHRLSPEyKQNEIN |
| P08034 | S233 | SIGNOR|ELM|iPTMNet|EPSD | GJB1 CX32 | IIRACARRAQRRSNPPsRKGsGFGHRLSPEyKQNEINKLLS |
| P08100 | S334 | SIGNOR|iPTMNet|EPSD | RHO OPN2 | RNCMLTTICCGKNPLGDDEAsAtVsKtETsQVAPA______ |
| P08100 | S338 | SIGNOR | RHO OPN2 | LTTICCGKNPLGDDEAsAtVsKtETsQVAPA__________ |
| P08100 | S343 | SIGNOR | RHO OPN2 | CGKNPLGDDEAsAtVsKtETsQVAPA_______________ |
| P08100 | T336 | SIGNOR|iPTMNet|EPSD | RHO OPN2 | CMLTTICCGKNPLGDDEAsAtVsKtETsQVAPA________ |
| P08183 | S661 | ELM|EPSD|PSP | ABCB1 MDR1 PGY1 | ADESKSEIDALEMssNDsRssLIRKRsTRRsVRGSQAQDRK |
| P08183 | S667 | ELM|EPSD|PSP | ABCB1 MDR1 PGY1 | EIDALEMssNDsRssLIRKRsTRRsVRGSQAQDRKLsTKEA |
| P08183 | S671 | ELM|EPSD|PSP | ABCB1 MDR1 PGY1 | LEMssNDsRssLIRKRsTRRsVRGSQAQDRKLsTKEALDES |
| P08195 | S253 | Sugiyama | SLC3A2 MDU1 | FQGHGAGNLAGLKGRLDyLssLKVKGLVLGPIHKNQKDDVA |
| P08195 | S296 | Sugiyama | SLC3A2 MDU1 | DLLQIDPNFGsKEDFDsLLQsAKKKSIRVILDLTPNYRGEN |
| P08238 | S482 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | sGDEMtsLsEyVsRMKEtQKsIyyItGEsKEQVANsAFVER |
| P08238 | T637 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MGyMMAKKHLEINPDHPIVEtLRQKAEADKNDKAVKDLVVL |
| P08253 | S160 | EPSD|PSP | MMP2 CLG4A | VDDAFARAFQVWSDVTPLRFsRIHDGEADIMINFGRWEHGD |
| P08253 | S365 | EPSD|PSP | MMP2 CLG4A | EGAPCVFPFTFLGNKYESCTsAGRSDGKMWCAttANYDDDR |
| P08253 | T250 | EPSD|PSP | MMP2 CLG4A | GEYCKFPFLFNGKEYNSCTDtGRSDGFLWCSTTYNFEKDGK |
| P08253 | T377 | EPSD|PSP | MMP2 CLG4A | GNKYESCTsAGRSDGKMWCAttANYDDDRKWGFCPDQGYSL |
| P08253 | T378 | EPSD|PSP | MMP2 CLG4A | NKYESCTsAGRSDGKMWCAttANYDDDRKWGFCPDQGYSLF |
| P08567 | S113 | GPS6|SIGNOR|ELM|EPSD|PSP | PLEK P47 | VRDIKKAIKCIEGGQKFARKstRRsIRLPEtIDLGALYLsM |
| P08567 | S117 | GPS6|SIGNOR|ELM|EPSD|PSP | PLEK P47 | KKAIKCIEGGQKFARKstRRsIRLPEtIDLGALYLsMKDTE |
| P08567 | T114 | ELM | PLEK P47 | RDIKKAIKCIEGGQKFARKstRRsIRLPEtIDLGALYLsMK |
| P08581 | S985 | SIGNOR|ELM|EPSD|PSP | MET | GsELVRYDARVHtPHLDRLVsARsVsPttEMVsNEsVDyRA |
| P08670 | S10 | SIGNOR|iPTMNet|EPSD|PSP | VIM | ___________MstRsVssssYRRMFGGPGtAsRPsssRsY |
| P08670 | S22 | SIGNOR | VIM | stRsVssssYRRMFGGPGtAsRPsssRsYVttsTRtYsLGs |
| P08670 | S25 | iPTMNet|EPSD | VIM | sVssssYRRMFGGPGtAsRPsssRsYVttsTRtYsLGsALR |
| P08670 | S26 | SIGNOR|iPTMNet|EPSD | VIM | VssssYRRMFGGPGtAsRPsssRsYVttsTRtYsLGsALRP |
| P08670 | S27 | SIGNOR | VIM | ssssYRRMFGGPGtAsRPsssRsYVttsTRtYsLGsALRPs |
| P08670 | S34 | SIGNOR|iPTMNet|EPSD | VIM | MFGGPGtAsRPsssRsYVttsTRtYsLGsALRPstsRsLyA |
| P08670 | S39 | SIGNOR|iPTMNet|EPSD | VIM | GtAsRPsssRsYVttsTRtYsLGsALRPstsRsLyAssPGG |
| P08670 | S42 | SIGNOR|iPTMNet|EPSD | VIM | sRPsssRsYVttsTRtYsLGsALRPstsRsLyAssPGGVyA |
| P08670 | S5 | EPSD|PSP | VIM | ________________MstRsVssssYRRMFGGPGtAsRPs |
| P08670 | S51 | SIGNOR | VIM | VttsTRtYsLGsALRPstsRsLyAssPGGVyAtRssAVRLR |
| P08670 | S66 | SIGNOR | VIM | PstsRsLyAssPGGVyAtRssAVRLRssVPGVRLLQDsVDF |
| P08670 | S7 | SIGNOR|iPTMNet|EPSD|PSP | VIM | ______________MstRsVssssYRRMFGGPGtAsRPsss |
| P08670 | S8 | EPSD|PSP | VIM | _____________MstRsVssssYRRMFGGPGtAsRPsssR |
| P08670 | S9 | SIGNOR|iPTMNet|EPSD|PSP | VIM | ____________MstRsVssssYRRMFGGPGtAsRPsssRs |
| P08684 | S100 | EPSD|PSP | CYP3A4 CYP3A3 | PVLAITDPDMIKtVLVKECYsVFtNRRPFGPVGFMKsAIsI |
| P08684 | S116 | EPSD|PSP | CYP3A4 CYP3A3 | KECYsVFtNRRPFGPVGFMKsAIsIAEDEEWKRLRsLLsPt |
| P08684 | S119 | EPSD|PSP | CYP3A4 CYP3A3 | YsVFtNRRPFGPVGFMKsAIsIAEDEEWKRLRsLLsPtFts |
| P08684 | S131 | EPSD|PSP | CYP3A4 CYP3A3 | VGFMKsAIsIAEDEEWKRLRsLLsPtFtsGKLKEMVPIIAQ |
| P08684 | S134 | EPSD|PSP | CYP3A4 CYP3A3 | MKsAIsIAEDEEWKRLRsLLsPtFtsGKLKEMVPIIAQYGD |
| P08684 | S139 | EPSD|PSP | CYP3A4 CYP3A3 | sIAEDEEWKRLRsLLsPtFtsGKLKEMVPIIAQYGDVLVRN |
| P08684 | S259 | EPSD|PSP | CYP3A4 CYP3A3 | CVFPREVTNFLRKSVKRMKEsRLEDtQKHRVDFLQLMIDSQ |
| P08684 | S398 | EPSD|PSP | CYP3A4 CYP3A3 | KKDVEINGMFIPKGVVVMIPsYALHRDPKYWTEPEKFLPER |
| P08684 | S420 | EPSD|PSP | CYP3A4 CYP3A3 | ALHRDPKYWTEPEKFLPERFsKKNKDNIDPYIYTPFGSGPR |
| P08684 | T103 | EPSD|PSP | CYP3A4 CYP3A3 | AITDPDMIKtVLVKECYsVFtNRRPFGPVGFMKsAIsIAED |
| P08684 | T136 | EPSD|PSP | CYP3A4 CYP3A3 | sAIsIAEDEEWKRLRsLLsPtFtsGKLKEMVPIIAQYGDVL |
| P08684 | T264 | EPSD|PSP | CYP3A4 CYP3A3 | EVTNFLRKSVKRMKEsRLEDtQKHRVDFLQLMIDSQNSKEt |
| P08684 | T284 | EPSD|PSP | CYP3A4 CYP3A3 | tQKHRVDFLQLMIDSQNSKEtESHKALSDLELVAQSIIFIF |
| P08684 | T92 | EPSD|PSP | CYP3A4 CYP3A3 | WGFYDGQQPVLAITDPDMIKtVLVKECYsVFtNRRPFGPVG |
| P08729 | S104 | Sugiyama | KRT7 SCL | LQRVRQEESEQIKTLNNKFAsFIDKVRFLEQQNKLLETKWT |
| P08754 | S153 | Sugiyama | GNAI3 | DGGVQACFSRsREYQLNDSAsyyLNDLDRISQSNyIPTQQD |
| P08833 | S123 | PSP | IGFBP1 IBP1 | ACVQESDASAPHAAEAGSPEsPEsTEITEEELLDNFHLMAP |
| P08833 | S126 | EPSD|PSP | IGFBP1 IBP1 | QESDASAPHAAEAGSPEsPEsTEITEEELLDNFHLMAPsEE |
| P08833 | S144 | EPSD|PSP | IGFBP1 IBP1 | PEsTEITEEELLDNFHLMAPsEEDHSILWDAISTYDGSKAL |
| P08833 | S194 | EPSD|PSP | IGFBP1 IBP1 | EPCRIELYRVVESLAKAQETsGEEIsKFYLPNCNKNGFYHS |
| P09038 | S206 | GPS6|EPSD | FGF2 FGFB | REKSDPHIKLQLQAEERGVVsIKGVCANRyLAMKEDGRLLA |
| P09211 | S185 | SIGNOR|EPSD|PSP | GSTP1 FAEES3 GST3 | VLAPGCLDAFPLLSAYVGRLsARPKLKAFLASPEyVNLPIN |
| P09211 | S43 | SIGNOR | GSTP1 FAEES3 GST3 | ADQGQSWKEEVVTVETWQEGsLKASCLyGQLPKFQDGDLtL |
| P09382 | T58 | Sugiyama | LGALS1 | DsNNLCLHFNPRFNAHGDANtIVCNsKDGGAWGTEQREAVF |
| P09543 | S9 | ELM | CNP | ____________MNRGFsRKsHTFLPKIFFRKMsSSGAKDK |
| P09651 | S360 | Sugiyama | HNRNPA1 HNRPA1 | PyGGGGQyFAKPRNQGGyGGssssssyGsGRRF________ |
| P09651 | S368 | Sugiyama | HNRNPA1 HNRPA1 | FAKPRNQGGyGGssssssyGsGRRF________________ |
| P09651 | S95 | SIGNOR|Sugiyama | HNRNPA1 HNRPA1 | RPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| P09693 | S148 | ELM|EPSD|PSP | CD3G T3G | VLAVGVYFIAGQDGVRQsRAsDKQTLLPNDQLyQPLKDRED |
| P09758 | S303 | GPS6|ELM|EPSD|PSP | TACSTD2 GA733-1 M1S1 TROP2 | VVVVALVAGMAVLVITNRRKsGKYKKVEIKELGELRKEPsL |
| P09758 | S322 | SIGNOR|PSP | TACSTD2 GA733-1 M1S1 TROP2 | KsGKYKKVEIKELGELRKEPsL___________________ |
| P0CG38 | S1068 | Sugiyama | POTEI | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0CG39 | S1031 | Sugiyama | POTEJ | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P10275 | S579 | EPSD|PSP | AR DHTR NR3C4 | TCLICGDEASGCHYGALTCGsCKVFFKRAAEGKQKYLCASR |
| P10276 | S157 | GPS6 | RARA NR1B1 | RNRCQYCRLQKCFEVGMSKEsVRNDRNKKKKEVPKPECSES |
| P10415 | S24 | iPTMNet|EPSD | BCL2 | AGRTGYDNREIVMKYIHYKLsQRGYEWDAGDVGAAPPGAAP |
| P10415 | S70 | GPS6|SIGNOR|EPSD|PSP | BCL2 | SSQPGHtPHPAASRDPVARtsPLQtPAAPGAAAGPALsPVP |
| P10588 | S83 | EPSD|PSP | NR2F6 EAR2 ERBAL2 | SSGKHYGVFTCEGCKSFFKRsIRRNLSYTCRSNRDCQIDQH |
| P10599 | T100 | EPSD|PSP | TXN TRDX TRX TRX1 | FKKGQKVGEFSGANKEKLEAtINELV_______________ |
| P10721 | S741 | GPS6|SIGNOR|ELM|EPSD|PSP | KIT SCFR | yMDMKPGVsyVVPTKADKRRsVRIGsyIERDVTPAIMEDDE |
| P10721 | S746 | GPS6|SIGNOR|ELM|EPSD|PSP | KIT SCFR | PGVsyVVPTKADKRRsVRIGsyIERDVTPAIMEDDELALDL |
| P10721 | S821 | GPS6|SIGNOR|ELM|EPSD | KIT SCFR | THGRITKICDFGLARDIKNDsNyVVKGNARLPVKWMAPESI |
| P10721 | S959 | GPS6|SIGNOR|ELM|EPSD | KIT SCFR | LANCsPNRQKPVVDHSVRINsVGstAsSSQPLLVHDDV___ |
| P11142 | S153 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | AyLGKtVTNAVVtVPAyFNDsQRQAtKDAGtIAGLNVLRII |
| P11142 | S340 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | ALRDAKLDKsQIHDIVLVGGstRIPKIQKLLQDFFNGKELN |
| P11142 | S40 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P11142 | T158 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | tVTNAVVtVPAyFNDsQRQAtKDAGtIAGLNVLRIINEPtA |
| P11142 | T163 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VVtVPAyFNDsQRQAtKDAGtIAGLNVLRIINEPtAAAIAy |
| P11234 | S198 | SIGNOR|EPSD|PSP | RALB | TKKMSENKDKNGKKSSKNKKsFKERCCLL____________ |
| P11387 | S21 | SIGNOR|EPSD|PSP | TOP1 | MsGDHLHNDsQIEADFRLNDsHKHKDKHKDREHRHKEHKKE |
| P11388 | S29 | ELM|iPTMNet|EPSD | TOP2A TOP2 | VNENMQVNKIKKNEDAKKRLsVERIYQKKTQLEHILLRPDT |
| P11473 | S51 | EPSD|PSP | VDR NR1I1 | ATGFHFNAMTCEGCKGFFRRsMKRKALFTCPFNGDCRITKD |
| P11831 | S162 | SIGNOR|EPSD|PSP | SRF | GRVKIKMEFIDNKLRRYttFsKRKTGIMKKAYELSTLTGTQ |
| P11831 | T159 | GPS6|SIGNOR|ELM|EPSD|PSP | SRF | KTRGRVKIKMEFIDNKLRRYttFsKRKTGIMKKAYELSTLT |
| P12035 | S211 | Sugiyama | KRT3 | IGQVKAQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWN |
| P12931 | S12 | SIGNOR|iPTMNet|EPSD | SRC SRC1 | _________MGSNKSKPKDAsQRRRsLEPAENVHGAGGGAF |
| P12956 | S77 | PSP | XRCC6 G22P1 | LTPFDMSIQCIQSVYISKIIssDRDLLAVVFYGTEKDKNSV |
| P12956 | S78 | PSP | XRCC6 G22P1 | TPFDMSIQCIQSVYISKIIssDRDLLAVVFYGTEKDKNSVN |
| P13498 | T147 | SIGNOR|EPSD|PSP | CYBA | RGEQWTPIEPKPRERPQIGGtIKQPPsNPPPRPPAEARKKP |
| P13569 | S641 | PSP | CFTR ABCC7 | EGSSYFYGTFSELQNLQPDFsSKLMGCDSFDQFSAERRNsI |
| P13569 | S660 | EPSD|PSP | CFTR ABCC7 | FsSKLMGCDSFDQFSAERRNsILTETLHRFsLEGDAPVSWT |
| P13569 | S686 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | CFTR ABCC7 | LHRFsLEGDAPVSWTEtKKQsFKQTGEFGEKRKNsILNPIN |
| P13569 | S737 | EPSD|PSP | CFTR ABCC7 | TPLQMNGIEEDSDEPLERRLsLVPDSEQGEAILPRIsVIST |
| P13569 | S790 | SIGNOR|ELM|iPTMNet|EPSD | CFTR ABCC7 | LNLMTHSVNQGQNIHRKTTAsTRKVsLAPQANLTELDIYsR |
| P13569 | S795 | EPSD|PSP | CFTR ABCC7 | HSVNQGQNIHRKTTAsTRKVsLAPQANLTELDIYsRRLsQE |
| P13569 | S813 | EPSD|PSP | CFTR ABCC7 | KVsLAPQANLTELDIYsRRLsQEtGLEISEEINEEDLKECF |
| P13569 | T682 | PSP | CFTR ABCC7 | LTETLHRFsLEGDAPVSWTEtKKQsFKQTGEFGEKRKNsIL |
| P13639 | S23 | Sugiyama | EEF2 EF2 | NFtVDQIRAIMDKKANIRNMsVIAHVDHGKStLtDsLVCKA |
| P13639 | S38 | Sugiyama | EEF2 EF2 | NIRNMsVIAHVDHGKStLtDsLVCKAGIIAsARAGEtRFtD |
| P13639 | S593 | Sugiyama | EEF2 EF2 | SDPVVsyREtVsEEsNVLCLsKsPNKHNRLyMKARPFPDGL |
| P13639 | S732 | Sugiyama | EEF2 EF2 | DAIHRGGGQIIPtARRCLyAsVLtAQPRLMEPIyLVEIQCP |
| P13647 | S181 | Sugiyama | KRT5 | IQRVRTEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P13726 | S285 | SIGNOR|ELM|EPSD|PSP | F3 | ILVIILAISLHKCRKAGVGQsWKENsPLNVs__________ |
| P13726 | S290 | ELM|EPSD|PSP | F3 | LAISLHKCRKAGVGQsWKENsPLNVs_______________ |
| P13796 | S5 | PSP | LCP1 PLS2 | ________________MARGsVsDEEMMELREAFAKVDtDG |
| P13861 | S99 | Sugiyama | PRKAR2A PKR2 PRKAR2 | EsEEDEDLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVI |
| P13987 | T76 | Sugiyama | CD59 MIC11 MIN1 MIN2 MIN3 MSK21 | AGLQVYNKCWKFEHCNFNDVtTRLRENELtyyCCKKDLCNF |
| P14136 | S13 | SIGNOR|ELM|iPTMNet|EPSD | GFAP | ________MERRRItsAARRsYVssGEMMVGGLAPGRRLGP |
| P14136 | S17 | ELM|iPTMNet|EPSD | GFAP | ____MERRRItsAARRsYVssGEMMVGGLAPGRRLGPGTRL |
| P14136 | S38 | SIGNOR|ELM|iPTMNet|EPSD | GFAP | GEMMVGGLAPGRRLGPGTRLsLARMPPPLPTRVDFSLAGAL |
| P14314 | S126 | Sugiyama | PRKCSH G19P1 | yNsGVICENtCKEKGRKEREsLQQMAEVtREGFRLKKILIE |
| P14314 | T479 | Sugiyama | PRKCSH G19P1 | KFSAMKyEQGtGCWQGPNRstTVRLLCGKEtMVtStTEPSR |
| P14416 | S228 | PSP | DRD2 | VYIKIYIVLRRRRKRVNtKRssRAFRAHLRAPLKGNCTHPE |
| P14416 | S229 | PSP | DRD2 | YIKIYIVLRRRRKRVNtKRssRAFRAHLRAPLKGNCTHPED |
| P14598 | S303 | GPS6|SIGNOR|ELM|EPSD|PSP | NCF1 NOXO2 SH3PXD1A | sGQDVsQAQRQIKRGAPPRRssIRNAHsIHQRsRKRLsQDA |
| P14598 | S304 | GPS6|SIGNOR|ELM|EPSD|PSP | NCF1 NOXO2 SH3PXD1A | GQDVsQAQRQIKRGAPPRRssIRNAHsIHQRsRKRLsQDAY |
| P14598 | S315 | GPS6|SIGNOR|ELM|EPSD|PSP | NCF1 NOXO2 SH3PXD1A | KRGAPPRRssIRNAHsIHQRsRKRLsQDAYRRNsVRFLQQR |
| P14598 | S320 | GPS6|SIGNOR|ELM|EPSD|PSP | NCF1 NOXO2 SH3PXD1A | PRRssIRNAHsIHQRsRKRLsQDAYRRNsVRFLQQRRRQAR |
| P14598 | S328 | GPS6|SIGNOR|ELM|EPSD|PSP | NCF1 NOXO2 SH3PXD1A | AHsIHQRsRKRLsQDAYRRNsVRFLQQRRRQARPGPQsPGs |
| P14598 | S348 | GPS6|ELM|EPSD | NCF1 NOXO2 SH3PXD1A | sVRFLQQRRRQARPGPQsPGsPLEEERQtQRsKPQPAVPPR |
| P14598 | S359 | GPS6|SIGNOR|ELM|EPSD|PSP | NCF1 NOXO2 SH3PXD1A | ARPGPQsPGsPLEEERQtQRsKPQPAVPPRPsADLILNRCs |
| P14598 | S370 | GPS6|SIGNOR|ELM|EPSD|PSP | NCF1 NOXO2 SH3PXD1A | LEEERQtQRsKPQPAVPPRPsADLILNRCsESTKRKLASAV |
| P14598 | S379 | GPS6|SIGNOR|EPSD|PSP | NCF1 NOXO2 SH3PXD1A | sKPQPAVPPRPsADLILNRCsESTKRKLASAV_________ |
| P14618 | S205 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | VKQKGADFLVtEVENGGsLGsKKGVNLPGAAVDLPAVsEKD |
| P14625 | S514 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | LGVIEDHsNRtRLAKLLRFQssHHPtDItsLDQyVERMKEK |
| P14625 | S515 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | GVIEDHsNRtRLAKLLRFQssHHPtDItsLDQyVERMKEKQ |
| P14625 | S64 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | tDDEVVQREEEAIQLDGLNAsQIRELREKSEKFAFQAEVNR |
| P14625 | S680 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | RIMKAQAYQtGKDIstNyyAsQKKTFEINPRHPLIRDMLRR |
| P14625 | T519 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | DHsNRtRLAKLLRFQssHHPtDItsLDQyVERMKEKQDKIy |
| P15172 | T115 | SIGNOR|ELM|iPTMNet|EPSD | MYOD1 BHLHC1 MYF3 MYOD | LWACKACKRKTTNADRRKAAtMRERRRLSKVNEAFETLKRC |
| P15311 | S535 | Sugiyama | EZR VIL2 | EKRITEAEKNERVQRQLLtLssELsQARDENKRTHNDIIHN |
| P15311 | S539 | Sugiyama | EZR VIL2 | TEAEKNERVQRQLLtLssELsQARDENKRTHNDIIHNENMR |
| P15311 | T533 | Sugiyama | EZR VIL2 | NEEKRITEAEKNERVQRQLLtLssELsQARDENKRTHNDII |
| P15311 | T567 | SIGNOR|iPTMNet|EPSD|PSP | EZR VIL2 | RTHNDIIHNENMRQGRDKYKtLRQIRQGNTKQRIDEFEAL_ |
| P15328 | S79 | Sugiyama | FOLR1 FOLR | PWRKNACCSTNTSQEAHKDVsyLyRFNWNHCGEMAPACKRH |
| P15336 | S121 | EPSD|PSP | ATF2 CREB2 CREBP1 | EDDIKKMPLDLsPLAtPIIRsKIEEPsVVEttHQDsPLPHP |
| P15382 | S102 | SIGNOR|iPTMNet|EPSD | KCNE1 | IESDAWQEKDKAYVQARVLEsYRSCYVVENHLAIEQPNTHL |
| P16070 | S291 | ELM | CD44 LHR MDU2 MDU3 MIC4 | TISAGWEPNEENEDERDRHLsFSGSGIDDDEDFISSTISTT |
| P16070 | S672 | GPS6|ELM|EPSD|PSP | CD44 LHR MDU2 MDU3 MIC4 | IILASLLALALILAVCIAVNsRRRCGQKKKLVINsGNGAVE |
| P16144 | S1356 | GPS6|ELM|EPSD|PSP | ITGB4 | DAQSGEDYDSFLMYSDDVLRsPSGsQRPsVSDDTGCGWKFE |
| P16144 | S1360 | GPS6|SIGNOR|ELM|EPSD|PSP | ITGB4 | GEDYDSFLMYSDDVLRsPSGsQRPsVSDDTGCGWKFEPLLG |
| P16144 | S1364 | GPS6|ELM|EPSD|PSP | ITGB4 | DSFLMYSDDVLRsPSGsQRPsVSDDTGCGWKFEPLLGEELD |
| P16144 | S1494 | SIGNOR|EPSD|PSP | ITGB4 | sPHVPHRVLstsstLTRDyNsLtRsEHsHsttLPRDystLt |
| P16150 | S351 | GPS6|ELM|EPSD|PSP | SPN CD43 | PDGEGssRRPtLtTFFGRRKsRQGsLAMEELKsGsGPsLKG |
| P16671 | T92 | EPSD|PSP | CD36 GP3B GP4 | NPQEVMMNSSNIQVKQRGPYtYRVRFLAKENVTQDAEDNTV |
| P17066 | S42 | Sugiyama | HSPA6 HSP70B' | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P17252 | S657 | GPS6|SIGNOR|ELM|EPSD | PRKCA PKCA PRKACA | LtPPDQLVIANIDQsDFEGFsyVNPQFVHPILQSAV_____ |
| P17252 | T250 | GPS6|EPSD | PRKCA PKCA PRKACA | KLKPSDKDRRLsVEIWDWDRtTRNDFMGSLSFGVSELMKMP |
| P17252 | T638 | GPS6|SIGNOR|EPSD | PRKCA PKCA PRKACA | VCGKGAENFDKFFTRGQPVLtPPDQLVIANIDQsDFEGFsy |
| P17302 | S262 | SIGNOR | GJA1 GJAL | GKSDPyHATsGALsPAKDCGsQKyAyFNGCssPtAPLsPMs |
| P17302 | S368 | SIGNOR|iPTMNet|EPSD|PSP | GJA1 GJAL | AAGHELQPLAIVDQRPssRAssRAssRPRPDDLEI______ |
| P17302 | S372 | PSP | GJA1 GJAL | ELQPLAIVDQRPssRAssRAssRPRPDDLEI__________ |
| P17812 | S462 | SIGNOR|EPSD|PSP | CTPS1 CTPS | GQMGGTMRLGKRRtLFQTKNsVMRKLyGDADyLEERHRHRF |
| P17812 | T455 | SIGNOR|EPSD|PSP | CTPS1 CTPS | DMPEHNPGQMGGTMRLGKRRtLFQTKNsVMRKLyGDADyLE |
| P17844 | S520 | Sugiyama | DDX5 G17P1 HELR HLR1 | GKRGGFNTFRDRENYDRGYssLLKRDFGAKTQNGVYSAANY |
| P17844 | S557 | SIGNOR|ELM|iPTMNet|EPSD | DDX5 G17P1 HELR HLR1 | AANYTNGSFGSNFVSAGIQTsFRTGNPtGTYQNGYDSTQQY |
| P17987 | S374 | Sugiyama | TCP1 CCT1 CCTA | ERICDDELILIKNTKARTsAsIILRGANDFMCDEMERSLHD |
| P18031 | S378 | GPS6|ELM|EPSD|PSP | PTPN1 PTP1B | PYGIEsMsQDtEVRSRVVGGsLRGAQAAsPAKGEPsLPEKD |
| P18206 | S1101 | GPS6|SIGNOR|ELM|EPSD | VCL | DEESEQATEMLVHNAQNLMQsVKETVREAEAAsIKIRtDAG |
| P18206 | S1113 | GPS6|SIGNOR|ELM|EPSD | VCL | HNAQNLMQsVKETVREAEAAsIKIRtDAGFtLRWVRKTPWy |
| P18505 | S434 | ELM | GABRB1 | YGRALDRHGVPSKGRIRRRAsQLKVKIPDLTDVNSIDKWSR |
| P18507 | S366 | ELM|iPTMNet|EPSD | GABRG2 | VFSALVEYGTLHYFVSNRKPsKDKDKKKKNPLLRMFSFKAP |
| P18621 | S5 | Sugiyama | RPL17 | ________________MVRysLDPENPtKsCKSRGSNLRVH |
| P18669 | S155 | Sugiyama | PGAM1 PGAMA CDABP0006 | NIsKDRRyADLtEDQLPsCEsLKDtIARALPFWNEEIVPQI |
| P18669 | T159 | Sugiyama | PGAM1 PGAMA CDABP0006 | DRRyADLtEDQLPsCEsLKDtIARALPFWNEEIVPQIKEGK |
| P19021 | S929 | ELM | PAM | VLGRFRGKGsGGLNLGNFFAsRKGYsRKGFDRLstEGsDQE |
| P19021 | S934 | ELM | PAM | RGKGsGGLNLGNFFAsRKGYsRKGFDRLstEGsDQEKEDDG |
| P19086 | S16 | GPS6|SIGNOR|ELM|EPSD|PSP | GNAZ | _____MGCRQSSEEKEAARRsRRIDRHLRSEsQRQRREIKL |
| P19086 | S27 | GPS6|SIGNOR|ELM|EPSD|PSP | GNAZ | SEEKEAARRsRRIDRHLRSEsQRQRREIKLLLLGTSNSGKS |
| P19174 | S1248 | GPS6|SIGNOR|ELM|EPSD|PSP | PLCG1 PLC1 | LRERGsDASGQLFHGRAREGsFEsRyQQPFEDFRIsQEHLA |
| P19338 | S460 | Sugiyama | NCL | ADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNST |
| P19429 | S166 | SIGNOR | TNNI3 TNNC1 | RVRIsADAMMQALLGARAKEsLDLRAHLKQVKKEDTEKENR |
| P19429 | S199 | EPSD|PSP | TNNI3 TNNC1 | EDTEKENREVGDWRKNIDALsGMEGRKKKFES_________ |
| P19429 | S23 | SIGNOR|iPTMNet|EPSD|PSP | TNNI3 TNNC1 | DGSSDAAREPRPAPAPIRRRssNyRAYAtEPHAKKKsKIsA |
| P19429 | S24 | SIGNOR|iPTMNet|EPSD|PSP | TNNI3 TNNC1 | GSSDAAREPRPAPAPIRRRssNyRAYAtEPHAKKKsKIsAs |
| P19429 | S39 | SIGNOR | TNNI3 TNNC1 | IRRRssNyRAYAtEPHAKKKsKIsAsRKLQLKtLLLQIAKQ |
| P19429 | S42 | SIGNOR|iPTMNet|EPSD|PSP | TNNI3 TNNC1 | RssNyRAYAtEPHAKKKsKIsAsRKLQLKtLLLQIAKQELE |
| P19429 | S44 | SIGNOR|iPTMNet|EPSD|PSP | TNNI3 TNNC1 | sNyRAYAtEPHAKKKsKIsAsRKLQLKtLLLQIAKQELERE |
| P19429 | S77 | SIGNOR|iPTMNet|EPSD | TNNI3 TNNC1 | AKQELEREAEERRGEKGRALsTRCQPLELAGLGFAELQDLC |
| P19429 | T143 | iPTMNet|EPSD|PSP | TNNI3 TNNC1 | TEIADLtQKIFDLRGKFKRPtLRRVRIsADAMMQALLGARA |
| P20020 | T1116 | iPTMNet|EPSD | ATP2B1 PMCA1 | AERELRRGQILWFRGLNRIQtQIRVVNAFRSSLYEGLEKPE |
| P20618 | S157 | Sugiyama | PSMB1 PSC5 | IIGGLDEEGKGAVysFDPVGsyQRDsFKAGGSASAMLQPLL |
| P20618 | S162 | Sugiyama | PSMB1 PSC5 | DEEGKGAVysFDPVGsyQRDsFKAGGSASAMLQPLLDNQVG |
| P20700 | S396 | ELM | LMNB1 LMN2 LMNB | AYRKLLEGEEERLKLsPsPssRVtVsRAsssRsVRTTRGKR |
| P20700 | S406 | ELM | LMNB1 LMN2 LMNB | ERLKLsPsPssRVtVsRAsssRsVRTTRGKRKRVDVEESEA |
| P21399 | S138 | GPS6|ELM|EPSD|PSP | ACO1 IREB1 | CPADLVIDHSIQVDFNRRADsLQKNQDLEFERNRERFEFLK |
| P21399 | S711 | GPS6|SIGNOR|ELM|EPSD|PSP | ACO1 IREB1 | PAARYLTNRGLTPREFNSYGsRRGNDAVMARGTFANIRLLN |
| P21730 | S314 | GPS6|ELM|EPSD|PSP | C5AR1 C5AR C5R1 | CINPIIYVVAGQGFQGRLRKsLPsLLRNVLTEEsVVREsKs |
| P21730 | S317 | GPS6|ELM|EPSD|PSP | C5AR1 C5AR C5R1 | PIIYVVAGQGFQGRLRKsLPsLLRNVLTEEsVVREsKsFTR |
| P21730 | S327 | EPSD|PSP | C5AR1 C5AR C5R1 | FQGRLRKsLPsLLRNVLTEEsVVREsKsFTRsTVDTMAQKT |
| P21730 | S332 | GPS6|ELM|EPSD|PSP | C5AR1 C5AR C5R1 | RKsLPsLLRNVLTEEsVVREsKsFTRsTVDTMAQKTQAV__ |
| P21730 | S334 | GPS6|ELM|EPSD|PSP | C5AR1 C5AR C5R1 | sLPsLLRNVLTEEsVVREsKsFTRsTVDTMAQKTQAV____ |
| P21730 | S338 | GPS6|ELM|EPSD|PSP | C5AR1 C5AR C5R1 | LLRNVLTEEsVVREsKsFTRsTVDTMAQKTQAV________ |
| P21731 | S145 | SIGNOR|PSP | TBXA2R | AMASERYLGITRPFSRPAVAsQRRAWATVGLVWAAALALGL |
| P21731 | S324 | EPSD|PSP | TBXA2R | DPWVYILFRRAVLRRLQPRLsTRPRsLsLQPQLtQRSGLQ_ |
| P21731 | S329 | EPSD|PSP | TBXA2R | ILFRRAVLRRLQPRLsTRPRsLsLQPQLtQRSGLQ______ |
| P21731 | S331 | EPSD|PSP | TBXA2R | FRRAVLRRLQPRLsTRPRsLsLQPQLtQRSGLQ________ |
| P21731 | T337 | EPSD|PSP | TBXA2R | RRLQPRLsTRPRsLsLQPQLtQRSGLQ______________ |
| P22460 | T15 | EPSD|PSP | KCNA5 | ______MEIALVPLENGGAMtVRGGDEARAGCGQATGGELQ |
| P22626 | S212 | Sugiyama | HNRNPA2B1 HNRPA2B1 | EMQEVQssRsGRGGNFGFGDsRGGGGNFGPGPGsNFRGGsD |
| P22681 | S619 | SIGNOR|iPTMNet|EPSD | CBL CBL2 RNF55 | PVSAPSSSDPWTGRELtNRHsLPFsLPSQMEPRPDVPRLGs |
| P22681 | S623 | SIGNOR|iPTMNet|EPSD | CBL CBL2 RNF55 | PSSSDPWTGRELtNRHsLPFsLPSQMEPRPDVPRLGstFsL |
| P22681 | S639 | SIGNOR|iPTMNet|EPSD | CBL CBL2 RNF55 | sLPFsLPSQMEPRPDVPRLGstFsLDtsMsMNssPLVGPEC |
| P22681 | S642 | SIGNOR|iPTMNet|EPSD | CBL CBL2 RNF55 | FsLPSQMEPRPDVPRLGstFsLDtsMsMNssPLVGPECDHP |
| P23246 | S283 | Sugiyama | SFPQ PSF | GPGGRsEEKIsDsEGFKANLsLLRRPGEKTyTQRCRLFVGN |
| P23381 | S358 | Sugiyama | WARS1 IFI53 WARS WRS | TFFPALQGAQTKMsAsDPNssIFLtDtAKQIKTKVNKHAFs |
| P23396 | S104 | Sugiyama | RPS3 OK/SW-cl.26 | VELyAEKVAtRGLCAIAQAEsLRyKLLGGLAVRRACyGVLR |
| P23528 | S23 | SIGNOR|EPSD|PSP | CFL1 CFL | sGVAVsDGVIKVFNDMKVRKsstPEEVKKRKKAVLFCLsED |
| P23528 | S24 | SIGNOR|EPSD|PSP | CFL1 CFL | GVAVsDGVIKVFNDMKVRKsstPEEVKKRKKAVLFCLsEDK |
| P23588 | S207 | Sugiyama | EIF4B | DRNRDsDKtDTDWRARPAtDsFDDyPPRRGDDsFGDKYRDR |
| P23677 | T311 | ELM|iPTMNet|EPSD | ITPKA | KMLAVDPEAPTEEEHAQRAVtKPRYMQWREGISSSTTLGFR |
| P23975 | S259 | PSP | SLC6A2 NAT1 NET1 SLC6A5 | LCLMVVVIVLYFSLWKGVKtsGKVVWITATLPYFVLFVLLV |
| P23975 | T258 | PSP | SLC6A2 NAT1 NET1 SLC6A5 | LLCLMVVVIVLYFSLWKGVKtsGKVVWITATLPYFVLFVLL |
| P24046 | S431 | iPTMNet|EPSD | GABRR1 | NYMPENGEKPDRMMVQLTLAsERssPQRKsQRssYVsMRID |
| P24046 | S440 | SIGNOR|iPTMNet|EPSD | GABRR1 | PDRMMVQLTLAsERssPQRKsQRssYVsMRIDTHAIDKYSR |
| P24046 | S443 | SIGNOR|iPTMNet|EPSD | GABRR1 | MMVQLTLAsERssPQRKsQRssYVsMRIDTHAIDKYSRIIF |
| P24046 | S444 | SIGNOR|iPTMNet|EPSD | GABRR1 | MVQLTLAsERssPQRKsQRssYVsMRIDTHAIDKYSRIIFP |
| P24046 | S447 | SIGNOR|iPTMNet|EPSD | GABRR1 | LTLAsERssPQRKsQRssYVsMRIDTHAIDKYSRIIFPAAY |
| P24534 | S141 | Sugiyama | EEF1B2 EEF1B EF1B | ERLAQYESKKAKKPALVAKssILLDVKPWDDEtDMAKLEEC |
| P24844 | S2 | SIGNOR|EPSD|PSP | MYL9 MLC2 MRLC1 MYRL2 | ___________________MssKRAKAKtTKKRPQRAtsNV |
| P24844 | S3 | SIGNOR|EPSD|PSP | MYL9 MLC2 MRLC1 MYRL2 | __________________MssKRAKAKtTKKRPQRAtsNVF |
| P24844 | T10 | SIGNOR|EPSD|PSP | MYL9 MLC2 MRLC1 MYRL2 | ___________MssKRAKAKtTKKRPQRAtsNVFAMFDQSQ |
| P25098 | S29 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | GRK2 ADRBK1 BARK BARK1 | ADVSyLMAMEKSKATPAARAsKKILLPEPSIRSVMQKYLED |
| P25100 | S300 | PSP | ADRA1D ADRA1A | VARSTTRSLEAGVKRERGKAsEVVLRIHCRGAATGADGAHG |
| P25100 | S323 | PSP | ADRA1D ADRA1A | VLRIHCRGAATGADGAHGMRsAKGHtFRssLsVRLLKFSRE |
| P25100 | S332 | PSP | ADRA1D ADRA1A | ATGADGAHGMRsAKGHtFRssLsVRLLKFSREKKAAKTLAI |
| P25100 | S334 | PSP | ADRA1D ADRA1A | GADGAHGMRsAKGHtFRssLsVRLLKFSREKKAAKTLAIVV |
| P25100 | S516 | PSP | ADRA1D ADRA1A | EWRLLGPFRRPtTQLRAKVssLsHKIRAGGAQRAEAACAQR |
| P25100 | S518 | PSP | ADRA1D ADRA1A | RLLGPFRRPtTQLRAKVssLsHKIRAGGAQRAEAACAQRSE |
| P25205 | S447 | Sugiyama | MCM3 | EQGRVTIAKAGIHARLNARCsVLAAANPVyGRyDQyKTPME |
| P25789 | T10 | Sugiyama | PSMA4 HC9 PSC9 | ___________MSRRyDsRttIFsPEGRLYQVEYAMEAIGH |
| P25789 | Y5 | Sugiyama | PSMA4 HC9 PSC9 | ________________MSRRyDsRttIFsPEGRLYQVEYAM |
| P26373 | S181 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | YKKEKARVItEEEKNFKAFAsLRMARANARLFGIRAKRAKE |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P26373 | T24 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | SRNGMVLKPHFHKDWQRRVAtWFNQPARKIRRRKARQAKAR |
| P26641 | T287 | Sugiyama | EEF1G EF1G PRO1608 | EQALAAEPKAKDPFAHLPKstFVLDEFKRKysNEDtLsVAL |
| P27348 | S45 | Sugiyama | YWHAQ | CMKAVtEQGAELsNEERNLLsVAyKNVVGGRRSAWRVIsSI |
| P27348 | S63 | Sugiyama | YWHAQ | LLsVAyKNVVGGRRSAWRVIsSIEQKTDTSDKKLQLIKDYR |
| P27635 | S137 | EPSD | RPL10 DXS648E QM | GAFGKPQGTVARVHIGQVIMsIRTKLQNKEHVIEALRRAKF |
| P27635 | S168 | SIGNOR|EPSD | RPL10 DXS648E QM | VIEALRRAKFKFPGRQKIHIsKKWGFTKFNADEFEDMVAEK |
| P27797 | S52 | Sugiyama | CALR CRTC | GWtsRWIEsKHKSDFGKFVLssGKFyGDEEKDKGLQTSQDA |
| P27797 | T34 | Sugiyama | CALR CRTC | LAVAEPAVYFKEQFLDGDGWtsRWIEsKHKSDFGKFVLssG |
| P27824 | S583 | ELM | CANX | VsQEEEDRKPKAEEDEILNRsPRNRKPRRE___________ |
| P28329 | S464 | SIGNOR|EPSD | CHAT | PFDGIVLVQCTEHLLKHVTQssRKLIRADsVSELPAPRRLR |
| P28329 | S465 | SIGNOR|EPSD | CHAT | FDGIVLVQCTEHLLKHVTQssRKLIRADsVSELPAPRRLRW |
| P28329 | S558 | SIGNOR|EPSD | CHAT | ALQLAFYRLHRRLVPTYESAsIRRFQEGRVDNIRSAtPEAL |
| P28329 | S594 | SIGNOR|EPSD | CHAT | tPEALAFVRAVTDHKAAVPAsEKLLLLKDAIRAQTAYTVMA |
| P28329 | T373 | SIGNOR|EPSD | CHAT | LTSDGRSEWAEARTVLVKDStNRDSLDMIERCICLVCLDAP |
| P29317 | S892 | PSP | EPHA2 ECK | DKLIRAPDSLKTLADFDPRVsIRLPstsGsEGVPFRTVsEW |
| P29350 | S591 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | PTPN6 HCP PTP1C | NKREEKVKKQRSADKEKSKGsLKRK________________ |
| P29353 | S139 | SIGNOR|EPSD | SHC1 SHC SHCA | GRRTRVEGGQLGGEEWTRHGsFVNKPTRGWLHPNDKVMGPG |
| P29474 | T495 | SIGNOR|EPSD|PSP | NOS3 | YQPDPWKGSAAKGTGITRKKtFKEVANAVKISASLMGTVMA |
| P29475 | S852 | iPTMNet|EPSD | NOS1 | EMRHPNSVQEERKSYKVRFNsVSSYSDsQKSSGDGPDLRDN |
| P29692 | S44 | Sugiyama | EEF1D EF1D | RFyEQMNGPVAGAsRQENGAsVILRDIARARENIQKsLAGs |
| P29966 | S101 | SIGNOR|iPTMNet|EPSD | MARCKS MACS PRKCSL | sPsAAEKGEPAAAAAPEAGAsPVEKEAPAEGEAAEPGsPtA |
| P29966 | S118 | SIGNOR|iPTMNet|EPSD | MARCKS MACS PRKCSL | AGAsPVEKEAPAEGEAAEPGsPtAAEGEAAsAAsstssPKA |
| P29966 | S159 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | MARCKS MACS PRKCSL | EDGAtPsPsNEtPKKKKKRFsFKKsFKLsGFsFKKNKKEAG |
| P29966 | S163 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | MARCKS MACS PRKCSL | tPsPsNEtPKKKKKRFsFKKsFKLsGFsFKKNKKEAGEGGE |
| P29966 | S167 | ELM|iPTMNet|EPSD|PSP | MARCKS MACS PRKCSL | sNEtPKKKKKRFsFKKsFKLsGFsFKKNKKEAGEGGEAEAP |
| P29966 | S170 | SIGNOR|ELM|iPTMNet|EPSD|PSP | MARCKS MACS PRKCSL | tPKKKKKRFsFKKsFKLsGFsFKKNKKEAGEGGEAEAPAAE |
| P29966 | S27 | iPTMNet|EPSD | MARCKS MACS PRKCSL | KTAAKGEAAAERPGEAAVAssPsKANGQENGHVKVNGDAsP |
| P29966 | S46 | SIGNOR|iPTMNet|EPSD | MARCKS MACS PRKCSL | ssPsKANGQENGHVKVNGDAsPAAAEsGAKEELQANGsAPA |
| P29966 | S81 | SIGNOR|iPTMNet|EPSD | MARCKS MACS PRKCSL | NGsAPAADKEEPAAAGsGAAsPsAAEKGEPAAAAAPEAGAs |
| P29972 | T157 | SIGNOR|ELM|EPSD|PSP | AQP1 CHIP28 | QGLGIEIIGTLQLVLCVLATtDRRRRDLGGSAPLAIGLSVA |
| P29972 | T239 | SIGNOR|ELM|EPSD|PSP | AQP1 CHIP28 | GGALAVLIYDFILAPRSSDLtDRVKVWtsGQVEEyDLDADD |
| P30050 | S138 | Sugiyama | RPL12 | HRSLARELsGtIKEILGtAQsVGCNVDGRHPHDIIDDINsG |
| P30086 | S153 | GPS6|ELM|iPTMNet|EPSD|PSP | PEBP1 PBP PEBP | CDEPILsNRsGDHRGKFKVAsFRKKyELRAPVAGtCyQAEW |
| P30086 | S52 | Sugiyama | PEBP1 PBP PEBP | AAVDELGKVLtPtQVKNRPtsIsWDGLDsGKLytLVLtDPD |
| P30411 | S373 | GPS6|ELM|EPSD|PSP | BDKRB2 BKR2 | KGGCRSEPIQMENsMGTLRTsIsVERQIHKLQDWAGSRQ__ |
| P30622 | S204 | Sugiyama | CLIP1 CYLN1 RSN | PISNLTKtAsEsIsNLsEAGsIKKGERELKIGDRVLVGGTK |
| P30622 | S312 | SIGNOR | CLIP1 CYLN1 RSN | KANAVRRVMATtsAsLKRsPsAssLsSMSSVASSVSSRPSR |
| P30679 | S336 | ELM|EPSD | GNA15 GNA16 | YTRMYTGCVDGPEGsKKGARsRRLFSHYTCATDTQNIRKVF |
| P31146 | T412 | PSP | CORO1A CORO1 | LKDGYVPPKSRELRVNRGLDtGRRRAAPEAsGtPssDAVSR |
| P31153 | S247 | Sugiyama | MAT2A AMS2 MATA2 | IKAVVPAKyLDEDtIyHLQPsGRFVIGGPQGDAGLtGRKII |
| P31431 | S179 | SIGNOR|iPTMNet|EPSD | SDC4 | LFAVFLILLLMYRMKKKDEGsyDLGKKPIYKKAPTNEFyA_ |
| P31645 | S149 | EPSD|PSP | SLC6A4 HTT SERT | GIPLFYMELALGQyHRNGCIsIWRKICPIFKGIGYAICIIA |
| P31645 | S277 | EPSD|PSP | SLC6A4 HTT SERT | LCIMLIFTVIYFSIWKGVKtsGKVVWVTATFPYIILSVLLV |
| P31645 | T603 | EPSD|PSP | SLC6A4 HTT SERT | TSSFICIPTYIAYRLIITPGtFKERIIKsItPEtPTEIPCG |
| P31749 | S473 | EPSD|PSP | AKT1 PKB RAC | DQDDSMECVDSERRPHFPQFsysAsGtA_____________ |
| P31749 | T308 | EPSD|PSP | AKT1 PKB RAC | IKITDFGLCKEGIKDGAtMKtFCGtPEyLAPEVLEDNDyGR |
| P31751 | S474 | Sugiyama | AKT2 | DRyDsLGLLELDQRTHFPQFsysAsIRE_____________ |
| P31751 | S476 | Sugiyama | AKT2 | yDsLGLLELDQRTHFPQFsysAsIRE_______________ |
| P31751 | S478 | Sugiyama | AKT2 | sLGLLELDQRTHFPQFsysAsIRE_________________ |
| P31751 | Y475 | Sugiyama | AKT2 | RyDsLGLLELDQRTHFPQFsysAsIRE______________ |
| P31946 | S47 | Sugiyama | YWHAB | AMKAVtEQGHELsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P31946 | S65 | Sugiyama | YWHAB | LLsVAyKNVVGARRSsWRVIsSIEQKTERNEKKQQMGKEYR |
| P31947 | S45 | Sugiyama | SFN HME1 | FMKGAVEKGEELsCEERNLLsVAyKNVVGGQRAAWRVLSsI |
| P32004 | T1172 | SIGNOR|EPSD|PSP | L1CAM CAML1 MIC5 | sVKDKEDtQVDsEARPMKDEtFGEyRsLEsDNEEKAFGssQ |
| P32119 | T142 | Sugiyama | PRDX2 NKEFB TDPX1 | EGIAYRGLFIIDGKGVLRQItVNDLPVGRsVDEALRLVQAF |
| P33316 | S120 | Sugiyama | DUT | PsKRARPAEVGGMQLRFARLsEHAtAPTRGsARAAGYDLYS |
| P33778 | S33 | EPSD | H2BC3 H2BFF HIST1H2BB | KGsKKAITKAQKKDGKKRKRsRKEsysIyVyKVLKQVHPDT |
| P33992 | S424 | Sugiyama | MCM5 CDC46 | tsGKGSSAAGLtAsVMRDPssRNFIMEGGAMVLADGGVVCI |
| P34741 | S187 | SIGNOR|ELM|iPTMNet|EPSD | SDC2 HSPG1 | LVYRMRKKDEGsyDLGERKPssAAYQKAPTKEFYA______ |
| P34741 | S188 | SIGNOR|ELM|iPTMNet|EPSD | SDC2 HSPG1 | VYRMRKKDEGsyDLGERKPssAAYQKAPTKEFYA_______ |
| P34931 | S42 | Sugiyama | HSPA1L | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P35221 | S641 | Sugiyama | CTNNA1 | GIRDIRKAVLMIRtPEELDDsDFEtEDFDVRsRtsVQtEDD |
| P35367 | S396 | GPS6|ELM|EPSD|PSP | HRH1 | LRsGsNtGLDYIKFTWKRLRsHsRQYVSGLHMNRERKAAKQ |
| P35367 | S398 | GPS6|SIGNOR|ELM|EPSD|PSP | HRH1 | sGsNtGLDYIKFTWKRLRsHsRQYVSGLHMNRERKAAKQLG |
| P35367 | T478 | GPS6|SIGNOR|ELM|EPSD|PSP | HRH1 | YINSTLNPLIYPLCNENFKKtFKRILHIRS___________ |
| P35368 | S396 | SIGNOR|iPTMNet|EPSD | ADRA1B | RRRRRLGGCAYTYRPWTRGGsLERSQsRKDsLDDsGsCLSG |
| P35368 | S402 | SIGNOR|iPTMNet|EPSD | ADRA1B | GGCAYTYRPWTRGGsLERSQsRKDsLDDsGsCLSGSQRTLP |
| P35368 | S406 | SIGNOR|iPTMNet|EPSD | ADRA1B | YTYRPWTRGGsLERSQsRKDsLDDsGsCLSGSQRTLPSASP |
| P35368 | S410 | SIGNOR|iPTMNet|EPSD | ADRA1B | PWTRGGsLERSQsRKDsLDDsGsCLSGSQRTLPSASPSPGY |
| P35368 | S412 | SIGNOR|iPTMNet|EPSD | ADRA1B | TRGGsLERSQsRKDsLDDsGsCLSGSQRTLPSASPSPGYLG |
| P35398 | S100 | PSP | RORA NR1F1 RZRA | SSGIHYGVITCEGCKGFFRRsQQSNATYSCPRQKNCLIDRT |
| P35398 | S35 | SIGNOR|EPSD|PSP | RORA NR1F1 RZRA | PGSSGADAAAGSRETPLNQEsARKSEPPAPVRRQSYSSTSR |
| P35408 | S259 | ELM | PTGER4 PTGER2 | RGHPAAsPALPRLSDFRRRRsFRRIAGAEIQMVILLIATSL |
| P35408 | S354 | ELM | PTGER4 PTGER2 | KTVLSKAIEKIKCLFCRIGGsRRERSGQHCSDSQRTSSAMs |
| P35408 | S430 | ELM | PTGER4 PTGER2 | GGRNLLPGVPGMGLAQEDttsLRtLRISETSDSSQGQDSES |
| P35408 | S460 | ELM | PTGER4 PTGER2 | SDSSQGQDSESVLLVDEAGGsGRAGPAPKGSSLQVTFPSET |
| P35408 | S484 | ELM | PTGER4 PTGER2 | GPAPKGSSLQVTFPSETLNLsEKCI________________ |
| P35408 | T433 | ELM | PTGER4 PTGER2 | NLLPGVPGMGLAQEDttsLRtLRISETSDSSQGQDSESVLL |
| P35503 | S43 | SIGNOR|PSP | UGT1A3 GNT1 UGT1 | QPWAESGKVLVVPIDGSHWLsMREVLRELHARGHQAVVLTP |
| P35568 | S24 | SIGNOR | IRS1 | PPEsDGFSDVRKVGYLRKPKsMHKRFFVLRAAsEAGGPARL |
| P35579 | S1916 | GPS6|ELM|EPSD|PSP | MYH9 | LQRELEDAtEtADAMNREVssLKNKLRRGDLPFVVPRRMAR |
| P35611 | S5 | GPS6|ELM|EPSD | ADD1 ADDA | ________________MNGDsRAAVVtsPPPttAPHKERyF |
| P35611 | S716 | GPS6|ELM|EPSD|PSP | ADD1 ADDA | AVEEGAAADPGsDGSPGKSPsKKKKKFRtPsFLKKSKKKSD |
| P35611 | S726 | GPS6|SIGNOR|ELM|EPSD|PSP | ADD1 ADDA | GsDGSPGKSPsKKKKKFRtPsFLKKSKKKSDS_________ |
| P35612 | S703 | GPS6|ELM|EPSD | ADD2 ADDB | KTESVTSGPMsPEGsPsKsPsKKKKKFRTPsFLKKSKKKEK |
| P35612 | S713 | SIGNOR|ELM|EPSD|PSP | ADD2 ADDB | sPEGsPsKsPsKKKKKFRTPsFLKKSKKKEKVEs_______ |
| P35612 | S726 | ELM|EPSD|PSP | ADD2 ADDB | KKKFRTPsFLKKSKKKEKVEs____________________ |
| P35869 | S12 | GPS6|ELM|EPSD|PSP | AHR BHLHE76 | _________MNSSSANITYAsRKRRKPVQKTVKPIPAEGIK |
| P35869 | S36 | GPS6|ELM|EPSD|PSP | AHR BHLHE76 | RKPVQKTVKPIPAEGIKSNPsKRHRDRLNTELDRLASLLPF |
| P35900 | S13 | EPSD|PSP | KRT20 | ________MDFSRRSFHRSLsSSLQAPVVSTVGMQRLGTTP |
| P35908 | S191 | Sugiyama | KRT2 KRT2A KRT2E | IQNVKAQEREQIKTLNNKFAsFIDKVRFLEQQNQVLQTKWE |
| P36542 | S146 | EPSD|PSP | ATP5F1C ATP5C ATP5C1 ATP5CL1 | KEVMLVGIGDKIRGILYRtHsDQFLVAFKEVGRKPPTFGDA |
| P36578 | S87 | Sugiyama | RPL4 RPL1 | WGtGRAVARIPRVRGGGtHRsGQGAFGNMCRGGRMFAPTKT |
| P36578 | T84 | Sugiyama | RPL4 RPL1 | AEsWGtGRAVARIPRVRGGGtHRsGQGAFGNMCRGGRMFAP |
| P36871 | S483 | Sugiyama | PGM1 | DKVYtVEKADNFEysDPVDGsIsRNQGLRLIFTDGSRIVFR |
| P36897 | T200 | EPSD|PSP | TGFBR1 ALK5 SKR4 | LIyDMttsGsGsGLPLLVQRtIARtIVLQESIGKGRFGEVW |
| P37108 | S25 | Sugiyama | SRP14 | EsEQFLtELTRLFQKCRTSGsVyItLKKYDGRTKPIPKKGt |
| P37231 | T166 | PSP | PPARG NR1C3 | ASGFHYGVHACEGCKGFFRRtIRLKLIYDRCDLNCRIHKKS |
| P37802 | S11 | EPSD|PSP | TAGLN2 KIAA0120 CDABP0035 | __________MANRGPAyGLsREVQQKIEKQyDADLEQILI |
| P37802 | S163 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | LFsGDPNWFPKKSKENPRNFsDNQLQEGKNVIGLQMGtNRG |
| P37802 | S185 | EPSD|PSP|Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL______ |
| P37802 | T180 | EPSD|PSP|Sugiyama | TAGLN2 KIAA0120 CDABP0035 | RNFsDNQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL_ |
| P38646 | S200 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | NyLGHtAKNAVItVPAyFNDsQRQAtKDAGQIsGLNVLRVI |
| P38646 | S89 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKRQA |
| P38646 | T116 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | DGERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKD |
| P38646 | T120 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | LVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIKNV |
| P38646 | T192 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | MKMKEtAENyLGHtAKNAVItVPAyFNDsQRQAtKDAGQIs |
| P38646 | T398 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | SDIGEVILVGGMTRMPKVQQtVQDLFGRAPsKAVNPDEAVA |
| P38646 | Y196 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | EtAENyLGHtAKNAVItVPAyFNDsQRQAtKDAGQIsGLNV |
| P38936 | S146 | GPS6|ELM|EPSD|PSP | CDKN1A CAP20 CDKN1 CIP1 MDA6 PIC1 SDI1 WAF1 | QAEGsPGGPGDSQGRKRRQtsMTDFYHsKRRLIFSKRKP__ |
| P38936 | S153 | SIGNOR|EPSD|PSP | CDKN1A CAP20 CDKN1 CIP1 MDA6 PIC1 SDI1 WAF1 | GPGDSQGRKRRQtsMTDFYHsKRRLIFSKRKP_________ |
| P38936 | T145 | GPS6|ELM|EPSD | CDKN1A CAP20 CDKN1 CIP1 MDA6 PIC1 SDI1 WAF1 | EQAEGsPGGPGDSQGRKRRQtsMTDFYHsKRRLIFSKRKP_ |
| P39023 | S13 | Sugiyama | RPL3 OK/SW-cl.32 | ________MSHRKFSAPRHGsLGFLPRKRSSRHRGKVKSFP |
| P39023 | S265 | Sugiyama | RPL3 OK/SW-cl.32 | HRGLRKVACIGAWHPARVAFsVARAGQKGYHHRTEINKKIY |
| P40818 | S719 | Sugiyama | USP8 KIAA0055 UBPY | KPQIPAERDREPSKLKRsyssPDItQAIQEEEKRKPTVtPT |
| P41091 | T22 | Sugiyama | EIF2S3 EIF2G | AGGEAGVtLGQPHLsRQDLttLDVtKLTPLSHEVISRQAtI |
| P41091 | T66 | EPSD|PSP | EIF2S3 EIF2G | tIGHVAHGKSTVVKAISGVHtVRFKNELERNITIKLGYANA |
| P41143 | S344 | SIGNOR|ELM|iPTMNet|EPSD | OPRD1 OPRD | NFKRCFRQLCRKPCGRPDPSsFSRAREATARERVtACtPsD |
| P41180 | S875 | PSP | CASR GPRC2A PCAR1 | NKIYIILFKPSRNTIEEVRCsTAAHAFKVAARAtLRRsNVs |
| P41180 | T888 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | CASR GPRC2A PCAR1 | TIEEVRCsTAAHAFKVAARAtLRRsNVsRKRsssLGGSTGS |
| P41181 | S256 | PSP | AQP2 | VLKGLEPDTDWEEREVRRRQsVELHsPQsLPRGtKA_____ |
| P41594 | S840 | SIGNOR|iPTMNet|EPSD | GRM5 GPRC1E MGLUR5 | PKVYIILAKPERNVRSAFTTstVVRMHVGDGKSSSAASRSS |
| P41594 | T841 | SIGNOR|iPTMNet|EPSD | GRM5 GPRC1E MGLUR5 | KVYIILAKPERNVRSAFTTstVVRMHVGDGKSSSAASRSSS |
| P42261 | S832 | SIGNOR | GRIA1 GLUA1 GLUH1 GLUR1 | ILIGGLGLAMLVALIEFCYKsRsEsKRMKGFCLIPQQsINE |
| P42261 | S834 | EPSD|PSP | GRIA1 GLUA1 GLUH1 GLUR1 | IGGLGLAMLVALIEFCYKsRsEsKRMKGFCLIPQQsINEAI |
| P42261 | S836 | EPSD|PSP | GRIA1 GLUA1 GLUH1 GLUR1 | GLGLAMLVALIEFCYKsRsEsKRMKGFCLIPQQsINEAIRT |
| P42261 | S849 | GPS6|ELM|iPTMNet|EPSD|PSP | GRIA1 GLUA1 GLUH1 GLUR1 | CYKsRsEsKRMKGFCLIPQQsINEAIRTStLPRNsGAGASS |
| P42262 | S683 | SIGNOR|iPTMNet|EPSD | GRIA2 GluA2 GLUR2 | QTEIAYGTLDSGSTKEFFRRsKIAVFDKMWTYMRSAEPSVF |
| P42262 | S717 | SIGNOR|iPTMNet|EPSD | GRIA2 GluA2 GLUR2 | SAEPSVFVRTTAEGVARVRKsKGKYAYLLESTMNEYIEQRK |
| P42262 | S880 | SIGNOR|iPTMNet|EPSD | GRIA2 GluA2 GLUR2 | SQNSQNFATYKEGYNVyGIEsVKI_________________ |
| P42677 | S78 | Sugiyama | RPS27 MPS1 | GCSTVLCQPTGGKARLtEGCsFRRKQH______________ |
| P43119 | S328 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | PTGIR PRIPR | CCLCLGPAHGDSQTPLSQLAsGRRDPRAPSAPVGKEGSCVP |
| P43243 | S188 | Sugiyama | MATR3 KIAA0723 | EPPyRVPRDDWEEKRHFRRDsFDDRGPsLNPVLDyDHGsRs |
| P43487 | S60 | Sugiyama | RANBP1 | TLEEDEEELFKMRAKLFRFAsENDLPEWKERGTGDVKLLKH |
| P43629 | S415 | SIGNOR|EPSD|PSP | KIR3DL1 CD158E NKAT3 NKB1 | EVTYAQLDHCVFTQRKITRPsQRPKtPPTDTILYTELPNAK |
| P45379 | S189 | EPSD|PSP | TNNT2 | REEEENRRKAEDEARKKKALsNMMHFGGYIQKQAQtERKsG |
| P46013 | S2299 | Sugiyama | MKI67 | MKAFMGtPVQKLDLPGNLPGsKRWPQTPKEKAQALEDLAGF |
| P46060 | S24 | Sugiyama | RANGAP1 KIAA1835 SD | EDIAKLAETLAKTQVAGGQLsFKGKSLKLNTAEDAKDVIKE |
| P46087 | S40 | Sugiyama | NOP2 NOL1 NSUN1 | KQKGAEtELVRFLPAVsDENsKRLsSRARKRAAKRRLGsVE |
| P46776 | S68 | Sugiyama | RPL27A | yHPGyFGKVGMKHYHLKRNQsFCPtVNLDKLWtLVsEQtRV |
| P46777 | S176 | Sugiyama | RPL5 MSTP030 | GNKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNAEVHR |
| P46777 | S224 | Sugiyama | RPL5 MSTP030 | VADyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAH |
| P46777 | T177 | Sugiyama | RPL5 MSTP030 | NKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNAEVHRK |
| P46783 | S146 | Sugiyama | RPS10 | TYRRSAVPPGADKKAEAGAGsAtEFQFRGGFGRGRGQPPQ_ |
| P46940 | S1443 | SIGNOR|EPSD|PSP | IQGAP1 KIAA0051 | AMQRRAIRDAKTPDKMKKsKsVKEDsNLtLQEKKEKIQTGL |
| P47712 | S727 | Sugiyama | PLA2G4A CPLA2 PLA2G4 | VIKEAMVESIEyRRQNPsRCsVsLsNVEARRFFNKEFLSKP |
| P47756 | S192 | Sugiyama | CAPZB | TVMLWLQTNKSGsGtMNLGGsLtRQMEKDEtVsDCsPHIAN |
| P48048 | S201 | SIGNOR|EPSD|PSP | KCNJ1 ROMK1 | KIsRPKKRAKtItFSKNAVIsKRGGKLCLLIRVANLRKsLL |
| P48048 | S4 | SIGNOR|EPSD|PSP | KCNJ1 ROMK1 | _________________MNAsSRNVFDTLIRVLTESMFKHL |
| P48048 | T193 | SIGNOR|PSP | KCNJ1 ROMK1 | FMCGAILAKIsRPKKRAKtItFSKNAVIsKRGGKLCLLIRV |
| P48050 | T53 | SIGNOR|EPSD|PSP | KCNJ4 IRK3 | ANLSNKSQRYMADIFTTCVDtRWRYMLMIFSAAFLVSWLFF |
| P48058 | S862 | SIGNOR|ELM|iPTMNet|EPSD | GRIA4 GluA4 GLUR4 | AEAKRMKLtFSEAIRNKARLsITGSVGENGRVLTPDCPKAV |
| P48058 | T850 | SIGNOR|ELM|iPTMNet|EPSD | GRIA4 GluA4 GLUR4 | LVALIEFCYKSRAEAKRMKLtFSEAIRNKARLsITGSVGEN |
| P48668 | S176 | Sugiyama | KRT6C KRT6E | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P48730 | S181 | GPS6|SIGNOR|PSP | CSNK1D HCKID | tHQHIPYRENKNLtGtARYAsINtHLGIEQsRRDDLESLGY |
| P48730 | S191 | PSP | CSNK1D HCKID | KNLtGtARYAsINtHLGIEQsRRDDLESLGYVLMYFNLGSL |
| P48730 | S298 | PSP | CSNK1D HCKID | HRQGFSYDYVFDWNMLKFGAsRAADDAERERRDREERLRHS |
| P48730 | S53 | GPS6|SIGNOR|PSP | CSNK1D HCKID | EEVAIKLECVKTKHPQLHIEsKIYKMMQGGVGIPTIRWCGA |
| P48730 | T161 | PSP | CSNK1D HCKID | KGNLVyIIDFGLAKKyRDARtHQHIPYRENKNLtGtARYAs |
| P48730 | T174 | PSP | CSNK1D HCKID | KKyRDARtHQHIPYRENKNLtGtARYAsINtHLGIEQsRRD |
| P48730 | T176 | GPS6|SIGNOR|PSP | CSNK1D HCKID | yRDARtHQHIPYRENKNLtGtARYAsINtHLGIEQsRRDDL |
| P48741 | S42 | Sugiyama | HSPA7 HSP70B | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P49407 | S163 | SIGNOR|PSP | ARRB1 ARR1 | DYEVKAFCAENLEEKIHKRNsVRLVIRKVQYAPERPGPQPT |
| P49685 | S357 | EPSD|PSP | GPR15 | LTKALstFIHAEDFARRRKRsVsL_________________ |
| P49768 | S346 | GPS6|SIGNOR|ELM|EPSD | PSEN1 AD3 PS1 PSNL1 | DtVAENDDGGFsEEWEAQRDsHLGPHRstPEsRAAVQELss |
| P49795 | S24 | iPTMNet|EPSD | RGS19 GAIP GNAI3IP | PHEAEKQITGPEEADRPPsMssHDTASPAAPSRNPCCLCWC |
| P49795 | T201 | ELM|iPTMNet|EPSD | RGS19 GAIP GNAI3IP | QLQIYTLMHRDSYPRFLSSPtYRALLLQGPSQsssEA____ |
| P49802 | S434 | GPS6|ELM|iPTMNet|EPSD|PSP | RGS7 | PGRYTFEDAQEHIYKLMKSDsYPRFIRSSAYQELLQAKKKS |
| P49840 | S21 | SIGNOR|ELM|iPTMNet|EPSD|PSP | GSK3A | MsGGGPsGGGPGGsGRARtssFAEPGGGGGGGGGGPGGsAs |
| P49841 | S9 | SIGNOR|EPSD|PSP | GSK3B | ____________MSGRPRttsFAEsCKPVQQPsAFGsMKVS |
| P50552 | S157 | GPS6|EPSD|PSP | VASP | EVEQQKRQQPGPSEHIERRVsNAGGPPAPPAGGPPPPPGPP |
| P51116 | S601 | Sugiyama | FXR2 FMR1L2 | RPQRRNRSRRRRNRGNRtDGsIsGDRQPVtVADyIsRAEsQ |
| P51674 | T10 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | GPM6A M6A | ___________MEENMEEGQtQKGCFECCIKCLGGIPYASL |
| P51811 | S63 | ELM | XK XKR1 XRG1 | FSLLPCALVQLTLLFVHRDLsRDRPLVLLLHLLQLGPLFRC |
| P51991 | S375 | Sugiyama | HNRNPA3 HNRPA3 | ssGsPyGGGyGsGGGsGGyGsRRF_________________ |
| P52565 | S34 | EPSD|PSP | ARHGDIA GDIA1 | IAAENEEDEHsVNyKPPAQKsIQEIQELDKDDEsLRKyKEA |
| P52565 | S96 | EPSD|PSP | ARHGDIA GDIA1 | TLVCSSAPGPLELDLtGDLEsFKKQsFVLKEGVEYRIKISF |
| P52566 | S31 | SIGNOR|EPSD|PSP | ARHGDIB GDIA2 GDID4 RAP1GN1 | EEDDDDELDsKLNyKPPPQKsLKELQEMDKDDEsLIKYKKT |
| P53004 | S149 | EPSD | BLVRA BLVR BVR | LMEEFAFLKKEVVGKDLLKGsLLFTAGPLEEERFGFPAFSG |
| P53004 | S230 | EPSD | BLVRA BLVR BVR | KsPLSWIEEKGPGLKRNRyLsFHFKsGsLENVPNVGVNKNI |
| P53396 | S455 | Sugiyama | ACLY | ANFLLNAsGststPAPsRtAsFsEsRADEVAPAKKAKPAMP |
| P54652 | S41 | Sugiyama | HSPA2 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P55042 | S214 | SIGNOR|iPTMNet|EPSD|PSP | RRAD RAD | DDVPIILVGNKSDLVRSREVsVDEGRACAVVFDCKFIETSA |
| P55042 | S257 | SIGNOR|iPTMNet|EPSD|PSP | RRAD RAD | HHNVQALFEGVVRQIRLRRDsKEANARRQAGTRRREsLGKK |
| P55042 | S273 | SIGNOR|EPSD|PSP | RRAD RAD | LRRDsKEANARRQAGTRRREsLGKKAKRFLGRIVARNsRKM |
| P55042 | S290 | SIGNOR|iPTMNet|EPSD|PSP | RRAD RAD | RREsLGKKAKRFLGRIVARNsRKMAFRAKsKsCHDLSVL__ |
| P55042 | S299 | SIGNOR|iPTMNet|EPSD|PSP | RRAD RAD | KRFLGRIVARNsRKMAFRAKsKsCHDLSVL___________ |
| P55087 | S180 | SIGNOR|EPSD|PSP | AQP4 | LLVELIITFQLVFTIFASCDsKRTDVTGSIALAIGFSVAIG |
| P55209 | T269 | Sugiyama | NAP1L1 NRP | GPEIMGCTGCQIDWKKGKNVtLKtIKKKQKHKGRGTVRTVT |
| P55209 | T272 | Sugiyama | NAP1L1 NRP | IMGCTGCQIDWKKGKNVtLKtIKKKQKHKGRGTVRTVTKTV |
| P55273 | S76 | SIGNOR | CDKN2D | IALELLKQGAsPNVQDTSGTsPVHDAARTGFLDTLKVLVEH |
| P55273 | T141 | SIGNOR | CDKN2D | AVVSFLAAESDLHRRDARGLtPLELALQRGAQDLVDILQGH |
| P56537 | S235 | GPS6|SIGNOR|ELM|EPSD|PSP | EIF6 EIF3A ITGB4BP OK/SW-cl.27 | LSVVESVFKLNEAQPstIAtsMRDsLIDsLt__________ |
| P60174 | S212 | Sugiyama | TPI1 TPI | WLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLV |
| P60174 | T217 | Sugiyama | TPI1 TPI | VsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLVGGAsL |
| P60709 | S199 | Sugiyama | ACTB | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P60709 | S323 | Sugiyama | ACTB | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P60709 | S368 | Sugiyama | ACTB | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P60709 | S52 | Sugiyama | ACTB | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P60709 | S60 | Sugiyama | ACTB | HQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEHGIVTNWD |
| P60709 | T324 | Sugiyama | ACTB | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P60709 | Y240 | Sugiyama | ACTB | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P60709 | Y53 | Sugiyama | ACTB | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P60880 | S187 | SIGNOR|iPTMNet|EPSD|PSP | SNAP25 SNAP | MGNEIDTQNRQIDRIMEKADsNKTRIDEANQRATKMLGSG_ |
| P60880 | T138 | SIGNOR|iPTMNet|EPSD|PSP | SNAP25 SNAP | ARVVDEREQMAISGGFIRRVtNDARENEMDENLEQVsGIIG |
| P60983 | S53 | SIGNOR | GMFB | IMKIDKDKRLVVLDEELEGIsPDELKDELPERQPRFIVYsY |
| P60983 | S72 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | GMFB | IsPDELKDELPERQPRFIVYsYKYQHDDGRVsYPLCFIFSS |
| P60983 | T27 | SIGNOR | GMFB | VCDVAEDLVEKLRKFRFRKEtNNAAIIMKIDKDKRLVVLDE |
| P61081 | S175 | Sugiyama | UBE2M UBC12 | NNRRLFEQNVQRSMRGGyIGstyFERCLK____________ |
| P61221 | S186 | Sugiyama | ABCE1 RLI RNASEL1 RNASELI RNS4I OK/SW-cl.40 | AIIKPQYVDQIPKAAKGtVGsILDRKDETKTQAIVCQQLDL |
| P61254 | S9 | Sugiyama | RPL26 | ____________MKFNPFVtsDRsKNRKRHFNAPsHIRRKI |
| P61353 | S86 | Sugiyama | RPL27 | SKIKSFVKVyNyNHLMPtRysVDIPLDKtVVNKDVFRDPAL |
| P61353 | T94 | Sugiyama | RPL27 | VyNyNHLMPtRysVDIPLDKtVVNKDVFRDPALKRKARREA |
| P61513 | S21 | Sugiyama | RPL37A | MAKRTKKVGIVGKyGtRYGAsLRKMVKKIEISQHAKYTCSF |
| P61513 | Y14 | Sugiyama | RPL37A | _______MAKRTKKVGIVGKyGtRYGAsLRKMVKKIEISQH |
| P61764 | S306 | SIGNOR|iPTMNet|EPSD | STXBP1 UNC18A | DLWIALRHKHIAEVSQEVTRsLKDFSSsKRMNTGEKTTMRD |
| P61764 | S313 | iPTMNet|EPSD | STXBP1 UNC18A | HKHIAEVSQEVTRsLKDFSSsKRMNTGEKTTMRDLSQMLKK |
| P61978 | S401 | Sugiyama | HNRNPK HNRPK | GDLGGPIIttQVtIPKDLAGsIIGKGGQRIKQIRHEsGAsI |
| P61978 | S75 | Sugiyama | HNRNPK HNRPK | GAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIE |
| P61981 | S46 | Sugiyama | YWHAG | AMKNVtELNEPLsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P61981 | S64 | Sugiyama | YWHAG | LLsVAyKNVVGARRSsWRVIsSIEQKtsADGNEKKIEMVRA |
| P62241 | S160 | Sugiyama | RPS8 OK/SW-cl.83 | KRSKKIQKKYDERKKNAKIssLLEEQFQQGKLLACIASRPG |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62258 | S46 | Sugiyama | YWHAE | SMKKVAGMDVELTVEERNLLsVAyKNVIGARRASWRIIssI |
| P62263 | S139 | Sugiyama | RPS14 PRO2640 | LARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL________ |
| P62269 | S96 | Sugiyama | RPS18 D6S218E | QYKIPDWFLNRQKDVKDGKysQVLANGLDNKLREDLERLKK |
| P62277 | S12 | Sugiyama | RPS13 | _________MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDD |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62280 | S67 | Sugiyama | RPS11 | PKEAIEGtyIDKKCPFTGNVsIRGRILsGVVTKMKMQRTIV |
| P62280 | T54 | Sugiyama | RPS11 | PRYYKNIGLGFKtPKEAIEGtyIDKKCPFTGNVsIRGRILs |
| P62491 | S177 | SIGNOR | RAB11A RAB11 | DSTNVEAAFQTILTEIYRIVsQKQMSDRRENDMsPsNNVVP |
| P62701 | T247 | Sugiyama | RPS4X CCG2 RPS4 SCAR | VIGKGNKPWIsLPRGKGIRLtIAEERDKRLAAKQSSG____ |
| P62736 | S325 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P62736 | S54 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P62736 | S62 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P62736 | T326 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P62736 | Y242 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P62736 | Y55 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P62857 | S39 | Sugiyama | RPS28 | GRtGsQGQCtQVRVEFMDDtsRsIIRNVKGPVREGDVLtLL |
| P62899 | S15 | Sugiyama | RPL31 | ______MAPAKKGGEKKKGRsAINEVVtREytINIHKRIHG |
| P62899 | T26 | Sugiyama | RPL31 | KGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRAPRAL |
| P62906 | S64 | Sugiyama | RPL10A NEDD6 | QKDKRFsGTVRLKSTPRPKFsVCVLGDQQHCDEAKAVDIPH |
| P62906 | T9 | Sugiyama | RPL10A NEDD6 | ____________MSSKVsRDtLyEAVREVLHGNQRKRRKFL |
| P62917 | S130 | Sugiyama | RPL8 | GTIVCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKL |
| P62917 | S14 | Sugiyama | RPL8 | _______MGRVIRGQRKGAGsVFRAHVKHRKGAARLRAVDF |
| P62917 | T135 | Sugiyama | RPL8 | CLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSK |
| P62917 | Y133 | Sugiyama | RPL8 | VCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSG |
| P62937 | S51 | Sugiyama | PPIA CYPA | KtAENFRALSTGEKGFGYKGsCFHRIIPGFMCQGGDFtRHN |
| P62937 | T157 | Sugiyama | PPIA CYPA | NIVEAMERFGsRNGKTSKKItIADCGQLE____________ |
| P62942 | T22 | Sugiyama | FKBP1A FKBP1 FKBP12 | GVQVEtIsPGDGRtFPKRGQtCVVHytGMLEDGKKFDSSRD |
| P62942 | T7 | Sugiyama | FKBP1A FKBP1 FKBP12 | ______________MGVQVEtIsPGDGRtFPKRGQtCVVHy |
| P62979 | S134 | Sugiyama | RPS27A UBA80 UBCEP1 | IsRLRRECPsDECGAGVFMAsHFDRHyCGKCCLtyCFNKPE |
| P63104 | S28 | Sugiyama | YWHAZ | QKAKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAy |
| P63104 | S45 | Sugiyama | YWHAZ | CMKsVtEQGAELsNEERNLLsVAyKNVVGARRssWRVVssI |
| P63173 | T14 | Sugiyama | RPL38 | _______MPRKIEEIKDFLLtARRKDAKSVKIKKNKDNVKF |
| P63220 | S68 | Sugiyama | RPS21 | GQFKtyAICGAIRRMGEsDDsILRLAKADGIVSKNF_____ |
| P63261 | S199 | Sugiyama | ACTG1 ACTG | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P63261 | S323 | Sugiyama | ACTG1 ACTG | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P63261 | S368 | Sugiyama | ACTG1 ACTG | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P63261 | S52 | Sugiyama | ACTG1 ACTG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P63261 | S60 | Sugiyama | ACTG1 ACTG | HQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEHGIVTNWD |
| P63261 | T324 | Sugiyama | ACTG1 ACTG | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P63261 | Y240 | Sugiyama | ACTG1 ACTG | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P63261 | Y53 | Sugiyama | ACTG1 ACTG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P63267 | S324 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P63267 | S53 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P63267 | S61 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P63267 | T325 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P63267 | Y241 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P63267 | Y54 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P67809 | S136 | Sugiyama | YBX1 NSEP1 YB1 | GEKGAEAANVtGPGGVPVQGsKYAADRNHYRRYPRRRGPPR |
| P68032 | S325 | Sugiyama | ACTC1 ACTC | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68032 | S54 | Sugiyama | ACTC1 ACTC | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68032 | S62 | Sugiyama | ACTC1 ACTC | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P68032 | T326 | Sugiyama | ACTC1 ACTC | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68032 | Y242 | Sugiyama | ACTC1 ACTC | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68032 | Y55 | Sugiyama | ACTC1 ACTC | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68104 | T432 | ELM|Sugiyama | EEF1A1 EEF1A EF1A LENG7 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| P68133 | S325 | Sugiyama | ACTA1 ACTA | TTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68133 | S54 | Sugiyama | ACTA1 ACTA | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68133 | S62 | Sugiyama | ACTA1 ACTA | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P68133 | T326 | Sugiyama | ACTA1 ACTA | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68133 | Y242 | Sugiyama | ACTA1 ACTA | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68133 | Y55 | Sugiyama | ACTA1 ACTA | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68431 | T46 | Sugiyama | H3C1 H3FA HIST1H3A; H3C2 H3FL HIST1H3B; H3C3 H3FC HIST1H3C; H3C4 H3FB HIST1H3D; H3C6 H3FD HIST1H3E; H3C7 H3FI HIST1H3F; H3C8 H3FH HIST1H3G; H3C10 H3FK HIST1H3H; H3C11 H3FF HIST1H3I; H3C12 H3FJ HIST1H3J | ARKsAPATGGVKKPHRyRPGtVALREIRRYQKstELLIRKL |
| P68431 | T7 | EPSD | H3C1 H3FA HIST1H3A; H3C2 H3FL HIST1H3B; H3C3 H3FC HIST1H3C; H3C4 H3FB HIST1H3D; H3C6 H3FD HIST1H3E; H3C7 H3FI HIST1H3F; H3C8 H3FH HIST1H3G; H3C10 H3FK HIST1H3H; H3C11 H3FF HIST1H3I; H3C12 H3FJ HIST1H3J | ______________MARtKQtARKstGGKAPRKQLATKAAR |
| P78314 | S225 | GPS6|ELM|EPSD | SH3BP2 3BP2 RES4-23 | PPPPVPTPRKPAFSDMPRAHsFTSKGPGPLLPPPPPKHGLP |
| P78345 | S253 | Sugiyama | RPP38 | DtsFEDLsKPKRKLADGRQAsVtLQPLKIKKLIPNPNKIRK |
| P78371 | S60 | Sugiyama | CCT2 99D8.1 CCTB | KSTLGPKGMDKILLsSGRDAsLMVtNDGAtILKNIGVDNPA |
| P78371 | T69 | Sugiyama | CCT2 99D8.1 CCTB | DKILLsSGRDAsLMVtNDGAtILKNIGVDNPAAKVLVDMSR |
| P78417 | S23 | Sugiyama | GSTO1 GSTTLP28 | GESARsLGKGsAPPGPVPEGsIRIySMRFCPFAERTRLVLK |
| P78536 | T735 | EPSD|PSP | ADAM17 CSVP TACE | MLSSMDSASVRIIKPFPAPQtPGRLQPAPVIPSAPAAPKLD |
| P81274 | S408 | EPSD|PSP | GPSM2 LGN | ENTEIDSSLNGVRPKLGRRHsMENMELMKLtPEKVQNWNSE |
| P83731 | S38 | Sugiyama | RPL24 | GRRYARTDGKVFQFLNAKCEsAFLSKRNPRQINWtVLyRRK |
| P83731 | S7 | Sugiyama | RPL24 | ______________MKVELCsFsGyKIYPGHGRRYARTDGK |
| P83731 | S86 | Sugiyama | RPL24 | EIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKAQRE |
| P83731 | S9 | Sugiyama | RPL24 | ____________MKVELCsFsGyKIYPGHGRRYARTDGKVF |
| P83731 | T52 | Sugiyama | RPL24 | LNAKCEsAFLSKRNPRQINWtVLyRRKHKKGQsEEIQKKRT |
| P84098 | S12 | Sugiyama | RPL19 | _________MSMLRLQKRLAssVLRCGKKKVWLDPNEtNEI |
| P84098 | S13 | Sugiyama | RPL19 | ________MSMLRLQKRLAssVLRCGKKKVWLDPNEtNEIA |
| P84098 | S37 | Sugiyama | RPL19 | CGKKKVWLDPNEtNEIANANsRQQIRKLIKDGLIIRKPVtV |
| P84243 | T46 | Sugiyama | H3-3A H3.3A H3F3 H3F3A PP781; H3-3B H3.3B H3F3B | ARKsAPsTGGVKKPHRyRPGtVALREIRRYQKstELLIRKL |
| P98082 | S24 | ELM | DAB2 DOC2 | EVEtSATNGQPDQQAAPKAPsKKEKKKGPEKTDEyLLARFK |
| Q00169 | S165 | GPS6|ELM|EPSD | PITPNA PITPN | DRSQVLSKDYKAEEDPAKFKsIKTGRGPLGPNWKQELVNQK |
| Q00341 | S904 | Sugiyama | HDLBP HBP VGL | FHRSVMGPKGSRIQQITRDFsVQIKFPDREENAVHSTEPVV |
| Q00613 | S307 | GPS6 | HSF1 HSTF1 | RPLSSsPLVRVKEEPPsPPQsPRVEEAsPGRPssVDtLLsP |
| Q01546 | S196 | Sugiyama | KRT76 KRT2B KRT2P | IGQVKAQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWE |
| Q01814 | T1139 | iPTMNet|EPSD | ATP2B2 PMCA2 | AERELRRGQILWFRGLNRIQtQIRVVKAFRssLyEGLEKPE |
| Q01826 | S185 | PSP | SATB1 | TLKIQLHSCPKLEDLPPEQWsHTtVRNALKDLLKDMNQSSL |
| Q01844 | S266 | SIGNOR|ELM|iPTMNet|EPSD|PSP | EWSR1 EWS | SYSQAPSQYSQQSSSYGQQSsFRQDHPssMGVyGQESGGFS |
| Q01954 | S541 | GPS6|ELM|EPSD|PSP | BNC1 BNC | QLISNEMPFDALPKKKsRKSsMPIKIEKEAVEIANEKRHNL |
| Q01959 | S12 | EPSD|PSP | SLC6A3 DAT1 | _________MsKsKCsVGLMssVVAPAKEPNAVGPKEVELI |
| Q01959 | S7 | EPSD|PSP | SLC6A3 DAT1 | ______________MsKsKCsVGLMssVVAPAKEPNAVGPK |
| Q01970 | S1105 | SIGNOR|EPSD|PSP | PLCB3 | EMNEREKKELQKILDRKRHNsIsEAKMRDKHKKEAELTEIN |
| Q01995 | S181 | ELM|EPSD|PSP | TAGLN SM22 WS3-10 | REFtEsQLQEGKHVIGLQMGsNRGAsQAGMTGYGRPRQIIS |
| Q02156 | S234 | EPSD|PSP | PRKCE PKCE | ELIITKCAGLKKQEtPDQVGsQRFsVNMPHKFGIHNYKVPT |
| Q02156 | S316 | EPSD|PSP | PRKCE PKCE | ARGIAKVLADLGVtPDKItNsGQRRKKLIAGAEsPQPAsGs |
| Q02156 | S368 | EPSD|PSP | PRKCE PKCE | PtsPCDQEIKELENNIRKALsFDNRGEEHRAAssPDGQLMs |
| Q02543 | S123 | Sugiyama | RPL18A | AGAVtQCyRDMGARHRARAHsIQIMKVEEIAASKCRRPAVK |
| Q03721 | S15 | GPS6|ELM|EPSD|PSP | KCNC4 C1orf30 | ______MISSVCVssYRGRKsGNKPPsKTCLKEEMAKGEAS |
| Q03721 | S21 | GPS6|ELM|EPSD|PSP | KCNC4 C1orf30 | MISSVCVssYRGRKsGNKPPsKTCLKEEMAKGEASEKIIIN |
| Q03721 | S8 | GPS6|ELM|EPSD | KCNC4 C1orf30 | _____________MISSVCVssYRGRKsGNKPPsKTCLKEE |
| Q03721 | S9 | GPS6|ELM|EPSD | KCNC4 C1orf30 | ____________MISSVCVssYRGRKsGNKPPsKTCLKEEM |
| Q04206 | S536 | EPSD|PSP | RELA NFKB3 | APLGAPGLPNGLLsGDEDFSsIADMDFsALLSQISS_____ |
| Q04637 | S1185 | GPS6|SIGNOR|EPSD|PSP | EIF4G1 EIF4F EIF4G EIF4GI | ERGGDRGDRLDRARTPATKRsFsKEVEERsRERPsQPEGLR |
| Q04917 | S46 | Sugiyama | YWHAH YWHA1 | AMKAVtELNEPLsNEDRNLLsVAyKNVVGARRSsWRVIsSI |
| Q04917 | S64 | Sugiyama | YWHAH YWHA1 | LLsVAyKNVVGARRSsWRVIsSIEQKTMADGNEKKLEKVKA |
| Q05193 | S778 | EPSD|PSP | DNM1 DNM | VDDSWLQVQSVPAGRRsPTSsPtPQRRAPAVPPARPGsRGP |
| Q05193 | S795 | SIGNOR|iPTMNet|EPSD | DNM1 DNM | PTSsPtPQRRAPAVPPARPGsRGPAPGPPPAGSALGGAPPV |
| Q05209 | S39 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | PTPN12 | sPDHNGEDNFARDFMRLRRLsTKYRTEKIyPTATGEKEENV |
| Q05209 | S435 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | PTPN12 | LPGKNESTIEQIDKKLERNLsFEIKKVPLQEGPKsFDGNtL |
| Q05586 | S889 | ELM | GRIN1 NMDAR1 | RAEPDPKKKATFRAITSTLAssFKRRRssKDTSTGGGRGAL |
| Q05586 | S890 | ELM | GRIN1 NMDAR1 | AEPDPKKKATFRAITSTLAssFKRRRssKDTSTGGGRGALQ |
| Q05586 | S896 | SIGNOR|ELM | GRIN1 NMDAR1 | KKATFRAITSTLAssFKRRRssKDTSTGGGRGALQNQKDTV |
| Q05586 | S897 | ELM | GRIN1 NMDAR1 | KATFRAITSTLAssFKRRRssKDTSTGGGRGALQNQKDTVL |
| Q05639 | T432 | Sugiyama | EEF1A2 EEF1AL STN | VESFSQYPPLGRFAVRDMRQtVAVGVIKNVEKKSGGAGKVT |
| Q05682 | S643 | SIGNOR | CALD1 CAD CDM | PEDGLsDDKKPFKCFTPKGSsLKIEERAEFLNKsVQKsSGV |
| Q05682 | S656 | SIGNOR | CALD1 CAD CDM | CFTPKGSsLKIEERAEFLNKsVQKsSGVKSTHQAAIVSKID |
| Q05682 | S677 | SIGNOR | CALD1 CAD CDM | VQKsSGVKSTHQAAIVSKIDsRLEQyTSAIEGTKsAKPTKP |
| Q05940 | S15 | EPSD|PSP | SLC18A2 SVMT VMAT2 | ______MALSELALVRWLQEsRRsRKLILFIVFLALLLDNM |
| Q05940 | S18 | EPSD|PSP | SLC18A2 SVMT VMAT2 | ___MALSELALVRWLQEsRRsRKLILFIVFLALLLDNMLLT |
| Q06124 | S576 | PSP | PTPN11 PTP2C SHPTP2 | DQSPLPPCTPTPPCAEMREDsARVyENVGLMQQQKsFR___ |
| Q06124 | S591 | PSP | PTPN11 PTP2C SHPTP2 | EMREDsARVyENVGLMQQQKsFR__________________ |
| Q06210 | S205 | SIGNOR|iPTMNet|EPSD | GFPT1 GFAT GFPT | FALVFKSVHFPGQAVGTRRGsPLLIGVRSEHKLSTDHIPIL |
| Q06210 | S235 | iPTMNet|EPSD | GFPT1 GFAT GFPT | HKLSTDHIPILYRTARTQIGsKFTRWGsQGERGKDKKGSCN |
| Q06481 | T723 | SIGNOR|ELM|iPTMNet|EPSD|PSP | APLP2 APPL2 | VAIATVIVISLVMLRKRQYGtISHGIVEVDPMLtPEERHLN |
| Q06830 | T143 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | EGIsFRGLFIIDDKGILRQItVNDLPVGRsVDEtLRLVQAF |
| Q07020 | T136 | Sugiyama | RPL18 | AGGKILtFDQLALDsPKGCGtVLLsGPRKGREVYRHFGKAP |
| Q07020 | T85 | Sugiyama | RPL18 | RMIRKMKLPGRENKtAVVVGtItDDVRVQEVPKLKVCALRV |
| Q07617 | S317 | iPTMNet|EPSD | SPAG1 | EDLSKVLDVEPDNDLAKKTLsEVERDLKNsEAASETQTKGK |
| Q07617 | S326 | SIGNOR | SPAG1 | EPDNDLAKKTLsEVERDLKNsEAASETQTKGKRMVIQEIEN |
| Q07866 | S524 | Sugiyama | KLC1 KLC KNS2 | QRVAEVLNDPENMEKRRsREsLNVDVVKYESGPDGGEEVSM |
| Q07869 | S179 | GPS6|EPSD|PSP | PPARA NR1C1 PPAR | HKCLSVGMSHNAIRFGRMPRsEKAKLKAEILTCEHDIEDSE |
| Q07869 | S230 | GPS6|EPSD|PSP | PPARA NR1C1 PPAR | IYEAYLKNFNMNKVKARVILsGKASNNPPFVIHDMETLCMA |
| Q07954 | S4517 | SIGNOR|EPSD|PSP | LRP1 A2MR APR | DKPTNFTNPVyATLYMGGHGsRHsLAsTDEKRELLGRGPED |
| Q07954 | S4520 | SIGNOR|EPSD|PSP | LRP1 A2MR APR | TNFTNPVyATLYMGGHGsRHsLAsTDEKRELLGRGPEDEIG |
| Q07954 | S4523 | SIGNOR|EPSD|PSP | LRP1 A2MR APR | TNPVyATLYMGGHGsRHsLAsTDEKRELLGRGPEDEIGDPL |
| Q07954 | T4460 | SIGNOR|EPSD|PSP | LRP1 A2MR APR | VVFWYKRRVQGAKGFQHQRMtNGAMNVEIGNPTyKMYEGGE |
| Q09472 | S89 | GPS6|ELM|EPSD|PSP | EP300 P300 | GMVQDAASKHKQLSELLRsGssPNLNMGVGGPGQVMAsQAQ |
| Q12791 | S1200 | SIGNOR|EPSD|PSP | KCNMA1 KCNMA SLO | HNAGQSRASLSHSSHSSQSSsKKsssVHSIPSTANRQNRPK |
| Q12809 | S890 | EPSD | KCNH2 ERG ERG1 HERG | GSPGSTELEGGFSRQRKRKLsFRRRtDKDTEQPGEVSALGP |
| Q12879 | S1416 | SIGNOR|iPTMNet | GRIN2A NMDAR2A | VNDSYLRSSLRSTASYCSRDsRGHNDVyISEHVMPYAANKN |
| Q12879 | S929 | PSP | GRIN2A NMDAR2A | NMNSSRMDSPKRAADFIQRGsLIMDMVSDKGNLMySDNRSF |
| Q12959 | T657 | EPSD|PSP | DLG1 | EVGVIPSKRRVEKKERARLKtVKFNSKTRDKGEIPDDMGSK |
| Q13002 | S868 | EPSD|PSP | GRIK2 GLUR6 | KNAQLEKRSFCSAMVEELRMsLKCQRRLKHKPQAPVIVKTE |
| Q13131 | S496 | SIGNOR|EPSD|PSP | PRKAA1 AMPK1 | sIDDEItEAKsGtAtPQRsGsVsNYRSCQRsDsDAEAQGKs |
| Q13224 | S1303 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | GRIN2B NMDAR2B | QSPTNSKAQKKNRNKLRRQHsYDTFVDLQKEEAALAPRSVs |
| Q13224 | S1323 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | GRIN2B NMDAR2B | sYDTFVDLQKEEAALAPRSVsLKDKGRFMDGSPyAHMFEMS |
| Q13224 | S1415 | PSP | GRIN2B NMDAR2B | QCLLHGSKSYFFRQPTVAGAsKARPDFRALVTNKPVVSALH |
| Q13247 | S297 | Sugiyama | SRSF6 SFRS6 SRP55 | RSRSPKENGKGDIKsKSRsRsQsRsNsPLPVPPsKARsVsP |
| Q13255 | T695 | SIGNOR|ELM|EPSD | GRM1 GPRC1A MGLUR1 | LVTKTNRIARILAGSKKKICtRKPRFMSAWAQVIIASILIS |
| Q13303 | S266 | EPSD|PSP | KCNAB2 KCNA2B KCNK2 | LACGIVSGKYDSGIPPYSRAsLKGyQWLKDKILSEEGRRQQ |
| Q13393 | S2 | SIGNOR|iPTMNet|EPSD | PLD1 | ___________________MsLKNEPRVNTSALQKIAADMs |
| Q13393 | S561 | SIGNOR|iPTMNet|EPSD | PLD1 | IDDVDSKLKGIGKPRKFSKFsLYKQLHRHHLHDADSISSID |
| Q13393 | T147 | SIGNOR|iPTMNet|EPSD | PLD1 | HRELLKYKAFIRIPIPTRRHtFRRQNVREEPREMPSLPRSS |
| Q13418 | T173 | EPSD|PSP | ILK ILK1 ILK2 | EKMGQNLNRIPYKDTFWKGttRTRPRNGtLNKHsGIDFKQL |
| Q13418 | T181 | EPSD|PSP | ILK ILK1 ILK2 | RIPYKDTFWKGttRTRPRNGtLNKHsGIDFKQLNFLTKLNE |
| Q13507 | S785 | PSP | TRPC3 TRP3 | LWLSYFDDGKTLPPPFsLVPsPKSFVYFIMRIVNFPKCRRR |
| Q13509 | S75 | Sugiyama | TUBB3 TUBB4 | SSHKYVPRAILVDLEPGtMDsVRSGAFGHLFRPDNFIFGQS |
| Q13522 | S67 | EPSD|PSP | PPP1R1A IPP1 | sPEIDEDRIPNPHLKSTLAMsPRQRKKMtRITPTMKELQMM |
| Q13522 | T75 | GPS6|EPSD|PSP | PPP1R1A IPP1 | IPNPHLKSTLAMsPRQRKKMtRITPTMKELQMMVEHHLGQQ |
| Q13574 | S265 | SIGNOR | DGKZ DAGK6 | ILRARRPQNTLKASKKKKRAsFKRKSSKKGPEEGRWRPFII |
| Q13769 | S5 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | THOC5 C22orf19 KIAA0983 | ________________MSSEssKKRKPKVIRsDGAPAEGKR |
| Q13769 | S6 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | THOC5 C22orf19 KIAA0983 | _______________MSSEssKKRKPKVIRsDGAPAEGKRN |
| Q13885 | S75 | Sugiyama | TUBB2A TUBB2 | AGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| Q13887 | S153 | ELM | KLF5 BTEB2 CKLF IKLF | SINMNVFLPDITHLRTGLYKsQRPCVTHIKTEPVAIFSHQS |
| Q13976 | T59 | GPS6|SIGNOR|ELM|EPSD|PSP | PRKG1 PRKG1B PRKGR1A PRKGR1B | KLHKCQSVLPVPsTHIGPRTtRAQGIsAEPQTYRsFHDLRQ |
| Q14011 | S159 | Sugiyama | CIRBP A18HNRNP CIRP | RDyySSRsQsGGYSDRssGGsyRDsyDsyATHNE_______ |
| Q14151 | S827 | Sugiyama | SAFB2 KIAA0138 | HGGPPERHGRDsRDGWGGyGsDKRLsEGRGLPPPPRGGRDW |
| Q14152 | S1028 | Sugiyama | EIF3A EIF3S10 KIAA0139 | NWRHADDDRPPRRGLDEDRGsWRtADEDRGPRRGMDDDRGP |
| Q14152 | S492 | Sugiyama | EIF3A EIF3S10 KIAA0139 | VDAARHCDLQVRIDHTSRTLsFGsDLNyAtREDAPIGPHLQ |
| Q14152 | S584 | Sugiyama | EIF3A EIF3S10 KIAA0139 | EHQRILARRQtIEERKERLEsLNIQREKEELEQREAELQKV |
| Q14152 | S988 | Sugiyama | EIF3A EIF3S10 KIAA0139 | PRRGPEEDRFsRRGADDDRPsWRNTDDDRPPRRIADEDRGN |
| Q14315 | S2236 | SIGNOR | FLNC ABPL FLN2 | DPFPAVFGDFLGRERLGsFGsITRQQEGEAsSQDMTAQVTs |
| Q14315 | S2623 | PSP | FLNC ABPL FLN2 | LHETSTVLVEtVTKSSssRGssyssIPKFsSDASKVVTRGP |
| Q14315 | S2624 | PSP | FLNC ABPL FLN2 | HETSTVLVEtVTKSSssRGssyssIPKFsSDASKVVTRGPG |
| Q14432 | S292 | EPSD|PSP | PDE3A | GsQLIAGTKEDIPVFKRRRRsssVVsAEMSGCSSKSHRRts |
| Q14432 | S293 | EPSD|PSP | PDE3A | sQLIAGTKEDIPVFKRRRRsssVVsAEMSGCSSKSHRRtsL |
| Q14432 | S312 | GPS6|SIGNOR|EPSD|PSP | PDE3A | sssVVsAEMSGCSSKSHRRtsLPCIPREQLMGHSEWDHKRG |
| Q14432 | S428 | GPS6|SIGNOR|EPSD|PSP | PDE3A | sDsEESSEKDKLAIPKRLRRsLPPGLLRRVsstWttttsAT |
| Q14432 | S438 | GPS6|SIGNOR|EPSD|PSP | PDE3A | KLAIPKRLRRsLPPGLLRRVsstWttttsATGLPTLEPAPV |
| Q14432 | S465 | GPS6|SIGNOR|EPSD|PSP | PDE3A | tsATGLPTLEPAPVRRDRSTsIKLQEAPsssPDsWNNPVMM |
| Q14432 | S492 | SIGNOR|EPSD|PSP | PDE3A | PsssPDsWNNPVMMtLTKsRsFtssyAISAANHVKAKKQSR |
| Q14432 | T568 | GPS6 | PDE3A | PEsADTTAKQSLGSHRALtYtQsAPDLsPQILtPPVICSSC |
| Q14469 | S37 | SIGNOR|ELM|iPTMNet|EPSD | HES1 BHLHB39 HL HRY | tPAsVNttPDKPKTASEHRKssKPIMEKRRRARINESLSQL |
| Q14469 | S38 | SIGNOR|ELM|iPTMNet|EPSD | HES1 BHLHB39 HL HRY | PAsVNttPDKPKTASEHRKssKPIMEKRRRARINESLSQLK |
| Q14524 | S1503 | PSP | SCN5A | QDIFMTEEQKKyyNAMKKLGsKKPQKPIPRPLNKYQGFIFD |
| Q14749 | S10 | PSP | GNMT | ___________MVDSVYRtRsLGVAAEGLPDQYADGEAARV |
| Q14994 | T38 | EPSD|PSP | NR1I3 CAR | ATGYHFNALTCEGCKGFFRRtVSKSIGPTCPFAGSCEVSKT |
| Q14CN4 | S138 | Sugiyama | KRT72 K6IRS2 KB35 KRT6 KRT6IRS2 | IQRVRAQEREQIKALNNKFAsFIDKVRFLEQQNQVLETKWN |
| Q15021 | S1310 | Sugiyama | NCAPD2 CAPD2 CNAP1 KIAA0159 | RACHTRGLDGIKELEIGQAGsQRAPsAKKPSTGSRyQPLAs |
| Q15052 | S640 | SIGNOR | ARHGEF6 COOL2 KIAA0006 PIXA | sKsPKTMKKFLHKRKTERKPsEEEyVIRKstAALEEDAQIL |
| Q15052 | S684 | SIGNOR | ARHGEF6 COOL2 KIAA0006 PIXA | EAYCTSANFQQGHGsstRKDsIPQVLLPEEEKLIIEETRsN |
| Q15056 | S66 | Sugiyama | EIF4H KIAA0038 WBSCR1 WSCR1 | VGNLPFNTVQGDIDAIFKDLsIRsVRLVRDKDTDKFKGFCy |
| Q15056 | S69 | Sugiyama | EIF4H KIAA0038 WBSCR1 WSCR1 | LPFNTVQGDIDAIFKDLsIRsVRLVRDKDTDKFKGFCyVEF |
| Q15080 | S315 | GPS6|ELM|EPSD|PSP | NCF4 SH3PXD4 | VRLLSDEDVALMVRQARGLPsQKRLFPWKLHITQKDNYRVY |
| Q15080 | T154 | GPS6|SIGNOR|ELM|EPSD|PSP | NCF4 SH3PXD4 | YQSPYDSEQVPQALRRLRPRtRKVKsVsPQGNsVDRMAAPR |
| Q15121 | S104 | SIGNOR|ELM|iPTMNet|EPSD | PEA15 | TRVLKIsEEDELDtKLtRIPsAKKYKDIIRQPsEEEIIKLA |
| Q15139 | S249 | ELM | PRKD1 PKD PKD1 PRKCM | EPLLQKsPsEsFIGREKRsNsQsyIGRPIHLDKILMSKVKV |
| Q15139 | S412 | PSP | PRKD1 PKD PKD1 PRKCM | ANRtIsPstsNNIPLMRVVQsVKHTKRKSsTVMKEGWMVHy |
| Q15139 | S738 | GPS6|SIGNOR|ELM|EPSD|PSP | PRKD1 PKD PKD1 PRKCM | DPFPQVKLCDFGFARIIGEKsFRRsVVGtPAyLAPEVLRNK |
| Q15139 | S742 | GPS6|SIGNOR|ELM|EPSD|PSP | PRKD1 PKD PKD1 PRKCM | QVKLCDFGFARIIGEKsFRRsVVGtPAyLAPEVLRNKGYNR |
| Q15172 | S41 | SIGNOR|EPSD|PSP | PPP2R5A | VDGFTRKsVRKAQRQKRsQGssQFRsQGsQAELHPLPQLKD |
| Q15185 | S113 | Sugiyama | PTGES3 P23 TEBP | RAKLNWLsVDFNNWKDWEDDsDEDMsNFDRFSEMMNNMGGD |
| Q15185 | S72 | Sugiyama | PTGES3 P23 TEBP | EIDLFHCIDPNDsKHKRtDRsILCCLRKGEsGQsWPRLTKE |
| Q15311 | S118 | EPSD|PSP | RALBP1 RLIP RLIP1 RLIP76 | EsPSKMKRSKGIHVFKKPsFsKKKEKDFKIKEKPKEEKHKE |
| Q15311 | S353 | EPSD|PSP | RALBP1 RLIP RLIP1 RLIP76 | LETKMNIQNISIVLSPTVQIsNRVLYVFFTHVQELFGNVVL |
| Q15311 | S509 | EPSD|PSP | RALBP1 RLIP RLIP1 RLIP76 | ILTEQEELLAMEQFLRRQIAsEKEEIERLRAEIAEIQSRQQ |
| Q15311 | T297 | SIGNOR|iPTMNet|EPSD|PSP | RALBP1 RLIP RLIP1 RLIP76 | NLLTKELMPRFEEACGRTTEtEKVQEFQRLLKELPECNYLL |
| Q15417 | S259 | Sugiyama | CNN3 | DNSTISLQMGTNKVAsQKGMsVyGLGRQVYDPKYCAAPTEP |
| Q15424 | S803 | Sugiyama | SAFB HAP HET SAFB1 | RHGGPERHGRDsRDGWGGyGsDKRMsEGRGLPPPPRRDWGD |
| Q15438 | S394 | ELM | CYTH1 D17S811E PSCD1 | AAISRDPFYEMLAARKKKVSstKRH________________ |
| Q15438 | T395 | ELM | CYTH1 D17S811E PSCD1 | AISRDPFYEMLAARKKKVSstKRH_________________ |
| Q15672 | S144 | SIGNOR|PSP | TWIST1 BHLHA38 TWIST | LNEAFAALRKIIPTLPSDKLsKIQTLKLAARYIDFLYQVLQ |
| Q15717 | S158 | EPSD|PSP | ELAVL1 HUR | LVDQTTGLSRGVAFIRFDKRsEAEEAITSFNGHKPPGSSEP |
| Q15717 | S221 | EPSD|PSP | ELAVL1 HUR | HsPARRFGGPVHHQAQRFRFsPMGVDHMSGLSGVNVPGNAS |
| Q15717 | S318 | EPSD|PSP | ELAVL1 HUR | AAMAIAsLNGYRLGDKILQVsFKTNKSHK____________ |
| Q15762 | S329 | GPS6|ELM|EPSD|PSP | CD226 DNAM1 | PtNQsMDDTREDIyVNyPtFsRRPKTRV_____________ |
| Q15906 | S132 | ELM | VPS72 TCFL1 YL1 | REEKALLPLELQDDGsDsRKsMRQStAEHTRQTFLRVQERQ |
| Q16236 | S40 | SIGNOR|ELM | NFE2L2 NRF2 | IDILWRQDIDLGVSREVFDFsQRRKEYELEKQKKLEKERQE |
| Q16625 | S340 | SIGNOR|ELM|iPTMNet|EPSD | OCLN | DsPMAYSsNGKVNDKRFYPEssyKstPVPEVVQELPLtsPV |
| Q16629 | S183 | Sugiyama | SRSF7 SFRS7 | sRSISLRRSRSASLRRSRSGsIKGsRyFQsPsRsRsRSRSI |
| Q16629 | S187 | Sugiyama | SRSF7 SFRS7 | SLRRSRSASLRRSRSGsIKGsRyFQsPsRsRsRSRSISRPR |
| Q16637 | S31 | Sugiyama | SMN1 SMN SMNT; SMN2 SMNC | GVPEQEDsVLFRRGtGQsDDsDIWDDtALIKAYDKAVAsFK |
| Q16658 | S39 | ELM|EPSD|PSP | FSCN1 FAN1 HSN SNL | CGNKyLTAEAFGFKVNASAssLKKKQIWTLEQPPDEAGSAA |
| Q16658 | T239 | Sugiyama | FSCN1 FAN1 HSN SNL | GKVAFRDCEGRyLAPsGPsGtLKAGKATKVGKDELFALEQs |
| Q16695 | T46 | Sugiyama | H3-4 H3FT HIST3H3 | ARKsAPATGGVKKPHRyRPGtVALREIRRYQKstELLIRKL |
| Q16760 | S66 | GPS6|SIGNOR|ELM|EPSD | DGKD KIAA0145 | SGQIRQKTIIKEGMLTKQNNsFQRsKRRYFKLRGRTLYYAK |
| Q16760 | S70 | GPS6|SIGNOR|ELM|EPSD | DGKD KIAA0145 | RQKTIIKEGMLTKQNNsFQRsKRRYFKLRGRTLYYAKTAKS |
| Q16820 | S687 | SIGNOR|ELM | MEP1B | MLIITLVSVYCTRKKYRERMsSNRPNLTPQNQHAF______ |
| Q16875 | S461 | EPSD|PSP | PFKFB3 | THRERSEDAKKGPNPLMRRNsVtPLAsPEPtKKPRINsFEE |
| Q2VIR3 | T22 | Sugiyama | EIF2S3B | AGGEAGVtLGQPHLsRQDLttLDVtKLTPLSHEVISRQAtI |
| Q32P51 | S95 | Sugiyama | HNRNPA1L2 HNRNPA1L | TPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| Q38SD2 | S1064 | SIGNOR|PSP | LRRK1 KIAA1790 | LQLFENKKNTKSRNRKVTIYsFTGNQRNRCstFRVKRNQTI |
| Q38SD2 | S1074 | SIGNOR|PSP | LRRK1 KIAA1790 | KSRNRKVTIYsFTGNQRNRCstFRVKRNQTIYWQEGLLVTF |
| Q38SD2 | T1075 | SIGNOR|PSP | LRRK1 KIAA1790 | SRNRKVTIYsFTGNQRNRCstFRVKRNQTIYWQEGLLVTFD |
| Q3SY84 | S143 | Sugiyama | KRT71 K6IRS1 KB34 KRT6IRS1 | IQKVRAQEREQIKALNNKFAsFIDKVRFLEQQNQVLETKWE |
| Q4G0X9 | S553 | Sugiyama | CCDC40 KIAA1640 | EIEAYKKSIMKEEEKNEKLAsILNRTETEATLLQKLTTQCL |
| Q53EL6 | S49 | Sugiyama | PDCD4 H731 | ENAGTEEIKNEINGNWIsAssINEARINAKAKRRLRKNssR |
| Q562R1 | Y241 | Sugiyama | ACTBL2 | ALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPEA |
| Q58FF8 | S258 | Sugiyama | HSP90AB2P HSP90BB | LAVRYFSVEEYVSRMKEIQKsIyyItGEsKEQVANSAFVEQ |
| Q5JVS0 | T354 | SIGNOR|iPTMNet|EPSD|PSP | HABP4 | MVKDDYEDDSHVFRKPANDItSQLEINFGNLPRPGRGARGG |
| Q5JVS0 | T375 | SIGNOR|iPTMNet|EPSD|PSP | HABP4 | SQLEINFGNLPRPGRGARGGtRGGRGRIRRAENYGPRAEVV |
| Q5VTE0 | T432 | Sugiyama | EEF1A1P5 EEF1AL3 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| Q5VV41 | S208 | Sugiyama | ARHGEF16 EPHEXIN4 NBR | HtRsPAKNKKTLGRKRGHKGsFKDDPQLyQEIQERGLNtsQ |
| Q5XKE5 | S155 | Sugiyama | KRT79 K6L KB38 KRT6L | IQRVRTQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWA |
| Q68EM7 | S702 | SIGNOR | ARHGAP17 RICH1 MSTP066 MSTP110 | tGQPPGQPSAPSQLSAPRRysssLsPIQAPNHPPPQPPTQA |
| Q6NXT2 | T45 | Sugiyama | H3-5 H3F3C | AARKSTPSTCGVKPHRyRPGtVALREIRRYQKstELLIRKL |
| Q6S8J3 | S1068 | Sugiyama | POTEE A26C1A POTE2 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q6S8J3 | Y940 | Sugiyama | POTEE A26C1A POTE2 | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| Q6UVK1 | T2252 | SIGNOR | CSPG4 MCSP | VLLLLALILPLLFYLRKRNKtGKHDVQVLtAKPRNGLAGDT |
| Q6ZMR3 | S161 | Sugiyama | LDHAL6A LDHL2 | DILTYVAWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIH |
| Q6ZMR3 | S167 | Sugiyama | LDHAL6A LDHL2 | AWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIHSESCHG |
| Q6ZN44 | S352 | SIGNOR | UNC5A KIAA1976 UNC5H1 | EGLDSDVADSSILTSGFQPVsIKPSKADNPHLLTIQPDLST |
| Q6ZN44 | S532 | SIGNOR | UNC5A KIAA1976 UNC5H1 | LTRPVILAMDHCGEPSPDSWsLRLKKQSCEGSWEDVLHLGE |
| Q71DI3 | T46 | Sugiyama | H3C15 HIST2H3A; H3C14 H3F2 H3FM HIST2H3C; H3C13 HIST2H3D | ARKsAPATGGVKKPHRyRPGtVALREIRRYQKstELLIRKL |
| Q71U36 | S165 | PSP | TUBA1A TUBA3 | TGSGFTSLLMERLsVDYGKKsKLEFSIYPAPQVSTAVVEPY |
| Q71UM5 | S78 | Sugiyama | RPS27L | GCSTVLCQPTGGKARLtEGCsFRRKQH______________ |
| Q7KZI7 | T596 | GPS6|ELM|EPSD | MARK2 EMK1 | sssGGAPDRTNFPRGVssRstFHAGQLRQVRDQQNLPyGVt |
| Q7RTS7 | S153 | Sugiyama | KRT74 K6IRS4 KB37 KRT5C KRT6IRS4 | IQKVRAQEREQIKVLNDKFAsFIDKVRFLEQQNQVLETKWE |
| Q7Z417 | S652 | Sugiyama | NUFIP2 KIAA1321 PIG1 | NtLLGsAKEQRYQRGLERNDsWGsFDLRAAIVYHTKEMEsI |
| Q7Z794 | S177 | Sugiyama | KRT77 KRT1B | IQRIKTQEREQIMVLNNKFAsFIDKVRFLEQQNQVLQTKWE |
| Q86UR1 | S172 | SIGNOR|EPSD|PSP | NOXA1 P51NOX | WPEGSLNGLDSALDQVQRRGsLPPRQVPRGEVFRPHRWHLK |
| Q86UX7 | S484 | SIGNOR|PSP | FERMT3 KIND3 MIG2B URP2 | SSYTSEVQAILAFLsLQRtGsGGPGNHPHGPDAsAEGLNPy |
| Q86VB7 | S1084 | SIGNOR|EPSD | CD163 M130 | IFVALFFLtKKRRQRQRLAVsSRGENLVHQIQYREMNSCLN |
| Q86VB7 | T1072 | EPSD | CD163 M130 | IAVGILGVVLLAIFVALFFLtKKRRQRQRLAVsSRGENLVH |
| Q86VQ1 | S223 | Sugiyama | GLCCI1 | QTPsCWAEEGAEKRSHQRsAsWGsADQLKEQIAKLRQQLQR |
| Q86Y46 | S145 | Sugiyama | KRT73 K6IRS3 KB36 KRT6IRS3 | IQKVRAQEREQIKVLNNKFAsFIDKVRFLEQQNQVLETKWE |
| Q8IWX8 | S904 | Sugiyama | CHERP DAN26 SCAF6 | KGVGVALDDPyENyRRNKsysFIARMKARDECK________ |
| Q8N0W4 | T707 | EPSD|PSP | NLGN4X KIAA1260 NLGN4 UNQ365/PRO701 | FLNILAFAALYYKKDKRRHEtHRRPSPQRNTTNDIAHIQNE |
| Q8N556 | S277 | EPSD|PSP | AFAP1 AFAP | SECPPPPssPVHKAELEKKLssERPssDGEGVVENGITTCN |
| Q8N5J4 | Y191 | PSP | SPIC | RALRNYGRSGEITKIRRKLTyQFSEAILQRLSPSYFLGKEI |
| Q8N726 | T8 | EPSD|PSP | CDKN2A CDKN2 MLM | _____________MVRRFLVtLRIRRACGPPRVRVFVVHIP |
| Q8NAF0 | S455 | Sugiyama | ZNF579 | AGGPAPHPCPRCPRRFSRAYsLLRHQRCHRAELERAAALQA |
| Q8NBJ7 | S256 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | EWTASPYQAAEQDMRVLRGAsWIDtADGsANHRARVttRMG |
| Q8NER1 | S502 | EPSD|PSP | TRPV1 VR1 | VLGGVYFFFRGIQYFLQRRPsMKTLFVDSYSEMLFFLQSLF |
| Q8NER1 | S801 | EPSD|PSP | TRPV1 VR1 | SRVSGRHWKNFALVPLLREAsARDRQSAQPEEVYLRQFSGs |
| Q8NF50 | S2077 | EPSD|PSP | DOCK8 | LRPMIERKIPELYKPIFRVEsQKRDsFHRssFRKCETQLsQ |
| Q8NF50 | S2082 | EPSD|PSP | DOCK8 | ERKIPELYKPIFRVEsQKRDsFHRssFRKCETQLsQGs___ |
| Q8NF50 | S2087 | EPSD|PSP | DOCK8 | ELYKPIFRVEsQKRDsFHRssFRKCETQLsQGs________ |
| Q8NFA2 | S159 | SIGNOR | NOXO1 P41NOX SH3PXD5 | SRVILPTPEEQPLSRAAGRLsIHsLEAQSLRCLQPFCTQDT |
| Q8NFA2 | T346 | SIGNOR | NOXO1 P41NOX SH3PXD5 | APPPTVPtRPsPGAIQSRCCtVTRRALERRPRRQGRPRGCV |
| Q8TD43 | S1145 | SIGNOR|EPSD|PSP | TRPM4 LTRPC4 | ESVHKENFLLARARDKRESDsERLKRTsQKVDLALKQLGHI |
| Q8TD43 | S1152 | SIGNOR|EPSD|PSP | TRPM4 LTRPC4 | FLLARARDKRESDsERLKRTsQKVDLALKQLGHIREYEQRL |
| Q8TD47 | T247 | Sugiyama | RPS4Y2 RPS4Y2P | VIGNGNKPWISLPRGKGIRLtIAEERDKRLAAKQSSG____ |
| Q8TDQ1 | T221 | PSP | CD300LF CD300F CLM1 IGSF13 IREM1 NKIR UNQ3105/PRO10111 | GDLCyADLTLQLAGTsPQKAtTKLSSAQVDQVEVEyVTMAS |
| Q8WTQ7 | S36 | EPSD|PSP | GRK7 GPRK7 | YLQARKPsDCDSKELQRRRRsLALPGLQGCAELRQKLSLNF |
| Q8WX93 | S479 | Sugiyama | PALLD KIAA0992 CGI-151 | VLECRVRGAPPLQVQWFRQGsEIQDsPDFRILQKKPRSTAE |
| Q8WZ42 | S11878 | EPSD|PSP | TTN | KVRKLLPERKPEPKEEVVLKsVLRKRPEEEEPKVEPKKLEK |
| Q8WZ42 | S12022 | EPSD|PSP | TTN | GVPKKTPSPIEAERRKLRPGsGGEKPPDEAPFTYQLKAVPL |
| Q92681 | S366 | EPSD|PSP | RSC1A1 | EESCPSITAALKELHELLVVsSKPASENTSEEVICQSETIA |
| Q92686 | S36 | SIGNOR|ELM|iPTMNet|EPSD|PSP | NRGN | ILDIPLDDPGANAAAAKIQAsFRGHMARKKIKSGERGRKGP |
| Q92793 | S437 | ELM | CREBBP CBP | SHWKNCTRHDCPVCLPLKNAsDKRNQQTILGSPASGIQNTI |
| Q92837 | S188 | EPSD|PSP | FRAT1 | CRRGWLRGAAASRRLQQRRGsQPETRTGDDDPHRLLQQLVL |
| Q92847 | T261 | PSP | GHSR | RRRRGDAVVGAsLRDQNHKQtVKMLAVVVFAFILCWLPFHV |
| Q92879 | S178 | PSP | CELF1 BRUNOL2 CUGBP CUGBP1 NAB50 | RAMAQTAIKAMHQAQtMEGCssPMVVKFADTQKDKEQKRMA |
| Q92879 | S179 | PSP | CELF1 BRUNOL2 CUGBP CUGBP1 NAB50 | AMAQTAIKAMHQAQtMEGCssPMVVKFADTQKDKEQKRMAQ |
| Q92879 | S241 | PSP | CELF1 BRUNOL2 CUGBP CUGBP1 NAB50 | NTLGPQYLALYLQLLQQTASsGNLNTLSSLHPMGGLNAMQL |
| Q92879 | S28 | PSP | CELF1 BRUNOL2 CUGBP CUGBP1 NAB50 | PDQPDLDAIKMFVGQVPRtWsEKDLRELFEQYGAVYEINVL |
| Q92879 | S300 | PSP | CELF1 BRUNOL2 CUGBP CUGBP1 NAB50 | GTNALTTSSSPLSVLTSSGSsPsSSSSNSVNPIASLGALQT |
| Q92879 | S302 | PSP | CELF1 BRUNOL2 CUGBP CUGBP1 NAB50 | NALTTSSSPLSVLTSSGSsPsSSSSNSVNPIASLGALQTLA |
| Q92879 | S52 | PSP | CELF1 BRUNOL2 CUGBP CUGBP1 NAB50 | LRELFEQYGAVYEINVLRDRsQNPPQSKGCCFVTFYTRKAA |
| Q92879 | T173 | PSP | CELF1 BRUNOL2 CUGBP CUGBP1 NAB50 | VTFTTRAMAQTAIKAMHQAQtMEGCssPMVVKFADTQKDKE |
| Q92888 | S240 | SIGNOR|PSP | ARHGEF1 | NAIGLYMRHLGVRTKSGDKKsGRNFFRKKVMGNRRsDEPAK |
| Q92890 | S299 | Sugiyama | UFD1 UFD1L | KKVEEDEAGGRFVAFsGEGQsLRKKGRKP____________ |
| Q969H0 | S10 | EPSD|PSP | FBXW7 FBW7 FBX30 SEL10 | ___________MNQELLSVGsKRRRTGGsLRGNPSssQVDE |
| Q969H0 | S18 | SIGNOR|EPSD|PSP | FBXW7 FBW7 FBX30 SEL10 | ___MNQELLSVGsKRRRTGGsLRGNPSssQVDEEQMNRVVE |
| Q96A00 | T38 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | PPP1R14A CPI17 PPP1INL | SRARGPGGsPGGLQKRHARVtVKYDRRELQRRLDVEKWIDG |
| Q96AX2 | T172 | SIGNOR|EPSD|PSP | RAB37 | VIRSEDGETLAREYGVPFLEtSAKTGMNVELAFLAIAKELK |
| Q96C90 | T57 | SIGNOR|EPSD|PSP | PPP1R14B PLCB3N PNG | AGEGPGGADDEGPVRRQGKVtVKYDRKELRKRLNLEEWILE |
| Q96KS0 | S132 | SIGNOR|EPSD|PSP | EGLN2 EIT6 | ARPEAPKRKWAEDGGDAPsPsKRPWARQENQEAEREGGMSC |
| Q96KS0 | S226 | EPSD|PSP | EGLN2 EIT6 | VLAEVEALKRGGRLRDGQLVsQRAIPPRsIRGDQIAWVEGH |
| Q96KS0 | S234 | SIGNOR|EPSD|PSP | EGLN2 EIT6 | KRGGRLRDGQLVsQRAIPPRsIRGDQIAWVEGHEPGCRSIG |
| Q96MS0 | S1330 | EPSD|PSP | ROBO3 | LAAQRVLHPDEEAWLPYSRPsFLSRGQGTSTCSTAGSNSSR |
| Q96PH1 | S536 | SIGNOR | NOX5 | NRLYEsFKASDPLGRGSKRLsRSVtMRKsQRssKGSEILLE |
| Q96PH1 | S544 | SIGNOR | NOX5 | ASDPLGRGSKRLsRSVtMRKsQRssKGSEILLEKHKFCNIK |
| Q96PH1 | T540 | SIGNOR | NOX5 | EsFKASDPLGRGSKRLsRSVtMRKsQRssKGSEILLEKHKF |
| Q96PX8 | S695 | SIGNOR | SLITRK1 KIAA1910 LRRC12 UNQ233/PRO266 | NGPYNADGAHRVYDCGSHSLsD___________________ |
| Q96PY5 | S1072 | SIGNOR|EPSD | FMNL2 FHOD2 KIAA1902 | EDIITVLKTVPFTARTAKRGsRFFCEPVLTEEYHY______ |
| Q96QS3 | S174 | SIGNOR|PSP | ARX | AAWDTLKISQAPQVSISRSKsYRENGAPFVPPPPALDELGG |
| Q96RD7 | Y199 | PSP | PANX1 MRS1 UNQ2529/PRO6028 | LGQsLWEVSESHFKYPIVEQyLKTKKNSNNLIIKYISCRLL |
| Q96RI1 | S145 | SIGNOR | NR1H4 BAR FXR HRR1 RIP14 | GASAGRIKGDELCVVCGDRAsGYHYNALTCEGCKGFFRRsI |
| Q96RI1 | S164 | SIGNOR | NR1H4 BAR FXR HRR1 RIP14 | AsGYHYNALTCEGCKGFFRRsITKNAVYKCKNGGNCVMDMY |
| Q96T49 | S331 | SIGNOR|EPSD|PSP | PPP1R16B ANKRD4 KIAA0823 | LLELKHKHDVIMKSQLRHKSsLsRRTsSAGSRGKVVRRAsL |
| Q99418 | S392 | GPS6|SIGNOR|ELM|EPSD|PSP | CYTH2 ARNO PSCD2 PSCD2L | QAAVSVDPFYEMLAARKKRIsVKKKQEQP____________ |
| Q99613 | S865 | Sugiyama | EIF3C EIF3S8 | HRTEPTAQQNLALQLAEKLGsLVENNERVFDHKQGtyGGyF |
| Q99623 | S39 | PSP | PHB2 BAP REA | MGTALKLLLGAGAVAYGVREsVFTVEGGHRAIFFNRIGGVQ |
| Q99801 | S48 | SIGNOR|EPSD|PSP | NKX3-1 NKX3.1 NKX3A | SFLIQDILRDGAQRQGGRTSsQRQRDPEPEPEPEPEGGRSR |
| Q99848 | S270 | Sugiyama | EBNA1BP2 EBP2 | FGGKKKGSKWNtREsyDDVssFRAKTAHGRGLKRPGKKGSN |
| Q9BPZ7 | S128 | PSP | MAPKAP1 MIP1 SIN1 | WKERNSKQSAQELKSLFEKKsLKEKPPISGKQSILSVRLEQ |
| Q9BQE3 | S158 | EPSD|PSP | TUBA1C TUBA6 | FHSFGGGTGSGFTSLLMERLsVDYGKKsKLEFSIYPAPQVS |
| Q9BQE3 | S165 | GPS6|EPSD|PSP | TUBA1C TUBA6 | TGSGFTSLLMERLsVDYGKKsKLEFSIYPAPQVSTAVVEPY |
| Q9BR39 | S165 | EPSD|PSP | JPH2 JP2 | QSVPYGMAVVVRsPLRtsLssLRsEHsNGtVAPDSPAsPAS |
| Q9BR76 | S2 | SIGNOR|iPTMNet|EPSD|PSP | CORO1B | ___________________MsFRKVVRQSKFRHVFGQPVKN |
| Q9BVA1 | S75 | Sugiyama | TUBB2B | tGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| Q9BX40 | S349 | Sugiyama | LSM14B C20orf40 FAM61B RAP55B | SSRRTTWAEERKLNtEtFGVsGRFLRGRSSRGGFRGGRGNG |
| Q9BXS6 | S363 | Sugiyama | NUSAP1 ANKT BM-037 PRO0310 | TtEAtQtPVsNKKPVFDLKAsLsRPLNyEPHKGKLKPWGQS |
| Q9BYX7 | S368 | Sugiyama | POTEKP ACTBL3 FKSG30 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q9BYX7 | Y240 | Sugiyama | POTEKP ACTBL3 FKSG30 | ALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPEA |
| Q9BZL6 | S706 | SIGNOR|EPSD|PSP | PRKD2 PKD2 HSPC187 | DPFPQVKLCDFGFARIIGEKsFRRsVVGtPAyLAPEVLLNQ |
| Q9BZL6 | S710 | SIGNOR|EPSD|PSP | PRKD2 PKD2 HSPC187 | QVKLCDFGFARIIGEKsFRRsVVGtPAyLAPEVLLNQGyNR |
| Q9BZL6 | S876 | SIGNOR|EPSD|PSP | PRKD2 PKD2 HSPC187 | DLGGACPPQDHDMQGLAERIsVL__________________ |
| Q9C0K0 | S2 | EPSD|PSP | BCL11B CTIP2 RIT1 | ___________________MsRRKQGNPQHLSQRELITPEA |
| Q9GZT3 | S15 | Sugiyama | SLIRP C14orf156 DC23 DC50 PD04872 | ______MAASAARGAAALRRsINQPVAFVRRIPWTAASSQL |
| Q9H0B6 | S539 | Sugiyama | KLC2 | sEsDLEDVGPTAEWNGDGsGsLRRSGsFGKLRDALRRsSEM |
| Q9H0H5 | T251 | Sugiyama | RACGAP1 KIAA1478 MGCRACGAP | EAVSTIETVPYWtRSRRKtGtLQPWNsDstLNSRQLEPRTE |
| Q9H1D0 | T742 | EPSD|PSP | TRPV6 ECAC2 | PSVSRStSRssANWERLRQGtLRRDLRGIINRGLEDGESWE |
| Q9H3Q1 | S18 | SIGNOR|PSP | CDC42EP4 BORG4 CEP4 | ___MPILKQLVSssVHSKRRsRADLtAEMISAPLGDFRHTM |
| Q9H3Q1 | S80 | SIGNOR|PSP | CDC42EP4 BORG4 CEP4 | PDGEsLDEQPsSsssKRsLLsRKFRGSKRSQSVTRGEREQR |
| Q9H788 | S315 | Sugiyama | SH2D4A PPP1R38 SH2A | LNSGAYPQKPLRNQGVVRtLsssAQEDIIRWFKEEQLPLRA |
| Q9HAN9 | S136 | EPSD|PSP | NMNAT1 NMNAT | NsPtLERPGRKRKWTETQDssQKKSLEPKTKAVPKVKLLCG |
| Q9HBA0 | S162 | SIGNOR | TRPV4 VRL2 VROAC | PPPILKVFNRPILFDIVSRGsTADLDGLLPFLLtHKKRLTD |
| Q9HBA0 | S189 | SIGNOR | TRPV4 VRL2 VROAC | LLPFLLtHKKRLTDEEFREPsTGKTCLPKALLNLSNGRNDT |
| Q9HBA0 | T175 | SIGNOR | TRPV4 VRL2 VROAC | FDIVSRGsTADLDGLLPFLLtHKKRLTDEEFREPsTGKTCL |
| Q9NPC2 | T341 | SIGNOR|PSP | KCNK9 TASK3 | KLAPHYFHSISYKIEEISPStLKNSLFPSPISSISPGLHSF |
| Q9NQ39 | S157 | Sugiyama | RPS10P5 RPS10L | TYRRCSVPPGADKKAEAGAGsAtEFQFRGRCGRGRGQPPQ_ |
| Q9NQ66 | S887 | SIGNOR|ELM|iPTMNet|EPSD | PLCB1 KIAA0581 | TTTLTPKPPSQALHSQPAPGsVKAPAKTEDLIQSVLTEVEA |
| Q9NQA5 | S299 | SIGNOR|EPSD|PSP | TRPV5 ECAC1 | DLTEIDSWGEELSFLELVVSsDKREARQILEQTPVKELVSF |
| Q9NQA5 | S654 | SIGNOR|EPSD|PSP | TRPV5 ECAC1 | ENHNDQNPLRVLRyVEVFKNsDKEDDQEHPSEKQPSGAESG |
| Q9NRF2 | S161 | EPSD|PSP | SH2B1 KIAA1299 SH2B | STTSSKPKLKKRFSLRSVGRsVRGsVRGILQWRGTVDPPSS |
| Q9NRF2 | S165 | EPSD|PSP | SH2B1 KIAA1299 SH2B | SKPKLKKRFSLRSVGRsVRGsVRGILQWRGTVDPPSSAGPL |
| Q9NRY4 | S1221 | GPS6|EPSD|PSP | ARHGAP35 GRF1 GRLF1 KIAA1722 P190A p190ARHOGAP | DNAVIPYETDEDPRRRNILRsLRRNtKKPKPKPRPsITKAT |
| Q9NRY4 | S1236 | GPS6|EPSD|PSP | ARHGAP35 GRF1 GRLF1 KIAA1722 P190A p190ARHOGAP | RNILRsLRRNtKKPKPKPRPsITKATWESNYFGVPLTTVVT |
| Q9NRY4 | T1226 | GPS6|EPSD|PSP | ARHGAP35 GRF1 GRLF1 KIAA1722 P190A p190ARHOGAP | PYETDEDPRRRNILRsLRRNtKKPKPKPRPsITKATWESNY |
| Q9NSB2 | S178 | Sugiyama | KRT84 KRTHB4 | AQRVKKDEKEQIKTLNNKFAsFIDKVRFLEQQNKLLETKWS |
| Q9NTW7 | S226 | PSP | ZFP64 ZNF338 | KTCDYAAADSSSLNKHLRIHsDERPFKCQICPYASRNSSQL |
| Q9NXH3 | T58 | GPS6|ELM|EPSD | PPP1R14D GBPI | ESKSHPDSSKIPRSRRPSRLtVKYDRGQLQRWLEMEQWVDA |
| Q9NZ01 | S49 | Sugiyama | TECR GPSN2 SC2 | IAEIKNLFTKTHPQWYPARQsLRLDPKGKsLKDEDVLQKLP |
| Q9P286 | S99 | PSP | PAK5 KIAA1264 PAK7 | ETSINGLLEDFDNISVTRSNsLRKESPPTPDQGASSHGPGH |
| Q9UBS0 | S473 | GPS6|SIGNOR|ELM|EPSD|PSP | RPS6KB2 STK14B | PPPPSTTAPLPIRPPSGTKKsKRGRGRPGR___________ |
| Q9UEY8 | S693 | SIGNOR|ELM|iPTMNet|EPSD | ADD3 ADDL | sPEGsPsKsPsKKKKKFRTPsFLKKNKKKEKVEA_______ |
| Q9UGV2 | S327 | Sugiyama | NDRG3 | KYFLQGMGYIPSASMTRLARsRtHstsssLGsGEsPFsRsV |
| Q9UGV2 | S333 | Sugiyama | NDRG3 | MGYIPSASMTRLARsRtHstsssLGsGEsPFsRsVtsNQsD |
| Q9UGV2 | T329 | Sugiyama | NDRG3 | FLQGMGYIPSASMTRLARsRtHstsssLGsGEsPFsRsVts |
| Q9UGV2 | T332 | Sugiyama | NDRG3 | GMGYIPSASMTRLARsRtHstsssLGsGEsPFsRsVtsNQs |
| Q9UH77 | S433 | SIGNOR|EPSD|PSP | KLHL3 KIAA1129 | AYSYKTNEWFFVAPMNTRRSsVGVGVVEGKLYAVGGYDGAS |
| Q9UI15 | S185 | Sugiyama | TAGLN3 NP25 | EQLRQGQNVIGLQMGSNKGAsQAGMtGyGMPRQIM______ |
| Q9UI26 | S214 | Sugiyama | IPO11 RANBP11 | QEVSSGNEAAILSSLERTLLsLKVLRKLTVNGFVEPHKNME |
| Q9UII2 | S39 | Sugiyama | ATP5IF1 ATPI ATPIF1 | TMQARGFGsDQSENVDRGAGsIREAGGAFGKREQAEEERyF |
| Q9UJY1 | S14 | SIGNOR|ELM|iPTMNet|EPSD | HSPB8 CRYAC E2IG1 HSP22 PP1629 | _______MADGQMPFSCHYPsRLRRDPFRDsPLsSRLLDDG |
| Q9UJY1 | T63 | SIGNOR|ELM|iPTMNet|EPSD | HSPB8 CRYAC E2IG1 HSP22 PP1629 | DLTASWPDWALPRLsSAWPGtLRSGMVPRGPTATARFGVPA |
| Q9UKF7 | S274 | SIGNOR|PSP | PITPNC1 | PAISISSIPLLPSSVRsAPssAPstPLSTDAPEFLSVPKDR |
| Q9UKF7 | S299 | SIGNOR|PSP | PITPNC1 | PLSTDAPEFLSVPKDRPRKKsAPEtLTLPDPEKKATLNLPG |
| Q9UKG1 | S430 | EPSD|PSP | APPL1 APPL DIP13A KIAA1428 | sLRPAAGQSRPPTARTSSSGsLGSESTNLAALSLDSLVAPD |
| Q9UKV8 | S387 | Sugiyama | AGO2 EIF2C2 | ATARSAPDRQEEISKLMRsAsFNTDPyVREFGIMVKDEMTD |
| Q9ULW6 | T342 | Sugiyama | NAP1L2 BPX | GTAIEYSTGCEIDWNEGKNVtLKtIKKKQKHRIWGTIRTVT |
| Q9ULW6 | T345 | Sugiyama | NAP1L2 BPX | IEYSTGCEIDWNEGKNVtLKtIKKKQKHRIWGTIRTVTEDF |
| Q9UNF0 | S313 | PSP | PACSIN2 | GMAMNWPQFEEWsADLNRtLsRREKKKAtDGVTLTGINQTG |
| Q9UNX3 | S9 | Sugiyama | RPL26L1 RPL26P1 | ____________MKFNPFVtsDRsKNRKRHFNAPSHVRRKI |
| Q9UNZ2 | S74 | Sugiyama | NSFL1C UBXN2C | SQATPssVsRGTAPSDNRVtsFRDLIHDQDEDEEEEEGQRF |
| Q9UQ13 | S297 | SIGNOR|EPSD|PSP | SHOC2 KIAA0862 | PDTIGNLSSLSRLGLRYNRLsAIPRSLAKCSALEELNLENN |
| Q9UQ13 | T71 | SIGNOR|EPSD|PSP | SHOC2 KIAA0862 | KDGKKDSSAAQPGVAFSVDNtIKRPNPAPGTRKKSSNAEVI |
| Q9UQ35 | S2692 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | ERRSRSPRKPIDsLRDsRsLsysPVERRRPsPQPsPRDQQS |
| Q9UQ35 | S854 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sHSsssPHPKVKsGtPPRQGsItsPQANEQsVtPQRRsCFE |
| Q9UQ80 | S360 | EPSD|PSP | PA2G4 EBP1 | PDLyKsEMEVQDAELKALLQssAsRKtQKKKKKKAsKtAEN |
| Q9UQ80 | S363 | SIGNOR|iPTMNet|EPSD | PA2G4 EBP1 | yKsEMEVQDAELKALLQssAsRKtQKKKKKKAsKtAENAts |
| Q9UQ80 | T366 | SIGNOR|iPTMNet|EPSD|PSP | PA2G4 EBP1 | EMEVQDAELKALLQssAsRKtQKKKKKKAsKtAENAtsGEt |
| Q9UQL6 | S259 | SIGNOR | HDAC5 KIAA0600 | KLPLPGPYDSRDDFPLRKTAsEPNLKVRSRLKQKVAERRss |
| Q9UQL6 | S498 | SIGNOR | HDAC5 KIAA0600 | ATSMRTVGKLPRHRPLSRtQssPLPQSPQALQQLVMQQQHQ |
| Q9Y271 | S313 | PSP | CYSLTR1 CYSLT1 | LLYFFSGGNFRKRLSTFRKHsLssVTYVPRKKAsLPEKGEE |
| Q9Y271 | S315 | PSP | CYSLTR1 CYSLT1 | YFFSGGNFRKRLSTFRKHsLssVTYVPRKKAsLPEKGEEIC |
| Q9Y271 | S316 | PSP | CYSLTR1 CYSLT1 | FFSGGNFRKRLSTFRKHsLssVTYVPRKKAsLPEKGEEICK |
| Q9Y2B0 | S55 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDELEWEIAQVDPKKTIQMGsFRINPDGsQsVVEVPyARsE |
| Q9Y2B0 | S65 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLEEI |
| Q9Y2R2 | S751 | PSP | PTPN22 PTPN8 | NSTSSKQTLKTPGKSFTRSKsLKILRNMKKSICNSCPPNKP |
| Q9Y2W1 | S257 | Sugiyama | THRAP3 BCLAF2 TRAP150 | sAVsELsPRERsPALKsPLQsVVVRRRsPRPsPVPKPSPPL |
| Q9Y2X3 | S440 | Sugiyama | NOP58 NOL5 NOP5 HSPC120 | EHKSEVKtyDPSGDstLPtCsKKRKIEQVDKEDEITEKKAK |
| Q9Y3B8 | S203 | Sugiyama | REXO2 SFN SMFN CGI-114 | EYEFAPKKAAsHRALDDIsEsIKELQFyRNNIFKKKIDEKK |
| Q9Y5B9 | S650 | Sugiyama | SUPT16H FACT140 FACTP140 | KRYKTREAEEKEKEGIVKQDsLVINLNRsNPKLKDLYIRPN |
| Q9Y624 | S284 | SIGNOR|EPSD|PSP | F11R JAM1 JCAM UNQ264/PRO301 | GHFDRTKKGtSSKKVIysQPsARsEGEFKQTSsFLV_____ |
| Q9Y624 | T70 | iPTMNet|EPSD | F11R JAM1 JCAM UNQ264/PRO301 | CAYSGFSSPRVEWKFDQGDTtRLVCYNNKITASYEDRVTFL |
| Q9Y624 | T92 | SIGNOR|iPTMNet|EPSD | F11R JAM1 JCAM UNQ264/PRO301 | LVCYNNKITASYEDRVTFLPtGITFKSVTREDTGTYTCMVS |
| Q9Y6H6 | S82 | EPSD|PSP | KCNE3 | LFVMFLFAVTVGSLILGYTRsRKVDKRSDPYHVYIKNRVSM |
| Q9Y6K9 | S141 | GPS6 | IKBKG FIP3 NEMO | ALREVEHLKRCQQQMAEDKAsVKAQVTSLLGELQESQSRLE |
| Q9Y6K9 | S85 | GPS6 | IKBKG FIP3 NEMO | IRQsNQILRERCEELLHFQAsQREEKEFLMCKFQEARKLVE |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle | R-HSA-1640170 | 3.839151e-13 | 12.416 | 1 | 0 |
| Signal Transduction | R-HSA-162582 | 1.410424e-10 | 9.851 | 1 | 0 |
| Cellular Senescence | R-HSA-2559583 | 2.678154e-10 | 9.572 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 6.113072e-10 | 9.214 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 6.924004e-10 | 9.160 | 1 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 1.521629e-09 | 8.818 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 2.729391e-09 | 8.564 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.483531e-08 | 7.829 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 3.661445e-08 | 7.436 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 6.015597e-08 | 7.221 | 0 | 0 |
| M Phase | R-HSA-68886 | 6.216715e-08 | 7.206 | 1 | 0 |
| DNA methylation | R-HSA-5334118 | 6.642281e-08 | 7.178 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 1.126864e-07 | 6.948 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.094265e-07 | 6.961 | 1 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 1.218238e-07 | 6.914 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 1.418915e-07 | 6.848 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.841226e-07 | 6.735 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.969235e-07 | 6.706 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 2.149438e-07 | 6.668 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 2.810392e-07 | 6.551 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 3.793903e-07 | 6.421 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 4.167307e-07 | 6.380 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 4.068044e-07 | 6.391 | 1 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 5.036293e-07 | 6.298 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 5.036293e-07 | 6.298 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 5.538641e-07 | 6.257 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 5.870879e-07 | 6.231 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 6.726384e-07 | 6.172 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 7.621664e-07 | 6.118 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 9.534072e-07 | 6.021 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 1.658665e-06 | 5.780 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 1.780646e-06 | 5.749 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 1.958238e-06 | 5.708 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.941070e-06 | 5.712 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 2.357414e-06 | 5.628 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 2.332070e-06 | 5.632 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 2.364088e-06 | 5.626 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 2.497823e-06 | 5.602 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 2.651666e-06 | 5.576 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 2.726050e-06 | 5.564 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 3.096036e-06 | 5.509 | 1 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 3.078154e-06 | 5.512 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 3.116656e-06 | 5.506 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 3.697914e-06 | 5.432 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 3.961687e-06 | 5.402 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 3.961687e-06 | 5.402 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 3.804491e-06 | 5.420 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 4.152359e-06 | 5.382 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 4.996530e-06 | 5.301 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 6.309291e-06 | 5.200 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 6.957398e-06 | 5.158 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 7.509678e-06 | 5.124 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 8.509311e-06 | 5.070 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 8.514761e-06 | 5.070 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 9.041943e-06 | 5.044 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 8.855631e-06 | 5.053 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 9.094422e-06 | 5.041 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 9.094422e-06 | 5.041 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 9.422468e-06 | 5.026 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 1.086603e-05 | 4.964 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 2.015196e-05 | 4.696 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 2.260484e-05 | 4.646 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 2.394292e-05 | 4.621 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 2.590793e-05 | 4.587 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 2.612380e-05 | 4.583 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 2.804215e-05 | 4.552 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 2.976781e-05 | 4.526 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 3.055875e-05 | 4.515 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 3.597826e-05 | 4.444 | 0 | 0 |
| Depurination | R-HSA-73927 | 3.769813e-05 | 4.424 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 3.984354e-05 | 4.400 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 4.620272e-05 | 4.335 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 4.669038e-05 | 4.331 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 5.093504e-05 | 4.293 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 4.985355e-05 | 4.302 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 5.388734e-05 | 4.269 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 6.151352e-05 | 4.211 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 6.288255e-05 | 4.201 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 6.811602e-05 | 4.167 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 6.811602e-05 | 4.167 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 7.021199e-05 | 4.154 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 7.577999e-05 | 4.120 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 8.407420e-05 | 4.075 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 8.749827e-05 | 4.058 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 9.734293e-05 | 4.012 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 9.799323e-05 | 4.009 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.052896e-04 | 3.978 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 1.113200e-04 | 3.953 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 1.384363e-04 | 3.859 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 1.450597e-04 | 3.838 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 1.450597e-04 | 3.838 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.483950e-04 | 3.829 | 1 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.644850e-04 | 3.784 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.861587e-04 | 3.730 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.873291e-04 | 3.727 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 1.926526e-04 | 3.715 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 2.038778e-04 | 3.691 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 2.211287e-04 | 3.655 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 2.434364e-04 | 3.614 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 2.465224e-04 | 3.608 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 2.584026e-04 | 3.588 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 2.640918e-04 | 3.578 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 2.642533e-04 | 3.578 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 3.146802e-04 | 3.502 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 3.211064e-04 | 3.493 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 3.316054e-04 | 3.479 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 3.413567e-04 | 3.467 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 3.492325e-04 | 3.457 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 3.939448e-04 | 3.405 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 4.008176e-04 | 3.397 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 4.453449e-04 | 3.351 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 5.107672e-04 | 3.292 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 5.164698e-04 | 3.287 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 5.770280e-04 | 3.239 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 5.840143e-04 | 3.234 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 6.147631e-04 | 3.211 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 6.509280e-04 | 3.186 | 1 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 6.667633e-04 | 3.176 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 7.037904e-04 | 3.153 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 8.083058e-04 | 3.092 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 8.432907e-04 | 3.074 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 8.432907e-04 | 3.074 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.004362e-03 | 2.998 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.004362e-03 | 2.998 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 1.022404e-03 | 2.990 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.107937e-03 | 2.955 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.167419e-03 | 2.933 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 1.303806e-03 | 2.885 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.221424e-03 | 2.913 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 1.211504e-03 | 2.917 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 1.475491e-03 | 2.831 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 1.582754e-03 | 2.801 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 1.710802e-03 | 2.767 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 1.722991e-03 | 2.764 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.774321e-03 | 2.751 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 1.779895e-03 | 2.750 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 1.811863e-03 | 2.742 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.859562e-03 | 2.731 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 1.979175e-03 | 2.704 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 2.106865e-03 | 2.676 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 2.106865e-03 | 2.676 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 1.998409e-03 | 2.699 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 2.107754e-03 | 2.676 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 2.160973e-03 | 2.665 | 0 | 0 |
| Kinesins | R-HSA-983189 | 2.227529e-03 | 2.652 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 2.299990e-03 | 2.638 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 2.302209e-03 | 2.638 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 2.619684e-03 | 2.582 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 2.776136e-03 | 2.557 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 2.887867e-03 | 2.539 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 3.005389e-03 | 2.522 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 3.036534e-03 | 2.518 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 3.006578e-03 | 2.522 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 3.005389e-03 | 2.522 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 2.887867e-03 | 2.539 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 3.315183e-03 | 2.479 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 3.367532e-03 | 2.473 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 3.367532e-03 | 2.473 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 3.515776e-03 | 2.454 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 3.822935e-03 | 2.418 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 3.978638e-03 | 2.400 | 1 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 4.002439e-03 | 2.398 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 4.002439e-03 | 2.398 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 4.002439e-03 | 2.398 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 4.543766e-03 | 2.343 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 4.543766e-03 | 2.343 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 4.515252e-03 | 2.345 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 4.700313e-03 | 2.328 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 5.254501e-03 | 2.279 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 5.304456e-03 | 2.275 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 5.304456e-03 | 2.275 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 5.345148e-03 | 2.272 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 5.583378e-03 | 2.253 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 5.583378e-03 | 2.253 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 5.590252e-03 | 2.253 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 5.615584e-03 | 2.251 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 6.112816e-03 | 2.214 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 6.189957e-03 | 2.208 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 6.241228e-03 | 2.205 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 6.269361e-03 | 2.203 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 6.328824e-03 | 2.199 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 7.149744e-03 | 2.146 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 7.134019e-03 | 2.147 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 6.498416e-03 | 2.187 | 1 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 7.134019e-03 | 2.147 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 7.208604e-03 | 2.142 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 7.352782e-03 | 2.134 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 7.439642e-03 | 2.128 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 7.617264e-03 | 2.118 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 7.870339e-03 | 2.104 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 7.952656e-03 | 2.099 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 8.214539e-03 | 2.085 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 8.594707e-03 | 2.066 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 8.594707e-03 | 2.066 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 8.616257e-03 | 2.065 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 9.250371e-03 | 2.034 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 9.311981e-03 | 2.031 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 9.828088e-03 | 2.008 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 1.109303e-02 | 1.955 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 1.109303e-02 | 1.955 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 1.143920e-02 | 1.942 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 1.120810e-02 | 1.950 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.207697e-02 | 1.918 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 1.120506e-02 | 1.951 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.281289e-02 | 1.892 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 1.360593e-02 | 1.866 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 1.474450e-02 | 1.831 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 1.485699e-02 | 1.828 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.552899e-02 | 1.809 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.588506e-02 | 1.799 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 1.591726e-02 | 1.798 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 1.592147e-02 | 1.798 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 1.632523e-02 | 1.787 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 1.651357e-02 | 1.782 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 1.863551e-02 | 1.730 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 1.881508e-02 | 1.725 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.881508e-02 | 1.725 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 1.920212e-02 | 1.717 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.983258e-02 | 1.703 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 1.990583e-02 | 1.701 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 2.014678e-02 | 1.696 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 2.022388e-02 | 1.694 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 2.117815e-02 | 1.674 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 2.136894e-02 | 1.670 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 2.183593e-02 | 1.661 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 2.572564e-02 | 1.590 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 2.301997e-02 | 1.638 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 2.414398e-02 | 1.617 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 2.572564e-02 | 1.590 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 2.572564e-02 | 1.590 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 2.545963e-02 | 1.594 | 1 | 0 |
| Developmental Biology | R-HSA-1266738 | 2.554144e-02 | 1.593 | 1 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 2.600033e-02 | 1.585 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 2.688885e-02 | 1.570 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 2.756828e-02 | 1.560 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 2.776960e-02 | 1.556 | 1 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 2.818928e-02 | 1.550 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 2.818928e-02 | 1.550 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 2.818928e-02 | 1.550 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 2.950078e-02 | 1.530 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 2.950078e-02 | 1.530 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 2.955419e-02 | 1.529 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 2.955419e-02 | 1.529 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 2.959219e-02 | 1.529 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 2.963499e-02 | 1.528 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 3.006059e-02 | 1.522 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 3.006059e-02 | 1.522 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 3.009245e-02 | 1.522 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 3.326238e-02 | 1.478 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 3.326238e-02 | 1.478 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 3.326238e-02 | 1.478 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 3.326238e-02 | 1.478 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 3.326238e-02 | 1.478 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 3.326238e-02 | 1.478 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 3.326238e-02 | 1.478 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 3.326238e-02 | 1.478 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 3.326238e-02 | 1.478 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 3.509026e-02 | 1.455 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 3.208655e-02 | 1.494 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 3.519741e-02 | 1.453 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 3.519741e-02 | 1.453 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 3.443930e-02 | 1.463 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 3.489338e-02 | 1.457 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 3.375496e-02 | 1.472 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 3.045155e-02 | 1.516 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 3.409916e-02 | 1.467 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 3.398257e-02 | 1.469 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 3.109929e-02 | 1.507 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 3.532036e-02 | 1.452 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 3.540961e-02 | 1.451 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 3.601274e-02 | 1.444 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 3.604641e-02 | 1.443 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 3.614542e-02 | 1.442 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 3.635637e-02 | 1.439 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 3.667169e-02 | 1.436 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 3.759350e-02 | 1.425 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 3.935281e-02 | 1.405 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 4.024840e-02 | 1.395 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 4.052707e-02 | 1.392 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 4.114850e-02 | 1.386 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 4.114850e-02 | 1.386 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 4.169758e-02 | 1.380 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 4.254792e-02 | 1.371 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 4.316871e-02 | 1.365 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 4.442395e-02 | 1.352 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 4.614769e-02 | 1.336 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 4.690948e-02 | 1.329 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 4.760200e-02 | 1.322 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 4.785412e-02 | 1.320 | 1 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 4.801611e-02 | 1.319 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 5.477328e-02 | 1.261 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 5.477328e-02 | 1.261 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 5.477328e-02 | 1.261 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 5.477328e-02 | 1.261 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 5.477328e-02 | 1.261 | 0 | 0 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | R-HSA-2644607 | 5.477328e-02 | 1.261 | 0 | 0 |
| FBXW7 Mutants and NOTCH1 in Cancer | R-HSA-2644605 | 5.477328e-02 | 1.261 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 5.547649e-02 | 1.256 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 5.583733e-02 | 1.253 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 5.583733e-02 | 1.253 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 5.758030e-02 | 1.240 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 5.470233e-02 | 1.262 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 5.673140e-02 | 1.246 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 5.406338e-02 | 1.267 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 5.406338e-02 | 1.267 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 5.336123e-02 | 1.273 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 6.128039e-02 | 1.213 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 5.583733e-02 | 1.253 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 5.477328e-02 | 1.261 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 5.470233e-02 | 1.262 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 6.010967e-02 | 1.221 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 6.228154e-02 | 1.206 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 5.436747e-02 | 1.265 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 5.347553e-02 | 1.272 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 5.388130e-02 | 1.269 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 6.246698e-02 | 1.204 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 6.246698e-02 | 1.204 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 6.254683e-02 | 1.204 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 6.442742e-02 | 1.191 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 6.442742e-02 | 1.191 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 6.501351e-02 | 1.187 | 1 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 6.708254e-02 | 1.173 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 6.729041e-02 | 1.172 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 6.779526e-02 | 1.169 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 6.824181e-02 | 1.166 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 6.824181e-02 | 1.166 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 6.824181e-02 | 1.166 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 6.824181e-02 | 1.166 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 6.824181e-02 | 1.166 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 6.824181e-02 | 1.166 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 6.829804e-02 | 1.166 | 0 | 0 |
| Transport of glycerol from adipocytes to the liver by Aquaporins | R-HSA-432030 | 6.829804e-02 | 1.166 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 6.829804e-02 | 1.166 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 6.829804e-02 | 1.166 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 6.829804e-02 | 1.166 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 6.905905e-02 | 1.161 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 7.090922e-02 | 1.149 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 7.090922e-02 | 1.149 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 7.090922e-02 | 1.149 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 7.113569e-02 | 1.148 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 7.299654e-02 | 1.137 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 7.299654e-02 | 1.137 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 7.299654e-02 | 1.137 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 7.299654e-02 | 1.137 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 7.553063e-02 | 1.122 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 7.611713e-02 | 1.119 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 7.659410e-02 | 1.116 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 7.863523e-02 | 1.104 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 7.863523e-02 | 1.104 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 7.863523e-02 | 1.104 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 9.297671e-02 | 1.032 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 9.297671e-02 | 1.032 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 7.966144e-02 | 1.099 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 7.966144e-02 | 1.099 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 7.966144e-02 | 1.099 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 7.966144e-02 | 1.099 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 7.966144e-02 | 1.099 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 7.966144e-02 | 1.099 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 9.664309e-02 | 1.015 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 9.664309e-02 | 1.015 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 8.112495e-02 | 1.091 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 9.580791e-02 | 1.019 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 8.894193e-02 | 1.051 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 9.384474e-02 | 1.028 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 9.405898e-02 | 1.027 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 9.551869e-02 | 1.020 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 8.456366e-02 | 1.073 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 8.257686e-02 | 1.083 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 9.664309e-02 | 1.015 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 8.894193e-02 | 1.051 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 9.297671e-02 | 1.032 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 9.023960e-02 | 1.045 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 7.755111e-02 | 1.110 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 9.254701e-02 | 1.034 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 7.871459e-02 | 1.104 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 9.013374e-02 | 1.045 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 9.664309e-02 | 1.015 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 9.287479e-02 | 1.032 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 9.504576e-02 | 1.022 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 8.573514e-02 | 1.067 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 8.697798e-02 | 1.061 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 8.424047e-02 | 1.074 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.097548e-02 | 1.041 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 8.003788e-02 | 1.097 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 8.771106e-02 | 1.057 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 9.580791e-02 | 1.019 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 1.003670e-01 | 0.998 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 1.003670e-01 | 0.998 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 1.012490e-01 | 0.995 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.025156e-01 | 0.989 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 1.062132e-01 | 0.974 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 1.062132e-01 | 0.974 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 1.062132e-01 | 0.974 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 1.064879e-01 | 0.973 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.068245e-01 | 0.971 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 1.072581e-01 | 0.970 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.102098e-01 | 0.958 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.105735e-01 | 0.956 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.109341e-01 | 0.955 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 1.109341e-01 | 0.955 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 1.109341e-01 | 0.955 | 0 | 0 |
| Diseases of cellular response to stress | R-HSA-9675132 | 1.109341e-01 | 0.955 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.109341e-01 | 0.955 | 0 | 0 |
| Diseases of Cellular Senescence | R-HSA-9630747 | 1.109341e-01 | 0.955 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.109341e-01 | 0.955 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.109341e-01 | 0.955 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.109341e-01 | 0.955 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.109341e-01 | 0.955 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.109341e-01 | 0.955 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 1.109341e-01 | 0.955 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.109341e-01 | 0.955 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.109341e-01 | 0.955 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.109341e-01 | 0.955 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.109341e-01 | 0.955 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 1.115623e-01 | 0.952 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 1.118074e-01 | 0.952 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 1.118074e-01 | 0.952 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 1.118074e-01 | 0.952 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 1.134859e-01 | 0.945 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 1.144582e-01 | 0.941 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 1.152502e-01 | 0.938 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 1.152502e-01 | 0.938 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.152502e-01 | 0.938 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.152502e-01 | 0.938 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 1.152502e-01 | 0.938 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 1.152965e-01 | 0.938 | 0 | 0 |
| Drug resistance of KIT mutants | R-HSA-9669937 | 1.320255e-01 | 0.879 | 0 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 1.320255e-01 | 0.879 | 0 | 0 |
| KIT mutants bind TKIs | R-HSA-9669921 | 1.320255e-01 | 0.879 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 1.320255e-01 | 0.879 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p14ARF Defects | R-HSA-9646303 | 1.320255e-01 | 0.879 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 1.320255e-01 | 0.879 | 0 | 0 |
| Imatinib-resistant KIT mutants | R-HSA-9669917 | 1.320255e-01 | 0.879 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 1.320255e-01 | 0.879 | 0 | 0 |
| Nilotinib-resistant KIT mutants | R-HSA-9669926 | 1.320255e-01 | 0.879 | 0 | 0 |
| Masitinib-resistant KIT mutants | R-HSA-9669924 | 1.320255e-01 | 0.879 | 0 | 0 |
| Sorafenib-resistant KIT mutants | R-HSA-9669936 | 1.320255e-01 | 0.879 | 0 | 0 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 1.320255e-01 | 0.879 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p14ARF Defects | R-HSA-9646304 | 1.320255e-01 | 0.879 | 0 | 0 |
| Regorafenib-resistant KIT mutants | R-HSA-9669929 | 1.320255e-01 | 0.879 | 0 | 0 |
| Sunitinib-resistant KIT mutants | R-HSA-9669934 | 1.320255e-01 | 0.879 | 0 | 0 |
| Dasatinib-resistant KIT mutants | R-HSA-9669914 | 1.320255e-01 | 0.879 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 1.320255e-01 | 0.879 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 1.320255e-01 | 0.879 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 1.320255e-01 | 0.879 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 1.320255e-01 | 0.879 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.320255e-01 | 0.879 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 1.369638e-01 | 0.863 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 1.355200e-01 | 0.868 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 1.218288e-01 | 0.914 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 1.378487e-01 | 0.861 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 1.378487e-01 | 0.861 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 1.548352e-01 | 0.810 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 1.434866e-01 | 0.843 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 1.434866e-01 | 0.843 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 1.502195e-01 | 0.823 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.191836e-01 | 0.924 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.389319e-01 | 0.857 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.389319e-01 | 0.857 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 1.384184e-01 | 0.859 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.376152e-01 | 0.861 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 1.340252e-01 | 0.873 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 1.333790e-01 | 0.875 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 1.190140e-01 | 0.924 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 1.548352e-01 | 0.810 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 1.290699e-01 | 0.889 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 1.197704e-01 | 0.922 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 1.218288e-01 | 0.914 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 1.190140e-01 | 0.924 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 1.172329e-01 | 0.931 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 1.258924e-01 | 0.900 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 1.258924e-01 | 0.900 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 1.228827e-01 | 0.911 | 1 | 0 |
| G-protein mediated events | R-HSA-112040 | 1.191973e-01 | 0.924 | 1 | 0 |
| Opioid Signalling | R-HSA-111885 | 1.473964e-01 | 0.832 | 1 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 1.491445e-01 | 0.826 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 1.396068e-01 | 0.855 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 1.502195e-01 | 0.823 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 1.388127e-01 | 0.858 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 1.355200e-01 | 0.868 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 1.396068e-01 | 0.855 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 1.355200e-01 | 0.868 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 1.359670e-01 | 0.867 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 1.491445e-01 | 0.826 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 1.434866e-01 | 0.843 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 1.565180e-01 | 0.805 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 1.585547e-01 | 0.800 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 1.585547e-01 | 0.800 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 1.585547e-01 | 0.800 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 1.585547e-01 | 0.800 | 0 | 0 |
| CASP5-mediated substrate cleavage | R-HSA-9960525 | 1.585547e-01 | 0.800 | 0 | 0 |
| CASP4-mediated substrate cleavage | R-HSA-9960519 | 1.585547e-01 | 0.800 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 1.592397e-01 | 0.798 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 1.599450e-01 | 0.796 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.607584e-01 | 0.794 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 1.617420e-01 | 0.791 | 1 | 1 |
| Metabolism of non-coding RNA | R-HSA-194441 | 1.619853e-01 | 0.791 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 1.619853e-01 | 0.791 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.657752e-01 | 0.780 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 1.658057e-01 | 0.780 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 1.664411e-01 | 0.779 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.677088e-01 | 0.775 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 1.702674e-01 | 0.769 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 1.703099e-01 | 0.769 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 1.703099e-01 | 0.769 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 1.703099e-01 | 0.769 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 1.703099e-01 | 0.769 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 1.727307e-01 | 0.763 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.733735e-01 | 0.761 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 1.767736e-01 | 0.753 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.771174e-01 | 0.752 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 1.771174e-01 | 0.752 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.773389e-01 | 0.751 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 1.802835e-01 | 0.744 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 1.804212e-01 | 0.744 | 0 | 0 |
| Defective Mismatch Repair Associated With MLH1 | R-HSA-5545483 | 2.466269e-01 | 0.608 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function | R-HSA-9645722 | 2.466269e-01 | 0.608 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9630791 | 2.466269e-01 | 0.608 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9632697 | 2.466269e-01 | 0.608 | 0 | 0 |
| Defective Mismatch Repair Associated With PMS2 | R-HSA-5632987 | 2.466269e-01 | 0.608 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 2.466269e-01 | 0.608 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 2.091019e-01 | 0.680 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 2.091019e-01 | 0.680 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 2.091019e-01 | 0.680 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 2.091019e-01 | 0.680 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 2.091019e-01 | 0.680 | 0 | 0 |
| PI and PC transport between ER and Golgi membranes | R-HSA-1483196 | 3.461028e-01 | 0.461 | 0 | 0 |
| Signaling by extracellular domain mutants of KIT | R-HSA-9680187 | 3.461028e-01 | 0.461 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects | R-HSA-9632693 | 3.461028e-01 | 0.461 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p16INK4A Defects | R-HSA-9630750 | 3.461028e-01 | 0.461 | 0 | 0 |
| Abasic sugar-phosphate removal via the single-nucleotide replacement pathway | R-HSA-73930 | 3.461028e-01 | 0.461 | 0 | 0 |
| NFG and proNGF binds to p75NTR | R-HSA-205017 | 3.461028e-01 | 0.461 | 0 | 0 |
| Signaling by juxtamembrane domain KIT mutants | R-HSA-9669935 | 3.461028e-01 | 0.461 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9632700 | 3.461028e-01 | 0.461 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 3.461028e-01 | 0.461 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9630794 | 3.461028e-01 | 0.461 | 0 | 0 |
| MPS IIID - Sanfilippo syndrome D | R-HSA-2206305 | 3.461028e-01 | 0.461 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5619081 | 3.461028e-01 | 0.461 | 0 | 0 |
| Signaling by kinase domain mutants of KIT | R-HSA-9669933 | 3.461028e-01 | 0.461 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 3.461028e-01 | 0.461 | 0 | 0 |
| Defective PGM1 causes PGM1-CDG | R-HSA-5609974 | 3.461028e-01 | 0.461 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5660724 | 3.461028e-01 | 0.461 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 3.461028e-01 | 0.461 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 2.609736e-01 | 0.583 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.609736e-01 | 0.583 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 2.609736e-01 | 0.583 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 2.609736e-01 | 0.583 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 2.056737e-01 | 0.687 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.935860e-01 | 0.713 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 2.424997e-01 | 0.615 | 1 | 1 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 2.424997e-01 | 0.615 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 3.129396e-01 | 0.505 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 3.129396e-01 | 0.505 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 3.129396e-01 | 0.505 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 3.129396e-01 | 0.505 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 3.129396e-01 | 0.505 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 3.129396e-01 | 0.505 | 0 | 0 |
| HHAT G278V doesn't palmitoylate Hh-Np | R-HSA-5658034 | 4.324489e-01 | 0.364 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 4.324489e-01 | 0.364 | 0 | 0 |
| Defective visual phototransduction due to STRA6 loss of function | R-HSA-9918449 | 4.324489e-01 | 0.364 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 4.324489e-01 | 0.364 | 0 | 0 |
| TWIK related potassium channel (TREK) | R-HSA-1299503 | 4.324489e-01 | 0.364 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 2.226769e-01 | 0.652 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 2.226769e-01 | 0.652 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 2.802700e-01 | 0.552 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 2.802700e-01 | 0.552 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 2.043019e-01 | 0.690 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 1.876900e-01 | 0.727 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 2.528055e-01 | 0.597 | 1 | 1 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 2.528055e-01 | 0.597 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 2.528055e-01 | 0.597 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 3.640713e-01 | 0.439 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 3.640713e-01 | 0.439 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 3.640713e-01 | 0.439 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 3.640713e-01 | 0.439 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 3.185143e-01 | 0.497 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 3.185143e-01 | 0.497 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 2.837041e-01 | 0.547 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 2.837041e-01 | 0.547 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 2.109814e-01 | 0.676 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 1.930101e-01 | 0.714 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 2.109255e-01 | 0.676 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 2.820061e-01 | 0.550 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 3.151152e-01 | 0.502 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 3.151152e-01 | 0.502 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 3.151152e-01 | 0.502 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 3.568142e-01 | 0.448 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 3.568142e-01 | 0.448 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 3.568142e-01 | 0.448 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 3.568142e-01 | 0.448 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 4.136833e-01 | 0.383 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 4.136833e-01 | 0.383 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 4.136833e-01 | 0.383 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 4.136833e-01 | 0.383 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 4.136833e-01 | 0.383 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 4.136833e-01 | 0.383 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of other transcription factors | R-HSA-8866906 | 5.073974e-01 | 0.295 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 5.073974e-01 | 0.295 | 0 | 0 |
| Adrenaline signalling through Alpha-2 adrenergic receptor | R-HSA-392023 | 5.073974e-01 | 0.295 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 5.073974e-01 | 0.295 | 0 | 0 |
| Defective GCLC causes HAGGSD | R-HSA-5578999 | 5.073974e-01 | 0.295 | 0 | 0 |
| Classical Kir channels | R-HSA-1296053 | 5.073974e-01 | 0.295 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 5.073974e-01 | 0.295 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 5.073974e-01 | 0.295 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 2.097288e-01 | 0.678 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 2.520105e-01 | 0.599 | 1 | 1 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 3.091237e-01 | 0.510 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 3.091237e-01 | 0.510 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 3.467957e-01 | 0.460 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 2.733640e-01 | 0.563 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 3.022654e-01 | 0.520 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 3.948052e-01 | 0.404 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 3.948052e-01 | 0.404 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 3.948052e-01 | 0.404 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 3.948052e-01 | 0.404 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 3.948052e-01 | 0.404 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 3.948052e-01 | 0.404 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 3.948052e-01 | 0.404 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 2.402437e-01 | 0.619 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 2.402437e-01 | 0.619 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 2.402437e-01 | 0.619 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 3.365789e-01 | 0.473 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 3.365789e-01 | 0.473 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 2.626316e-01 | 0.581 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 2.571182e-01 | 0.590 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 3.785202e-01 | 0.422 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 3.785202e-01 | 0.422 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 4.612856e-01 | 0.336 | 1 | 1 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 4.612856e-01 | 0.336 | 0 | 0 |
| RSK activation | R-HSA-444257 | 4.612856e-01 | 0.336 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 4.612856e-01 | 0.336 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 3.173251e-01 | 0.498 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 2.614834e-01 | 0.583 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 2.614834e-01 | 0.583 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 2.614834e-01 | 0.583 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 2.614834e-01 | 0.583 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 2.614834e-01 | 0.583 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 3.514080e-01 | 0.454 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 4.100826e-01 | 0.387 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 4.100826e-01 | 0.387 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 3.918941e-01 | 0.407 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 3.762403e-01 | 0.425 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 2.574764e-01 | 0.589 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 4.011062e-01 | 0.397 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 4.194718e-01 | 0.377 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 4.194718e-01 | 0.377 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 4.194718e-01 | 0.377 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 4.686678e-01 | 0.329 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 5.065442e-01 | 0.295 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 5.065442e-01 | 0.295 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 3.920104e-01 | 0.407 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 3.473813e-01 | 0.459 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 4.259069e-01 | 0.371 | 1 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 4.720020e-01 | 0.326 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 3.794428e-01 | 0.421 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 5.040674e-01 | 0.298 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 5.040674e-01 | 0.298 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 5.040674e-01 | 0.298 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 4.738384e-01 | 0.324 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 4.749484e-01 | 0.323 | 1 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 5.020525e-01 | 0.299 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 5.020525e-01 | 0.299 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 5.492478e-01 | 0.260 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 5.492478e-01 | 0.260 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 5.492478e-01 | 0.260 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 4.182231e-01 | 0.379 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 5.004089e-01 | 0.301 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 5.004089e-01 | 0.301 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 5.004089e-01 | 0.301 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 4.213903e-01 | 0.375 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 5.382071e-01 | 0.269 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 5.382071e-01 | 0.269 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 4.978236e-01 | 0.303 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 5.313274e-01 | 0.275 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 4.958025e-01 | 0.305 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 5.264447e-01 | 0.279 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 5.264447e-01 | 0.279 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 5.264447e-01 | 0.279 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 5.227043e-01 | 0.282 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 5.227043e-01 | 0.282 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 5.340110e-01 | 0.272 | 1 | 1 |
| Viral mRNA Translation | R-HSA-192823 | 5.475883e-01 | 0.262 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 3.676297e-01 | 0.435 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 5.518654e-01 | 0.258 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 3.623901e-01 | 0.441 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 2.179294e-01 | 0.662 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 4.920012e-01 | 0.308 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 1.931267e-01 | 0.714 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 4.413174e-01 | 0.355 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 4.749484e-01 | 0.323 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 3.079268e-01 | 0.512 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 4.760971e-01 | 0.322 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 2.092031e-01 | 0.679 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 4.342323e-01 | 0.362 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 2.837041e-01 | 0.547 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 2.294524e-01 | 0.639 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 5.500175e-01 | 0.260 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 2.553865e-01 | 0.593 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 1.935860e-01 | 0.713 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 1.914699e-01 | 0.718 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 3.568142e-01 | 0.448 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 3.467957e-01 | 0.460 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 2.919600e-01 | 0.535 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 2.781758e-01 | 0.556 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 5.065442e-01 | 0.295 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 4.131374e-01 | 0.384 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 2.614834e-01 | 0.583 | 1 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 5.259998e-01 | 0.279 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 2.802700e-01 | 0.552 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 4.686678e-01 | 0.329 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 5.020525e-01 | 0.299 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 4.958025e-01 | 0.305 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 4.259869e-01 | 0.371 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 2.130602e-01 | 0.671 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 4.590097e-01 | 0.338 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 5.500175e-01 | 0.260 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 2.424997e-01 | 0.615 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 4.612856e-01 | 0.336 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 1.908321e-01 | 0.719 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 1.908321e-01 | 0.719 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 4.100826e-01 | 0.387 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 2.294524e-01 | 0.639 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 2.494461e-01 | 0.603 | 1 | 0 |
| Signaling by PDGF | R-HSA-186797 | 5.311625e-01 | 0.275 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 2.091019e-01 | 0.680 | 0 | 0 |
| Formation of lateral plate mesoderm | R-HSA-9758920 | 3.129396e-01 | 0.505 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 2.837041e-01 | 0.547 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 4.136833e-01 | 0.383 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 3.267135e-01 | 0.486 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 3.642177e-01 | 0.439 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 3.397618e-01 | 0.469 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 3.042359e-01 | 0.517 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 3.528639e-01 | 0.452 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 5.020525e-01 | 0.299 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 5.492478e-01 | 0.260 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 4.598140e-01 | 0.337 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 5.114767e-01 | 0.291 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 5.227043e-01 | 0.282 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 2.402437e-01 | 0.619 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 4.131374e-01 | 0.384 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 4.933696e-01 | 0.307 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 5.510321e-01 | 0.259 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 2.091019e-01 | 0.680 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 2.609736e-01 | 0.583 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 1.935860e-01 | 0.713 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 1.935860e-01 | 0.713 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 3.640713e-01 | 0.439 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 3.640713e-01 | 0.439 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 2.109814e-01 | 0.676 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 3.568142e-01 | 0.448 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 3.948052e-01 | 0.404 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 4.100826e-01 | 0.387 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 2.700992e-01 | 0.568 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 3.762403e-01 | 0.425 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 5.020525e-01 | 0.299 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 4.949279e-01 | 0.305 | 0 | 0 |
| S Phase | R-HSA-69242 | 2.004720e-01 | 0.698 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 2.485299e-01 | 0.605 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 4.621613e-01 | 0.335 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 4.511004e-01 | 0.346 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 3.554318e-01 | 0.449 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 4.926654e-01 | 0.307 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 3.948052e-01 | 0.404 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 2.337763e-01 | 0.631 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 4.766116e-01 | 0.322 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 3.060538e-01 | 0.514 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 3.151152e-01 | 0.502 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 3.920104e-01 | 0.407 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 4.207320e-01 | 0.376 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 2.226769e-01 | 0.652 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 1.869006e-01 | 0.728 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 2.634397e-01 | 0.579 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 2.243088e-01 | 0.649 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 3.880997e-01 | 0.411 | 1 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 4.078971e-01 | 0.389 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 1.892626e-01 | 0.723 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 5.290458e-01 | 0.277 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 2.609736e-01 | 0.583 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 4.136833e-01 | 0.383 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 2.294524e-01 | 0.639 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 4.612856e-01 | 0.336 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 4.612856e-01 | 0.336 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 4.612856e-01 | 0.336 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 2.743714e-01 | 0.562 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 4.321764e-01 | 0.364 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 3.397618e-01 | 0.469 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 3.384961e-01 | 0.470 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 2.830187e-01 | 0.548 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 5.065442e-01 | 0.295 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 2.809831e-01 | 0.551 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 4.468249e-01 | 0.350 | 1 | 1 |
| Nuclear RNA decay | R-HSA-9930044 | 4.749484e-01 | 0.323 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 5.382071e-01 | 0.269 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 5.382071e-01 | 0.269 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 4.944959e-01 | 0.306 | 1 | 0 |
| Neuronal System | R-HSA-112316 | 2.199128e-01 | 0.658 | 1 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 4.990239e-01 | 0.302 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 2.553865e-01 | 0.593 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 2.820061e-01 | 0.550 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 3.437336e-01 | 0.464 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 4.131374e-01 | 0.384 | 1 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 2.226769e-01 | 0.652 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 2.130602e-01 | 0.671 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 5.065442e-01 | 0.295 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 4.078971e-01 | 0.389 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 4.468249e-01 | 0.350 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 5.382071e-01 | 0.269 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 3.315394e-01 | 0.479 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 4.173162e-01 | 0.380 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 4.293322e-01 | 0.367 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 2.460974e-01 | 0.609 | 1 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 3.851283e-01 | 0.414 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 4.078971e-01 | 0.389 | 1 | 1 |
| DAG and IP3 signaling | R-HSA-1489509 | 4.760971e-01 | 0.322 | 1 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 5.114767e-01 | 0.291 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 3.378712e-01 | 0.471 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 2.056737e-01 | 0.687 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 1.935860e-01 | 0.713 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 3.129396e-01 | 0.505 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 2.837041e-01 | 0.547 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 3.151152e-01 | 0.502 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 3.568142e-01 | 0.448 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 4.612856e-01 | 0.336 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 5.040674e-01 | 0.298 | 0 | 0 |
| TET1,2,3 and TDG demethylate DNA | R-HSA-5221030 | 5.492478e-01 | 0.260 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 4.327717e-01 | 0.364 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 4.618488e-01 | 0.336 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 3.173251e-01 | 0.498 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 3.378712e-01 | 0.471 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 2.735829e-01 | 0.563 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 5.171787e-01 | 0.286 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 3.748493e-01 | 0.426 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 3.762403e-01 | 0.425 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 4.078971e-01 | 0.389 | 1 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 3.376531e-01 | 0.472 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 3.748493e-01 | 0.426 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 3.173251e-01 | 0.498 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 4.145639e-01 | 0.382 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 2.609736e-01 | 0.583 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 2.445299e-01 | 0.612 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 2.843285e-01 | 0.546 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 3.762403e-01 | 0.425 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 3.981202e-01 | 0.400 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 2.796793e-01 | 0.553 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 1.930101e-01 | 0.714 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 5.065442e-01 | 0.295 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 2.603928e-01 | 0.584 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 2.130602e-01 | 0.671 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 2.130602e-01 | 0.671 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 2.780090e-01 | 0.556 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 3.467957e-01 | 0.460 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 5.040674e-01 | 0.298 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 2.802700e-01 | 0.552 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 3.365789e-01 | 0.473 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 4.749484e-01 | 0.323 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 1.930932e-01 | 0.714 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 3.851283e-01 | 0.414 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 2.159087e-01 | 0.666 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 1.996784e-01 | 0.700 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 2.466269e-01 | 0.608 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 2.466269e-01 | 0.608 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 2.091019e-01 | 0.680 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 2.091019e-01 | 0.680 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 3.461028e-01 | 0.461 | 0 | 0 |
| Inhibition of Host mRNA Processing and RNA Silencing | R-HSA-168315 | 3.461028e-01 | 0.461 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 2.609736e-01 | 0.583 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 2.056737e-01 | 0.687 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 1.935860e-01 | 0.713 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 2.424997e-01 | 0.615 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 2.424997e-01 | 0.615 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 4.324489e-01 | 0.364 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 4.324489e-01 | 0.364 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 4.324489e-01 | 0.364 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 2.226769e-01 | 0.652 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 1.876900e-01 | 0.727 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 3.151152e-01 | 0.502 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 3.151152e-01 | 0.502 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 4.136833e-01 | 0.383 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 5.073974e-01 | 0.295 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 2.781758e-01 | 0.556 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 2.237896e-01 | 0.650 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 3.191187e-01 | 0.496 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 3.093618e-01 | 0.510 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 4.173162e-01 | 0.380 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 5.040674e-01 | 0.298 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 3.670200e-01 | 0.435 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 4.624204e-01 | 0.335 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 4.958025e-01 | 0.305 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 5.518654e-01 | 0.258 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 4.624204e-01 | 0.335 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 2.440446e-01 | 0.613 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 4.901997e-01 | 0.310 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 4.363302e-01 | 0.360 | 1 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 5.317157e-01 | 0.274 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 4.321764e-01 | 0.364 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 3.177922e-01 | 0.498 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 5.264447e-01 | 0.279 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 5.382071e-01 | 0.269 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 2.811324e-01 | 0.551 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 4.100826e-01 | 0.387 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 4.259869e-01 | 0.371 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 5.311625e-01 | 0.275 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 3.185143e-01 | 0.497 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 4.612856e-01 | 0.336 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 2.999794e-01 | 0.523 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 2.929021e-01 | 0.533 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 5.004089e-01 | 0.301 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 2.553865e-01 | 0.593 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 2.781758e-01 | 0.556 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 5.382071e-01 | 0.269 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 5.313274e-01 | 0.275 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 4.498640e-01 | 0.347 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 3.785202e-01 | 0.422 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 4.612856e-01 | 0.336 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 5.065442e-01 | 0.295 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 5.065442e-01 | 0.295 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 4.720020e-01 | 0.326 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 3.777973e-01 | 0.423 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 4.280507e-01 | 0.369 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 3.777973e-01 | 0.423 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 3.777973e-01 | 0.423 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 2.237896e-01 | 0.650 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 4.720020e-01 | 0.326 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 5.492478e-01 | 0.260 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 3.402801e-01 | 0.468 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 5.453482e-01 | 0.263 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 2.761809e-01 | 0.559 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 5.114767e-01 | 0.291 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 3.318329e-01 | 0.479 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 4.978236e-01 | 0.303 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 4.978236e-01 | 0.303 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 3.011251e-01 | 0.521 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 4.517127e-01 | 0.345 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in invasion | R-HSA-9854909 | 2.609736e-01 | 0.583 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 4.324489e-01 | 0.364 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.294296e-01 | 0.639 | 1 | 1 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 3.568142e-01 | 0.448 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 2.951641e-01 | 0.530 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 3.173251e-01 | 0.498 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 3.918941e-01 | 0.407 | 1 | 1 |
| ARMS-mediated activation | R-HSA-170984 | 5.065442e-01 | 0.295 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 5.065442e-01 | 0.295 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 5.492478e-01 | 0.260 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 5.382071e-01 | 0.269 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 5.150265e-01 | 0.288 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 5.131460e-01 | 0.290 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 5.431834e-01 | 0.265 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 3.290526e-01 | 0.483 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 5.332862e-01 | 0.273 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 5.340110e-01 | 0.272 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 3.091237e-01 | 0.510 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 4.412978e-01 | 0.355 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 2.396399e-01 | 0.620 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 5.073974e-01 | 0.295 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 1.965821e-01 | 0.706 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 5.193974e-01 | 0.285 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 5.040674e-01 | 0.298 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 2.609736e-01 | 0.583 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 2.609736e-01 | 0.583 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 3.129396e-01 | 0.505 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 5.073974e-01 | 0.295 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 3.365789e-01 | 0.473 | 0 | 0 |
| Interleukin-18 signaling | R-HSA-9012546 | 4.612856e-01 | 0.336 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 3.918941e-01 | 0.407 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 4.756494e-01 | 0.323 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 5.382071e-01 | 0.269 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 5.004089e-01 | 0.301 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 2.570646e-01 | 0.590 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 4.614726e-01 | 0.336 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 4.896507e-01 | 0.310 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 2.494546e-01 | 0.603 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 2.528055e-01 | 0.597 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 2.402437e-01 | 0.619 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 3.981202e-01 | 0.400 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 4.100826e-01 | 0.387 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 3.151152e-01 | 0.502 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 4.098149e-01 | 0.387 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 4.765471e-01 | 0.322 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 4.321764e-01 | 0.364 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 4.686678e-01 | 0.329 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 5.527206e-01 | 0.257 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 5.597250e-01 | 0.252 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 5.597250e-01 | 0.252 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 5.597250e-01 | 0.252 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 5.643342e-01 | 0.248 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 5.685809e-01 | 0.245 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 5.686283e-01 | 0.245 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 5.686283e-01 | 0.245 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 5.708736e-01 | 0.243 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 5.709584e-01 | 0.243 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 5.709584e-01 | 0.243 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 5.709584e-01 | 0.243 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 5.709584e-01 | 0.243 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 5.709584e-01 | 0.243 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 5.709584e-01 | 0.243 | 1 | 1 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 5.709584e-01 | 0.243 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 5.709584e-01 | 0.243 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 5.709584e-01 | 0.243 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 5.711224e-01 | 0.243 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 5.724523e-01 | 0.242 | 0 | 0 |
| Nucleotide catabolism defects | R-HSA-9735786 | 5.724523e-01 | 0.242 | 0 | 0 |
| ATP sensitive Potassium channels | R-HSA-1296025 | 5.724523e-01 | 0.242 | 0 | 0 |
| Defective PNP disrupts phosphorolysis of (deoxy)guanosine and (deoxy)inosine | R-HSA-9735763 | 5.724523e-01 | 0.242 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 5.724523e-01 | 0.242 | 0 | 0 |
| Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate | R-HSA-2978092 | 5.724523e-01 | 0.242 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 5.724523e-01 | 0.242 | 0 | 0 |
| Alanine metabolism | R-HSA-8964540 | 5.724523e-01 | 0.242 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 5.724523e-01 | 0.242 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 5.724523e-01 | 0.242 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 5.724523e-01 | 0.242 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 5.765343e-01 | 0.239 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 5.766021e-01 | 0.239 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 5.766021e-01 | 0.239 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 5.766021e-01 | 0.239 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 5.766021e-01 | 0.239 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 5.788656e-01 | 0.237 | 0 | 0 |
| Protein folding | R-HSA-391251 | 5.820416e-01 | 0.235 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 5.871620e-01 | 0.231 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 5.871620e-01 | 0.231 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 5.871620e-01 | 0.231 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 5.889469e-01 | 0.230 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 5.891866e-01 | 0.230 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 5.892822e-01 | 0.230 | 0 | 0 |
| FGFR2b ligand binding and activation | R-HSA-190377 | 5.892822e-01 | 0.230 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 5.892822e-01 | 0.230 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 5.892822e-01 | 0.230 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 5.892822e-01 | 0.230 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 5.892822e-01 | 0.230 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 5.892822e-01 | 0.230 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 5.892822e-01 | 0.230 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 5.892822e-01 | 0.230 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 5.892822e-01 | 0.230 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 5.892822e-01 | 0.230 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 5.892822e-01 | 0.230 | 0 | 0 |
| Prostanoid ligand receptors | R-HSA-391908 | 5.892822e-01 | 0.230 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 5.892822e-01 | 0.230 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 5.907645e-01 | 0.229 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 5.907645e-01 | 0.229 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 5.955618e-01 | 0.225 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 5.984771e-01 | 0.223 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 6.005967e-01 | 0.221 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 6.005967e-01 | 0.221 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 6.022279e-01 | 0.220 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 6.022279e-01 | 0.220 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 6.022279e-01 | 0.220 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 6.022279e-01 | 0.220 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 6.023622e-01 | 0.220 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 6.041426e-01 | 0.219 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 6.094968e-01 | 0.215 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 6.135729e-01 | 0.212 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 6.135729e-01 | 0.212 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 6.135729e-01 | 0.212 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 6.135729e-01 | 0.212 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 6.135729e-01 | 0.212 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 6.238014e-01 | 0.205 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 6.238014e-01 | 0.205 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 6.266074e-01 | 0.203 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 6.266074e-01 | 0.203 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 6.266074e-01 | 0.203 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 6.266074e-01 | 0.203 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 6.266074e-01 | 0.203 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 6.266074e-01 | 0.203 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 6.266074e-01 | 0.203 | 0 | 0 |
| Activation of AMPA receptors | R-HSA-399710 | 6.289191e-01 | 0.201 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 6.289191e-01 | 0.201 | 0 | 0 |
| Defective SLC1A3 causes episodic ataxia 6 (EA6) | R-HSA-5619062 | 6.289191e-01 | 0.201 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 6.289191e-01 | 0.201 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 6.289191e-01 | 0.201 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 6.289191e-01 | 0.201 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 6.289191e-01 | 0.201 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 6.289191e-01 | 0.201 | 0 | 0 |
| Trafficking of myristoylated proteins to the cilium | R-HSA-5624138 | 6.289191e-01 | 0.201 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 6.289191e-01 | 0.201 | 0 | 0 |
| Biosynthesis of DPAn-3-derived 13-series resolvins | R-HSA-9026403 | 6.289191e-01 | 0.201 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 6.289191e-01 | 0.201 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 6.289191e-01 | 0.201 | 0 | 0 |
| Zinc efflux and compartmentalization by the SLC30 family | R-HSA-435368 | 6.289191e-01 | 0.201 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 6.289191e-01 | 0.201 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 6.319535e-01 | 0.199 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 6.319535e-01 | 0.199 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 6.319535e-01 | 0.199 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 6.319535e-01 | 0.199 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 6.319535e-01 | 0.199 | 0 | 0 |
| PKA activation | R-HSA-163615 | 6.319535e-01 | 0.199 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 6.319535e-01 | 0.199 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 6.319535e-01 | 0.199 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 6.319535e-01 | 0.199 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 6.319535e-01 | 0.199 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 6.323118e-01 | 0.199 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 6.323118e-01 | 0.199 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 6.323118e-01 | 0.199 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 6.331704e-01 | 0.198 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 6.365152e-01 | 0.196 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 6.389084e-01 | 0.195 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 6.389084e-01 | 0.195 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 6.410978e-01 | 0.193 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 6.418478e-01 | 0.193 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 6.434820e-01 | 0.191 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 6.461782e-01 | 0.190 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 6.487946e-01 | 0.188 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 6.533743e-01 | 0.185 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 6.533743e-01 | 0.185 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 6.533743e-01 | 0.185 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 6.575701e-01 | 0.182 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 6.600995e-01 | 0.180 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 6.600995e-01 | 0.180 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 6.600995e-01 | 0.180 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 6.600995e-01 | 0.180 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 6.600995e-01 | 0.180 | 1 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 6.600995e-01 | 0.180 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 6.612407e-01 | 0.180 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 6.612407e-01 | 0.180 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 6.612407e-01 | 0.180 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 6.612407e-01 | 0.180 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 6.612407e-01 | 0.180 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 6.612407e-01 | 0.180 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 6.631336e-01 | 0.178 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 6.631336e-01 | 0.178 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 6.631336e-01 | 0.178 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 6.631336e-01 | 0.178 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 6.653143e-01 | 0.177 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 6.676983e-01 | 0.175 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 6.727017e-01 | 0.172 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 6.735978e-01 | 0.172 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 6.779311e-01 | 0.169 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 6.779311e-01 | 0.169 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 6.779311e-01 | 0.169 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 6.779311e-01 | 0.169 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 6.779311e-01 | 0.169 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 6.779311e-01 | 0.169 | 0 | 0 |
| Phase 1 - inactivation of fast Na+ channels | R-HSA-5576894 | 6.779311e-01 | 0.169 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 6.779311e-01 | 0.169 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 6.779311e-01 | 0.169 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 6.779311e-01 | 0.169 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 6.779311e-01 | 0.169 | 0 | 0 |
| Ceramide signalling | R-HSA-193681 | 6.779311e-01 | 0.169 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 6.779311e-01 | 0.169 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 6.779311e-01 | 0.169 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 6.779311e-01 | 0.169 | 0 | 0 |
| Formation of the Editosome | R-HSA-75094 | 6.779311e-01 | 0.169 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 6.779311e-01 | 0.169 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 6.779311e-01 | 0.169 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 6.779311e-01 | 0.169 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 6.798395e-01 | 0.168 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 6.798395e-01 | 0.168 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 6.837497e-01 | 0.165 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 6.851920e-01 | 0.164 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 6.862270e-01 | 0.164 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 6.862270e-01 | 0.164 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 6.862270e-01 | 0.164 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 6.866531e-01 | 0.163 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 6.866531e-01 | 0.163 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 6.866531e-01 | 0.163 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 6.866531e-01 | 0.163 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 6.883413e-01 | 0.162 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 6.883413e-01 | 0.162 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 6.883413e-01 | 0.162 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 6.910605e-01 | 0.160 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 6.916660e-01 | 0.160 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 6.916660e-01 | 0.160 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 6.919588e-01 | 0.160 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 6.932421e-01 | 0.159 | 0 | 0 |
| FGFR2c ligand binding and activation | R-HSA-190375 | 6.932421e-01 | 0.159 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 6.932421e-01 | 0.159 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 6.932421e-01 | 0.159 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 6.932421e-01 | 0.159 | 0 | 0 |
| FGFR4 ligand binding and activation | R-HSA-190322 | 6.932421e-01 | 0.159 | 0 | 0 |
| Signaling by activated point mutants of FGFR3 | R-HSA-1839130 | 6.932421e-01 | 0.159 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 6.932421e-01 | 0.159 | 0 | 0 |
| FGFR3 mutant receptor activation | R-HSA-2033514 | 6.932421e-01 | 0.159 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 6.932421e-01 | 0.159 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 6.942820e-01 | 0.158 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 6.956064e-01 | 0.158 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 7.005012e-01 | 0.155 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 7.025976e-01 | 0.153 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 7.080945e-01 | 0.150 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 7.080945e-01 | 0.150 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 7.081789e-01 | 0.150 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 7.087339e-01 | 0.150 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 7.116208e-01 | 0.148 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 7.116208e-01 | 0.148 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 7.116208e-01 | 0.148 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 7.116208e-01 | 0.148 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 7.116208e-01 | 0.148 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 7.123045e-01 | 0.147 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 7.166746e-01 | 0.145 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 7.204720e-01 | 0.142 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 7.204720e-01 | 0.142 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 7.204720e-01 | 0.142 | 0 | 0 |
| Highly sodium permeable postsynaptic acetylcholine nicotinic receptors | R-HSA-629587 | 7.204720e-01 | 0.142 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 7.204720e-01 | 0.142 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 7.204720e-01 | 0.142 | 0 | 0 |
| Defective CHST14 causes EDS, musculocontractural type | R-HSA-3595174 | 7.204720e-01 | 0.142 | 0 | 0 |
| Defective CHST3 causes SEDCJD | R-HSA-3595172 | 7.204720e-01 | 0.142 | 0 | 0 |
| Toxicity of botulinum toxin type F (botF) | R-HSA-5250981 | 7.204720e-01 | 0.142 | 0 | 0 |
| Toxicity of botulinum toxin type D (botD) | R-HSA-5250955 | 7.204720e-01 | 0.142 | 0 | 0 |
| Intracellular metabolism of fatty acids regulates insulin secretion | R-HSA-434313 | 7.204720e-01 | 0.142 | 0 | 0 |
| Abacavir transmembrane transport | R-HSA-2161517 | 7.204720e-01 | 0.142 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 7.204720e-01 | 0.142 | 0 | 0 |
| Lipid particle organization | R-HSA-8964572 | 7.204720e-01 | 0.142 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 7.204720e-01 | 0.142 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 7.204720e-01 | 0.142 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 7.227025e-01 | 0.141 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 7.227025e-01 | 0.141 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 7.227025e-01 | 0.141 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 7.227025e-01 | 0.141 | 0 | 0 |
| FGFR3c ligand binding and activation | R-HSA-190372 | 7.227025e-01 | 0.141 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 7.227025e-01 | 0.141 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 7.227025e-01 | 0.141 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 7.227025e-01 | 0.141 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 7.227025e-01 | 0.141 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 7.269523e-01 | 0.138 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 7.270456e-01 | 0.138 | 1 | 1 |
| Signaling by Erythropoietin | R-HSA-9006335 | 7.289898e-01 | 0.137 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 7.289898e-01 | 0.137 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 7.289898e-01 | 0.137 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 7.289898e-01 | 0.137 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 7.304666e-01 | 0.136 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 7.339050e-01 | 0.134 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 7.350248e-01 | 0.134 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 7.350248e-01 | 0.134 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 7.350248e-01 | 0.134 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 7.359160e-01 | 0.133 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 7.359160e-01 | 0.133 | 1 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 7.395144e-01 | 0.131 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 7.438192e-01 | 0.129 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 7.438192e-01 | 0.129 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 7.438192e-01 | 0.129 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 7.449153e-01 | 0.128 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 7.454726e-01 | 0.128 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 7.486690e-01 | 0.126 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 7.486690e-01 | 0.126 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 7.497347e-01 | 0.125 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 7.497347e-01 | 0.125 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 7.497347e-01 | 0.125 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 7.497347e-01 | 0.125 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 7.497347e-01 | 0.125 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 7.497347e-01 | 0.125 | 0 | 0 |
| FGFR3 ligand binding and activation | R-HSA-190239 | 7.497347e-01 | 0.125 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 7.497347e-01 | 0.125 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 7.497347e-01 | 0.125 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 7.497347e-01 | 0.125 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 7.512962e-01 | 0.124 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 7.569005e-01 | 0.121 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 7.569005e-01 | 0.121 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 7.569005e-01 | 0.121 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 7.569005e-01 | 0.121 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 7.573961e-01 | 0.121 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 7.573961e-01 | 0.121 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 7.573961e-01 | 0.121 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 7.573961e-01 | 0.121 | 0 | 0 |
| Defective CHSY1 causes TPBS | R-HSA-3595177 | 7.573961e-01 | 0.121 | 0 | 0 |
| FGFR3b ligand binding and activation | R-HSA-190371 | 7.573961e-01 | 0.121 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 7.573961e-01 | 0.121 | 0 | 0 |
| mRNA Editing: C to U Conversion | R-HSA-72200 | 7.573961e-01 | 0.121 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 7.573961e-01 | 0.121 | 1 | 1 |
| LDL remodeling | R-HSA-8964041 | 7.573961e-01 | 0.121 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 7.573961e-01 | 0.121 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 7.573961e-01 | 0.121 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 7.573961e-01 | 0.121 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 7.573961e-01 | 0.121 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 7.573961e-01 | 0.121 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 7.586314e-01 | 0.120 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 7.588784e-01 | 0.120 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 7.588784e-01 | 0.120 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 7.594725e-01 | 0.119 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 7.672337e-01 | 0.115 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 7.675950e-01 | 0.115 | 1 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 7.725383e-01 | 0.112 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 7.742769e-01 | 0.111 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 7.744661e-01 | 0.111 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 7.744661e-01 | 0.111 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 7.744661e-01 | 0.111 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 7.745847e-01 | 0.111 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 7.781861e-01 | 0.109 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 7.801567e-01 | 0.108 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 7.803695e-01 | 0.108 | 1 | 1 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 7.847074e-01 | 0.105 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 7.847302e-01 | 0.105 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 7.868186e-01 | 0.104 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 7.869474e-01 | 0.104 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 7.894445e-01 | 0.103 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 7.894445e-01 | 0.103 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 7.894445e-01 | 0.103 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 7.894445e-01 | 0.103 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 7.894445e-01 | 0.103 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 7.894445e-01 | 0.103 | 0 | 0 |
| Highly calcium permeable nicotinic acetylcholine receptors | R-HSA-629597 | 7.894445e-01 | 0.103 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 7.894445e-01 | 0.103 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 7.894445e-01 | 0.103 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 7.894445e-01 | 0.103 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 7.894445e-01 | 0.103 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 7.894445e-01 | 0.103 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 7.894445e-01 | 0.103 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 7.894445e-01 | 0.103 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 7.894445e-01 | 0.103 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 7.894445e-01 | 0.103 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 7.935204e-01 | 0.100 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 7.935204e-01 | 0.100 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 7.935204e-01 | 0.100 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 7.935204e-01 | 0.100 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 7.935204e-01 | 0.100 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 7.935204e-01 | 0.100 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 7.962082e-01 | 0.099 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 7.962570e-01 | 0.099 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 7.962570e-01 | 0.099 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 7.962570e-01 | 0.099 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 7.970328e-01 | 0.099 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 7.970328e-01 | 0.099 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 7.970328e-01 | 0.099 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 7.970328e-01 | 0.099 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 7.970328e-01 | 0.099 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 7.970328e-01 | 0.099 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 7.970328e-01 | 0.099 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 7.973876e-01 | 0.098 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 7.982370e-01 | 0.098 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 7.993225e-01 | 0.097 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 8.071290e-01 | 0.093 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 8.076689e-01 | 0.093 | 1 | 1 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 8.077766e-01 | 0.093 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 8.080113e-01 | 0.093 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 8.080113e-01 | 0.093 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 8.091458e-01 | 0.092 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 8.116619e-01 | 0.091 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 8.138508e-01 | 0.089 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 8.138508e-01 | 0.089 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 8.138508e-01 | 0.089 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 8.140671e-01 | 0.089 | 1 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 8.165019e-01 | 0.088 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 8.172609e-01 | 0.088 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 8.172609e-01 | 0.088 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 8.172609e-01 | 0.088 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 8.172609e-01 | 0.088 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 8.172609e-01 | 0.088 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 8.172609e-01 | 0.088 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 8.172609e-01 | 0.088 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 8.172609e-01 | 0.088 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 8.172609e-01 | 0.088 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 8.172609e-01 | 0.088 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 8.172609e-01 | 0.088 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 8.172609e-01 | 0.088 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 8.172609e-01 | 0.088 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 8.175750e-01 | 0.087 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 8.175750e-01 | 0.087 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 8.175750e-01 | 0.087 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 8.175750e-01 | 0.087 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 8.175750e-01 | 0.087 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 8.175750e-01 | 0.087 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 8.175750e-01 | 0.087 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 8.184266e-01 | 0.087 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 8.216808e-01 | 0.085 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 8.216808e-01 | 0.085 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 8.216808e-01 | 0.085 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 8.216808e-01 | 0.085 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 8.216808e-01 | 0.085 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 8.216808e-01 | 0.085 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 8.216808e-01 | 0.085 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 8.234065e-01 | 0.084 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 8.274575e-01 | 0.082 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 8.274575e-01 | 0.082 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 8.301386e-01 | 0.081 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 8.301386e-01 | 0.081 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 8.308925e-01 | 0.080 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 8.308925e-01 | 0.080 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 8.345535e-01 | 0.079 | 0 | 0 |
| Activated point mutants of FGFR2 | R-HSA-2033519 | 8.362336e-01 | 0.078 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 8.362336e-01 | 0.078 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 8.362336e-01 | 0.078 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 8.414038e-01 | 0.075 | 0 | 0 |
| Highly calcium permeable postsynaptic nicotinic acetylcholine receptors | R-HSA-629594 | 8.414038e-01 | 0.075 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 8.414038e-01 | 0.075 | 1 | 1 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 8.414038e-01 | 0.075 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 8.414038e-01 | 0.075 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 8.414038e-01 | 0.075 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 8.414038e-01 | 0.075 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 8.414038e-01 | 0.075 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 8.414038e-01 | 0.075 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 8.414038e-01 | 0.075 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 8.414038e-01 | 0.075 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 8.414038e-01 | 0.075 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 8.414038e-01 | 0.075 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 8.414038e-01 | 0.075 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 8.424666e-01 | 0.074 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 8.443302e-01 | 0.073 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 8.451867e-01 | 0.073 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 8.451867e-01 | 0.073 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 8.457399e-01 | 0.073 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 8.466559e-01 | 0.072 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 8.466559e-01 | 0.072 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 8.505411e-01 | 0.070 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 8.531478e-01 | 0.069 | 0 | 0 |
| Synthesis of 5-eicosatetraenoic acids | R-HSA-2142688 | 8.531478e-01 | 0.069 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 8.531478e-01 | 0.069 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 8.531478e-01 | 0.069 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 8.531478e-01 | 0.069 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 8.568561e-01 | 0.067 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 8.568561e-01 | 0.067 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 8.568561e-01 | 0.067 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 8.568561e-01 | 0.067 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 8.580161e-01 | 0.067 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 8.580161e-01 | 0.067 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 8.590631e-01 | 0.066 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 8.590631e-01 | 0.066 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 8.590631e-01 | 0.066 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 8.623583e-01 | 0.064 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 8.623583e-01 | 0.064 | 0 | 0 |
| FGFRL1 modulation of FGFR1 signaling | R-HSA-5658623 | 8.623583e-01 | 0.064 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 8.623583e-01 | 0.064 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 8.623583e-01 | 0.064 | 0 | 0 |
| Cholesterol biosynthesis via desmosterol | R-HSA-6807047 | 8.623583e-01 | 0.064 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 8.623583e-01 | 0.064 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 8.623583e-01 | 0.064 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 8.623583e-01 | 0.064 | 0 | 0 |
| Biosynthesis of DPAn-3-derived maresins | R-HSA-9026290 | 8.623583e-01 | 0.064 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 8.623583e-01 | 0.064 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 8.623583e-01 | 0.064 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 8.623583e-01 | 0.064 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 8.644277e-01 | 0.063 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 8.654231e-01 | 0.063 | 0 | 0 |
| Immune System | R-HSA-168256 | 8.654729e-01 | 0.063 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 8.684526e-01 | 0.061 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 8.684526e-01 | 0.061 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 8.684526e-01 | 0.061 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 8.684526e-01 | 0.061 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 8.686635e-01 | 0.061 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 8.686635e-01 | 0.061 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 8.703156e-01 | 0.060 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 8.718361e-01 | 0.060 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 8.727885e-01 | 0.059 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 8.735347e-01 | 0.059 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 8.743010e-01 | 0.058 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 8.793428e-01 | 0.056 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 8.798520e-01 | 0.056 | 0 | 0 |
| DS-GAG biosynthesis | R-HSA-2022923 | 8.805453e-01 | 0.055 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 8.805453e-01 | 0.055 | 0 | 0 |
| Presynaptic nicotinic acetylcholine receptors | R-HSA-622323 | 8.805453e-01 | 0.055 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 8.805453e-01 | 0.055 | 0 | 0 |
| Endosomal/Vacuolar pathway | R-HSA-1236977 | 8.805453e-01 | 0.055 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 8.805453e-01 | 0.055 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 8.805453e-01 | 0.055 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 8.805453e-01 | 0.055 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 8.805453e-01 | 0.055 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 8.822780e-01 | 0.054 | 0 | 0 |
| FGFR2 ligand binding and activation | R-HSA-190241 | 8.822780e-01 | 0.054 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 8.822780e-01 | 0.054 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 8.822780e-01 | 0.054 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 8.822780e-01 | 0.054 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 8.822780e-01 | 0.054 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 8.822780e-01 | 0.054 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 8.822780e-01 | 0.054 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 8.822780e-01 | 0.054 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 8.822780e-01 | 0.054 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 8.822780e-01 | 0.054 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 8.835735e-01 | 0.054 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 8.835735e-01 | 0.054 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 8.879412e-01 | 0.052 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 8.879412e-01 | 0.052 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 8.884805e-01 | 0.051 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.943422e-01 | 0.048 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 8.943422e-01 | 0.048 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 8.947477e-01 | 0.048 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 8.947477e-01 | 0.048 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 8.947477e-01 | 0.048 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 8.947477e-01 | 0.048 | 0 | 0 |
| Defective EXT2 causes exostoses 2 | R-HSA-3656237 | 8.963300e-01 | 0.048 | 0 | 0 |
| Defective EXT1 causes exostoses 1, TRPS2 and CHDS | R-HSA-3656253 | 8.963300e-01 | 0.048 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 8.963300e-01 | 0.048 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 8.963300e-01 | 0.048 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 8.963300e-01 | 0.048 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 8.963300e-01 | 0.048 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 8.963300e-01 | 0.048 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 8.963300e-01 | 0.048 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 8.963300e-01 | 0.048 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 8.963300e-01 | 0.048 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 8.963300e-01 | 0.048 | 0 | 0 |
| Biosynthesis of DPAn-3-derived protectins and resolvins | R-HSA-9026286 | 8.963300e-01 | 0.048 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 8.963300e-01 | 0.048 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 8.963300e-01 | 0.048 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 8.963300e-01 | 0.048 | 0 | 0 |
| Estrogen biosynthesis | R-HSA-193144 | 8.963300e-01 | 0.048 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 8.963300e-01 | 0.048 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 8.966329e-01 | 0.047 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 8.986968e-01 | 0.046 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 8.986968e-01 | 0.046 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 8.986968e-01 | 0.046 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 8.986968e-01 | 0.046 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 8.995114e-01 | 0.046 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.018877e-01 | 0.045 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 9.018877e-01 | 0.045 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.019702e-01 | 0.045 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.025267e-01 | 0.045 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 9.042070e-01 | 0.044 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 9.059784e-01 | 0.043 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 9.059784e-01 | 0.043 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 9.059784e-01 | 0.043 | 0 | 0 |
| Free fatty acid receptors | R-HSA-444209 | 9.059784e-01 | 0.043 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 9.059784e-01 | 0.043 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 9.059784e-01 | 0.043 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.059784e-01 | 0.043 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 9.059784e-01 | 0.043 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.066157e-01 | 0.043 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 9.072530e-01 | 0.042 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.085316e-01 | 0.042 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 9.100298e-01 | 0.041 | 0 | 0 |
| Acetylcholine binding and downstream events | R-HSA-181431 | 9.100298e-01 | 0.041 | 0 | 0 |
| Postsynaptic nicotinic acetylcholine receptors | R-HSA-622327 | 9.100298e-01 | 0.041 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 9.100298e-01 | 0.041 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 9.100298e-01 | 0.041 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 9.100298e-01 | 0.041 | 0 | 0 |
| Diseases of nucleotide metabolism | R-HSA-9735804 | 9.100298e-01 | 0.041 | 0 | 0 |
| Mtb iron assimilation by chelation | R-HSA-1222449 | 9.100298e-01 | 0.041 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 9.100298e-01 | 0.041 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 9.100298e-01 | 0.041 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 9.100298e-01 | 0.041 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 9.100298e-01 | 0.041 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 9.106312e-01 | 0.041 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 9.132311e-01 | 0.039 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.151142e-01 | 0.039 | 1 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 9.160799e-01 | 0.038 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 9.160799e-01 | 0.038 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.179099e-01 | 0.037 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.192880e-01 | 0.037 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 9.214748e-01 | 0.036 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.214748e-01 | 0.036 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 9.219198e-01 | 0.035 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 9.219198e-01 | 0.035 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 9.219198e-01 | 0.035 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 9.219198e-01 | 0.035 | 0 | 0 |
| Biosynthesis of E-series 18(R)-resolvins | R-HSA-9023661 | 9.219198e-01 | 0.035 | 0 | 0 |
| N-glycan trimming and elongation in the cis-Golgi | R-HSA-964739 | 9.219198e-01 | 0.035 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 9.219198e-01 | 0.035 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 9.219198e-01 | 0.035 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 9.219198e-01 | 0.035 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 9.219198e-01 | 0.035 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 9.219198e-01 | 0.035 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.225977e-01 | 0.035 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 9.225977e-01 | 0.035 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.225977e-01 | 0.035 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 9.236643e-01 | 0.034 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 9.241133e-01 | 0.034 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 9.251543e-01 | 0.034 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.251543e-01 | 0.034 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.257999e-01 | 0.033 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 9.257999e-01 | 0.033 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 9.257999e-01 | 0.033 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.281517e-01 | 0.032 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 9.289958e-01 | 0.032 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.289958e-01 | 0.032 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.293596e-01 | 0.032 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 9.299011e-01 | 0.032 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.299011e-01 | 0.032 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.299011e-01 | 0.032 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.300300e-01 | 0.032 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.308526e-01 | 0.031 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 9.318406e-01 | 0.031 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 9.318406e-01 | 0.031 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 9.322391e-01 | 0.030 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 9.322391e-01 | 0.030 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 9.322391e-01 | 0.030 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 9.322391e-01 | 0.030 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 9.322391e-01 | 0.030 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 9.322391e-01 | 0.030 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 9.322391e-01 | 0.030 | 0 | 0 |
| Synthesis of 12-eicosatetraenoic acid derivatives | R-HSA-2142712 | 9.322391e-01 | 0.030 | 0 | 0 |
| Dopamine clearance from the synaptic cleft | R-HSA-379401 | 9.322391e-01 | 0.030 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 9.322391e-01 | 0.030 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 9.332966e-01 | 0.030 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 9.332966e-01 | 0.030 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 9.332966e-01 | 0.030 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 9.332966e-01 | 0.030 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.332966e-01 | 0.030 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 9.358492e-01 | 0.029 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.358492e-01 | 0.029 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 9.403180e-01 | 0.027 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.405947e-01 | 0.027 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 9.405947e-01 | 0.027 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 9.405947e-01 | 0.027 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 9.411951e-01 | 0.026 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 9.411951e-01 | 0.026 | 0 | 0 |
| Activation of the phototransduction cascade | R-HSA-2485179 | 9.411951e-01 | 0.026 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 9.411951e-01 | 0.026 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 9.411951e-01 | 0.026 | 1 | 1 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 9.411951e-01 | 0.026 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 9.411951e-01 | 0.026 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 9.411951e-01 | 0.026 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 9.411951e-01 | 0.026 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 9.413049e-01 | 0.026 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 9.413049e-01 | 0.026 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 9.420868e-01 | 0.026 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.420868e-01 | 0.026 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.431286e-01 | 0.025 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.436814e-01 | 0.025 | 1 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.465593e-01 | 0.024 | 1 | 1 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 9.471295e-01 | 0.024 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 9.471295e-01 | 0.024 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 9.471295e-01 | 0.024 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.471295e-01 | 0.024 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 9.477576e-01 | 0.023 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 9.489679e-01 | 0.023 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 9.489679e-01 | 0.023 | 0 | 0 |
| Scavenging by Class B Receptors | R-HSA-3000471 | 9.489679e-01 | 0.023 | 0 | 0 |
| Vitamin B6 activation to pyridoxal phosphate | R-HSA-964975 | 9.489679e-01 | 0.023 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 9.489679e-01 | 0.023 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 9.489679e-01 | 0.023 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 9.489679e-01 | 0.023 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.506972e-01 | 0.022 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.506972e-01 | 0.022 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.508259e-01 | 0.022 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.512609e-01 | 0.022 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.518346e-01 | 0.021 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.529078e-01 | 0.021 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 9.529078e-01 | 0.021 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 9.529078e-01 | 0.021 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 9.529751e-01 | 0.021 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.533616e-01 | 0.021 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.545268e-01 | 0.020 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 9.557136e-01 | 0.020 | 0 | 0 |
| Biosynthesis of aspirin-triggered D-series resolvins | R-HSA-9020265 | 9.557136e-01 | 0.020 | 0 | 0 |
| Synthesis of 15-eicosatetraenoic acid derivatives | R-HSA-2142770 | 9.557136e-01 | 0.020 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 9.557136e-01 | 0.020 | 0 | 0 |
| Sulfide oxidation to sulfate | R-HSA-1614517 | 9.557136e-01 | 0.020 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.557968e-01 | 0.020 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 9.573937e-01 | 0.019 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.575802e-01 | 0.019 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.581996e-01 | 0.019 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 9.581996e-01 | 0.019 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 9.581996e-01 | 0.019 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.588685e-01 | 0.018 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.596834e-01 | 0.018 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 9.615680e-01 | 0.017 | 1 | 1 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 9.615680e-01 | 0.017 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 9.615680e-01 | 0.017 | 0 | 0 |
| Biosynthesis of Lipoxins (LX) | R-HSA-2142700 | 9.615680e-01 | 0.017 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 9.615680e-01 | 0.017 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 9.615680e-01 | 0.017 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.628650e-01 | 0.016 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.628650e-01 | 0.016 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.631515e-01 | 0.016 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.635402e-01 | 0.016 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.656498e-01 | 0.015 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.656498e-01 | 0.015 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.656498e-01 | 0.015 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.656498e-01 | 0.015 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.663432e-01 | 0.015 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.665364e-01 | 0.015 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 9.666487e-01 | 0.015 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 9.666487e-01 | 0.015 | 0 | 0 |
| Methionine salvage pathway | R-HSA-1237112 | 9.666487e-01 | 0.015 | 0 | 0 |
| HDL remodeling | R-HSA-8964058 | 9.666487e-01 | 0.015 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 9.666487e-01 | 0.015 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 9.666487e-01 | 0.015 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.668470e-01 | 0.015 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.669205e-01 | 0.015 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.669205e-01 | 0.015 | 1 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 9.670277e-01 | 0.015 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 9.670277e-01 | 0.015 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.670277e-01 | 0.015 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.672861e-01 | 0.014 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.691191e-01 | 0.014 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 9.691191e-01 | 0.014 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 9.691191e-01 | 0.014 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.691191e-01 | 0.014 | 0 | 0 |
| HS-GAG degradation | R-HSA-2024096 | 9.707391e-01 | 0.013 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.710353e-01 | 0.013 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 9.710581e-01 | 0.013 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 9.710581e-01 | 0.013 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.710581e-01 | 0.013 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 9.710581e-01 | 0.013 | 0 | 0 |
| Keratan sulfate degradation | R-HSA-2022857 | 9.710581e-01 | 0.013 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 9.710581e-01 | 0.013 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 9.710581e-01 | 0.013 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 9.710581e-01 | 0.013 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.736777e-01 | 0.012 | 0 | 0 |
| Defective B3GALTL causes PpS | R-HSA-5083635 | 9.740458e-01 | 0.011 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 9.744497e-01 | 0.011 | 0 | 0 |
| Biosynthesis of E-series 18(S)-resolvins | R-HSA-9018896 | 9.748847e-01 | 0.011 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 9.748847e-01 | 0.011 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 9.748847e-01 | 0.011 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 9.750875e-01 | 0.011 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 9.753884e-01 | 0.011 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.754554e-01 | 0.011 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.769899e-01 | 0.010 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.776437e-01 | 0.010 | 0 | 0 |
| CS-GAG biosynthesis | R-HSA-2022870 | 9.782055e-01 | 0.010 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 9.782055e-01 | 0.010 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 9.782055e-01 | 0.010 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 9.782055e-01 | 0.010 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.796094e-01 | 0.009 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.796094e-01 | 0.009 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.796094e-01 | 0.009 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 9.796094e-01 | 0.009 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 9.798525e-01 | 0.009 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.799487e-01 | 0.009 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 9.799487e-01 | 0.009 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 9.799487e-01 | 0.009 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 9.810874e-01 | 0.008 | 0 | 0 |
| Biosynthesis of D-series resolvins | R-HSA-9018676 | 9.810874e-01 | 0.008 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 9.810874e-01 | 0.008 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 9.810874e-01 | 0.008 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 9.810874e-01 | 0.008 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 9.819387e-01 | 0.008 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.820164e-01 | 0.008 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 9.820258e-01 | 0.008 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 9.820258e-01 | 0.008 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.820258e-01 | 0.008 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 9.825579e-01 | 0.008 | 1 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 9.835884e-01 | 0.007 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 9.835884e-01 | 0.007 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 9.835884e-01 | 0.007 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 9.835884e-01 | 0.007 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 9.835884e-01 | 0.007 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.835884e-01 | 0.007 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 9.835884e-01 | 0.007 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 9.835884e-01 | 0.007 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.840086e-01 | 0.007 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 9.840086e-01 | 0.007 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.840086e-01 | 0.007 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.851400e-01 | 0.007 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 9.855052e-01 | 0.006 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.855052e-01 | 0.006 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.857588e-01 | 0.006 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.857588e-01 | 0.006 | 0 | 0 |
| Synthesis of dolichyl-phosphate | R-HSA-446199 | 9.857588e-01 | 0.006 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 9.857588e-01 | 0.006 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 9.858471e-01 | 0.006 | 0 | 0 |
| O-glycosylation of TSR domain-containing proteins | R-HSA-5173214 | 9.858471e-01 | 0.006 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.858471e-01 | 0.006 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 9.858973e-01 | 0.006 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.865881e-01 | 0.006 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.868369e-01 | 0.006 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.874792e-01 | 0.005 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.874792e-01 | 0.005 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.876423e-01 | 0.005 | 0 | 0 |
| Biosynthesis of electrophilic ω-3 PUFA oxo-derivatives | R-HSA-9027604 | 9.876423e-01 | 0.005 | 0 | 0 |
| Retinoid cycle disease events | R-HSA-2453864 | 9.876423e-01 | 0.005 | 0 | 0 |
| Diseases associated with visual transduction | R-HSA-2474795 | 9.876423e-01 | 0.005 | 0 | 0 |
| Diseases of the neuronal system | R-HSA-9675143 | 9.876423e-01 | 0.005 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.879172e-01 | 0.005 | 1 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.885962e-01 | 0.005 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 9.889272e-01 | 0.005 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.889272e-01 | 0.005 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.892767e-01 | 0.005 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 9.892767e-01 | 0.005 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.894229e-01 | 0.005 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 9.896747e-01 | 0.005 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 9.901715e-01 | 0.004 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.902114e-01 | 0.004 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.902443e-01 | 0.004 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.904058e-01 | 0.004 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.906951e-01 | 0.004 | 0 | 0 |
| Biosynthesis of DPAn-3 SPMs | R-HSA-9025094 | 9.906951e-01 | 0.004 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.906951e-01 | 0.004 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 9.906951e-01 | 0.004 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.906951e-01 | 0.004 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.906951e-01 | 0.004 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.910829e-01 | 0.004 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 9.910921e-01 | 0.004 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.917633e-01 | 0.004 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 9.919259e-01 | 0.004 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 9.919259e-01 | 0.004 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.919259e-01 | 0.004 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.919259e-01 | 0.004 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 9.919259e-01 | 0.004 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 9.921486e-01 | 0.003 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.924199e-01 | 0.003 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.926930e-01 | 0.003 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.928248e-01 | 0.003 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.928564e-01 | 0.003 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 9.929940e-01 | 0.003 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.929940e-01 | 0.003 | 0 | 0 |
| Biosynthesis of EPA-derived SPMs | R-HSA-9018679 | 9.929940e-01 | 0.003 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 9.929940e-01 | 0.003 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.933245e-01 | 0.003 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.933866e-01 | 0.003 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.933866e-01 | 0.003 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.934275e-01 | 0.003 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 9.939209e-01 | 0.003 | 0 | 0 |
| Mucopolysaccharidoses | R-HSA-2206281 | 9.939209e-01 | 0.003 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.941965e-01 | 0.003 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.946336e-01 | 0.002 | 0 | 0 |
| Biosynthesis of DPA-derived SPMs | R-HSA-9018683 | 9.947251e-01 | 0.002 | 0 | 0 |
| Synthesis of glycosylphosphatidylinositol (GPI) | R-HSA-162710 | 9.947251e-01 | 0.002 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.950390e-01 | 0.002 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 9.953362e-01 | 0.002 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.953603e-01 | 0.002 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 9.953603e-01 | 0.002 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.954230e-01 | 0.002 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.957917e-01 | 0.002 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.957917e-01 | 0.002 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.958433e-01 | 0.002 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.959074e-01 | 0.002 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.959074e-01 | 0.002 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.960287e-01 | 0.002 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.962223e-01 | 0.002 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.962966e-01 | 0.002 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.962966e-01 | 0.002 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.963911e-01 | 0.002 | 0 | 0 |
| CS/DS degradation | R-HSA-2024101 | 9.965542e-01 | 0.001 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 9.965542e-01 | 0.001 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 9.965542e-01 | 0.001 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.965542e-01 | 0.001 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.967017e-01 | 0.001 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.967017e-01 | 0.001 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.968184e-01 | 0.001 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.969593e-01 | 0.001 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.970102e-01 | 0.001 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 9.970102e-01 | 0.001 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.972516e-01 | 0.001 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.972735e-01 | 0.001 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 9.974058e-01 | 0.001 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.975292e-01 | 0.001 | 0 | 0 |
| HS-GAG biosynthesis | R-HSA-2022928 | 9.977492e-01 | 0.001 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.978525e-01 | 0.001 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 9.980386e-01 | 0.001 | 1 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.980471e-01 | 0.001 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.980471e-01 | 0.001 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.980471e-01 | 0.001 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.980471e-01 | 0.001 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.980700e-01 | 0.001 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.980700e-01 | 0.001 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.981546e-01 | 0.001 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.982438e-01 | 0.001 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.982578e-01 | 0.001 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 9.983056e-01 | 0.001 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.983121e-01 | 0.001 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.985299e-01 | 0.001 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.985299e-01 | 0.001 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.985299e-01 | 0.001 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.985934e-01 | 0.001 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.987308e-01 | 0.001 | 0 | 0 |
| Aflatoxin activation and detoxification | R-HSA-5423646 | 9.988933e-01 | 0.000 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.988933e-01 | 0.000 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.989825e-01 | 0.000 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.989877e-01 | 0.000 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.991528e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.991528e-01 | 0.000 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 9.992170e-01 | 0.000 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.992170e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.992324e-01 | 0.000 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.992773e-01 | 0.000 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.992827e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.993346e-01 | 0.000 | 1 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.993730e-01 | 0.000 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.993730e-01 | 0.000 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.993730e-01 | 0.000 | 0 | 0 |
| The canonical retinoid cycle in rods (twilight vision) | R-HSA-2453902 | 9.994560e-01 | 0.000 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 9.994560e-01 | 0.000 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.994772e-01 | 0.000 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.995666e-01 | 0.000 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.995893e-01 | 0.000 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 9.995906e-01 | 0.000 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.995906e-01 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.995940e-01 | 0.000 | 0 | 0 |
| Keratan sulfate/keratin metabolism | R-HSA-1638074 | 9.996918e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.997000e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.997183e-01 | 0.000 | 1 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.997218e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.997218e-01 | 0.000 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.997438e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.997442e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.997442e-01 | 0.000 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.997681e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.997797e-01 | 0.000 | 1 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.998117e-01 | 0.000 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.998255e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.998348e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.998550e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.998653e-01 | 0.000 | 0 | 0 |
| Chondroitin sulfate/dermatan sulfate metabolism | R-HSA-1793185 | 9.998686e-01 | 0.000 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.998860e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.999243e-01 | 0.000 | 0 | 0 |
| Sialic acid metabolism | R-HSA-4085001 | 9.999256e-01 | 0.000 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.999256e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.999345e-01 | 0.000 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.999355e-01 | 0.000 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.999440e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.999555e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.999579e-01 | 0.000 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.999635e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.999668e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999668e-01 | 0.000 | 0 | 0 |
| Latent infection - Other responses of Mtb to phagocytosis | R-HSA-1222499 | 9.999683e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.999701e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.999724e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999726e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999742e-01 | 0.000 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.999762e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.999772e-01 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.999799e-01 | 0.000 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.999844e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999846e-01 | 0.000 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.999846e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999862e-01 | 0.000 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.999898e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.999898e-01 | 0.000 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.999924e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.999931e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999943e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999949e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999950e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.999957e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.999973e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999977e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999985e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999988e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999988e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999990e-01 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.999995e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999995e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.999996e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999996e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999997e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 9.999999e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999999e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 1.000000e+00 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 1.000000e+00 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 1.000000e+00 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 1 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 1 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle | R-HSA-1640170 | 1.110223e-16 | 15.955 | 1 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.110223e-16 | 15.955 | 1 | 0 |
| Axon guidance | R-HSA-422475 | 1.110223e-16 | 15.955 | 1 | 0 |
| Nervous system development | R-HSA-9675108 | 1.110223e-16 | 15.955 | 1 | 0 |
| M Phase | R-HSA-68886 | 2.553513e-15 | 14.593 | 1 | 0 |
| Signal Transduction | R-HSA-162582 | 5.750955e-14 | 13.240 | 1 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 5.373479e-14 | 13.270 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 2.654543e-13 | 12.576 | 1 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 4.949374e-13 | 12.305 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 6.966649e-13 | 12.157 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 6.319389e-12 | 11.199 | 1 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 1.404288e-11 | 10.853 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 1.404288e-11 | 10.853 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 2.227440e-11 | 10.652 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 9.176704e-11 | 10.037 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.223162e-10 | 9.913 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 1.174664e-10 | 9.930 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 1.609227e-10 | 9.793 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 1.609227e-10 | 9.793 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 2.548862e-10 | 9.594 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 2.485836e-10 | 9.605 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 2.608869e-10 | 9.584 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 3.299782e-10 | 9.482 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 4.103580e-10 | 9.387 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 4.939307e-10 | 9.306 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 5.975330e-10 | 9.224 | 1 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 7.136218e-10 | 9.147 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 7.256108e-10 | 9.139 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 7.340335e-10 | 9.134 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 9.508844e-10 | 9.022 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 1.220298e-09 | 8.914 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 1.930245e-09 | 8.714 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 1.936301e-09 | 8.713 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 1.869434e-09 | 8.728 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 2.532830e-09 | 8.596 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 3.018948e-09 | 8.520 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 3.838410e-09 | 8.416 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 4.462961e-09 | 8.350 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 4.906865e-09 | 8.309 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 5.947593e-09 | 8.226 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 6.699144e-09 | 8.174 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 8.169642e-09 | 8.088 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 8.145695e-09 | 8.089 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 9.763201e-09 | 8.010 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 1.081672e-08 | 7.966 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 1.495317e-08 | 7.825 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.662159e-08 | 7.779 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 2.071775e-08 | 7.684 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 2.195766e-08 | 7.658 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 2.234227e-08 | 7.651 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 2.658541e-08 | 7.575 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 2.658541e-08 | 7.575 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 3.100612e-08 | 7.509 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 3.073274e-08 | 7.512 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 3.550372e-08 | 7.450 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 3.974159e-08 | 7.401 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 3.974159e-08 | 7.401 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 4.131466e-08 | 7.384 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 4.385588e-08 | 7.358 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 4.676509e-08 | 7.330 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 4.705420e-08 | 7.327 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 5.161474e-08 | 7.287 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 6.527554e-08 | 7.185 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 6.527554e-08 | 7.185 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 8.008718e-08 | 7.096 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.068426e-07 | 6.971 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.159924e-07 | 6.936 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 1.275478e-07 | 6.894 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 1.390094e-07 | 6.857 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 1.493290e-07 | 6.826 | 0 | 0 |
| Depurination | R-HSA-73927 | 1.442585e-07 | 6.841 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.529681e-07 | 6.815 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 1.569690e-07 | 6.804 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.599825e-07 | 6.796 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 1.811275e-07 | 6.742 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 2.440917e-07 | 6.612 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 2.992086e-07 | 6.524 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 3.138805e-07 | 6.503 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 3.270920e-07 | 6.485 | 1 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 3.291621e-07 | 6.483 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 3.584674e-07 | 6.446 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 4.339488e-07 | 6.363 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 4.475171e-07 | 6.349 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 5.275551e-07 | 6.278 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 5.279763e-07 | 6.277 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 5.437213e-07 | 6.265 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 6.959437e-07 | 6.157 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 8.222501e-07 | 6.085 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 8.600841e-07 | 6.065 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 8.818185e-07 | 6.055 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 9.782564e-07 | 6.010 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.066819e-06 | 5.972 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.067850e-06 | 5.971 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.119958e-06 | 5.951 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.105938e-06 | 5.956 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 1.069194e-06 | 5.971 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.183479e-06 | 5.927 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.194665e-06 | 5.923 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 1.228421e-06 | 5.911 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.262289e-06 | 5.899 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.447050e-06 | 5.840 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 2.159229e-06 | 5.666 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 2.320956e-06 | 5.634 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 2.763969e-06 | 5.558 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 2.822199e-06 | 5.549 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 2.756308e-06 | 5.560 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 2.822199e-06 | 5.549 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 2.937855e-06 | 5.532 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 4.247093e-06 | 5.372 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 4.608777e-06 | 5.336 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 5.018038e-06 | 5.299 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 8.033628e-06 | 5.095 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 9.144402e-06 | 5.039 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.260482e-06 | 5.033 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.008659e-05 | 4.996 | 1 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.183835e-05 | 4.927 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 1.260177e-05 | 4.900 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 1.416973e-05 | 4.849 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 1.416973e-05 | 4.849 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 1.333982e-05 | 4.875 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 1.331753e-05 | 4.876 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 1.361977e-05 | 4.866 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.526859e-05 | 4.816 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 1.578959e-05 | 4.802 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 1.656054e-05 | 4.781 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.761374e-05 | 4.754 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.833877e-05 | 4.737 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 1.939218e-05 | 4.712 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.946117e-05 | 4.711 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 1.972554e-05 | 4.705 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 1.989890e-05 | 4.701 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 2.703258e-05 | 4.568 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 2.778564e-05 | 4.556 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 3.688904e-05 | 4.433 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 3.960453e-05 | 4.402 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 4.385272e-05 | 4.358 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 4.996673e-05 | 4.301 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 5.330506e-05 | 4.273 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 5.353164e-05 | 4.271 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 5.386033e-05 | 4.269 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 7.055876e-05 | 4.151 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 7.237455e-05 | 4.140 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 7.237455e-05 | 4.140 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 7.443213e-05 | 4.128 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 7.844647e-05 | 4.105 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 8.339380e-05 | 4.079 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 8.556085e-05 | 4.068 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 8.801852e-05 | 4.055 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 9.130384e-05 | 4.040 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 9.970574e-05 | 4.001 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 1.135540e-04 | 3.945 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 1.142020e-04 | 3.942 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 1.157176e-04 | 3.937 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.172870e-04 | 3.931 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.193840e-04 | 3.923 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.242888e-04 | 3.906 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.247573e-04 | 3.904 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.247573e-04 | 3.904 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 1.268434e-04 | 3.897 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.431172e-04 | 3.844 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.484820e-04 | 3.828 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 1.493280e-04 | 3.826 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.517006e-04 | 3.819 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 1.643838e-04 | 3.784 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 1.847968e-04 | 3.733 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 1.802572e-04 | 3.744 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 1.866699e-04 | 3.729 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.876865e-04 | 3.727 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 2.118122e-04 | 3.674 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 2.145766e-04 | 3.668 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 2.259462e-04 | 3.646 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 2.373917e-04 | 3.625 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 2.373917e-04 | 3.625 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 2.487519e-04 | 3.604 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 2.520801e-04 | 3.598 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 2.832015e-04 | 3.548 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 3.087473e-04 | 3.510 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 3.273617e-04 | 3.485 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 3.435068e-04 | 3.464 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 3.831493e-04 | 3.417 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 4.283773e-04 | 3.368 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 4.688439e-04 | 3.329 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 4.857185e-04 | 3.314 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 4.687998e-04 | 3.329 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 5.041905e-04 | 3.297 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 5.444150e-04 | 3.264 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 5.733006e-04 | 3.242 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 5.759801e-04 | 3.240 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 5.814171e-04 | 3.236 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 5.824236e-04 | 3.235 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 7.507060e-04 | 3.125 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 7.507060e-04 | 3.125 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 7.507073e-04 | 3.125 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 7.507073e-04 | 3.125 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 7.794590e-04 | 3.108 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 8.105465e-04 | 3.091 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 8.386345e-04 | 3.076 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 8.449115e-04 | 3.073 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 8.933801e-04 | 3.049 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 9.159934e-04 | 3.038 | 1 | 1 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.035977e-03 | 2.985 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 9.858441e-04 | 3.006 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.098529e-03 | 2.959 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 1.098529e-03 | 2.959 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.134567e-03 | 2.945 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.147797e-03 | 2.940 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 1.154358e-03 | 2.938 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 1.176921e-03 | 2.929 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.215717e-03 | 2.915 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 1.225424e-03 | 2.912 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.258102e-03 | 2.900 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 1.301928e-03 | 2.885 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 1.301928e-03 | 2.885 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 1.301928e-03 | 2.885 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 1.304376e-03 | 2.885 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 1.334823e-03 | 2.875 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.399397e-03 | 2.854 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 1.454499e-03 | 2.837 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.491622e-03 | 2.826 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 1.606560e-03 | 2.794 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.707895e-03 | 2.768 | 1 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 1.713292e-03 | 2.766 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.739391e-03 | 2.760 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.770569e-03 | 2.752 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 1.804453e-03 | 2.744 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 1.804453e-03 | 2.744 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 2.082855e-03 | 2.681 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 2.082855e-03 | 2.681 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 2.014165e-03 | 2.696 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.947730e-03 | 2.710 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 2.254363e-03 | 2.647 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 2.254363e-03 | 2.647 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 2.254363e-03 | 2.647 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 2.254363e-03 | 2.647 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 2.284755e-03 | 2.641 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 2.344076e-03 | 2.630 | 1 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 2.379246e-03 | 2.624 | 1 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 2.495031e-03 | 2.603 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 2.538285e-03 | 2.595 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 2.618250e-03 | 2.582 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 2.686038e-03 | 2.571 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 2.883465e-03 | 2.540 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 3.053409e-03 | 2.515 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 3.074448e-03 | 2.512 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 3.166635e-03 | 2.499 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 3.286689e-03 | 2.483 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 3.524021e-03 | 2.453 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 3.566137e-03 | 2.448 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 3.590248e-03 | 2.445 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 3.802570e-03 | 2.420 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 3.829415e-03 | 2.417 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 3.937052e-03 | 2.405 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 4.027468e-03 | 2.395 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 4.036860e-03 | 2.394 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 4.036860e-03 | 2.394 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 4.066088e-03 | 2.391 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 4.548506e-03 | 2.342 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 4.956032e-03 | 2.305 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 4.267026e-03 | 2.370 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 4.666682e-03 | 2.331 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 4.274949e-03 | 2.369 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 4.905012e-03 | 2.309 | 1 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 4.964892e-03 | 2.304 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 4.964892e-03 | 2.304 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 4.267026e-03 | 2.370 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 5.030926e-03 | 2.298 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 5.030926e-03 | 2.298 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 5.447419e-03 | 2.264 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 5.700467e-03 | 2.244 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 5.727786e-03 | 2.242 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 5.732422e-03 | 2.242 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 6.464345e-03 | 2.189 | 1 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 6.570197e-03 | 2.182 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 6.727591e-03 | 2.172 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 6.727591e-03 | 2.172 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 6.727591e-03 | 2.172 | 1 | 1 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 6.838990e-03 | 2.165 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 6.838990e-03 | 2.165 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 6.883937e-03 | 2.162 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 6.888949e-03 | 2.162 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 6.973542e-03 | 2.157 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 7.229661e-03 | 2.141 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 7.690219e-03 | 2.114 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 8.134198e-03 | 2.090 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 8.163214e-03 | 2.088 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 8.207181e-03 | 2.086 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 8.781195e-03 | 2.056 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 8.863363e-03 | 2.052 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 9.451074e-03 | 2.025 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 9.460124e-03 | 2.024 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 9.530260e-03 | 2.021 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 9.548675e-03 | 2.020 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 9.548675e-03 | 2.020 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 9.548675e-03 | 2.020 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 9.637371e-03 | 2.016 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 9.723515e-03 | 2.012 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 1.040754e-02 | 1.983 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 1.054314e-02 | 1.977 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 1.082895e-02 | 1.965 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.082895e-02 | 1.965 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 1.082895e-02 | 1.965 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.090049e-02 | 1.963 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 1.309211e-02 | 1.883 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 1.309211e-02 | 1.883 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 1.215017e-02 | 1.915 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 1.278679e-02 | 1.893 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 1.132824e-02 | 1.946 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 1.312259e-02 | 1.882 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 1.320287e-02 | 1.879 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 1.323446e-02 | 1.878 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 1.423538e-02 | 1.847 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.470187e-02 | 1.833 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 1.470187e-02 | 1.833 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 1.470187e-02 | 1.833 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.520913e-02 | 1.818 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 1.573931e-02 | 1.803 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 1.577692e-02 | 1.802 | 1 | 1 |
| Activation of the pre-replicative complex | R-HSA-68962 | 1.577692e-02 | 1.802 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 1.598849e-02 | 1.796 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.662532e-02 | 1.779 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 1.682522e-02 | 1.774 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 1.705708e-02 | 1.768 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 1.775545e-02 | 1.751 | 1 | 1 |
| GPER1 signaling | R-HSA-9634597 | 1.785090e-02 | 1.748 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 1.785090e-02 | 1.748 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 1.871379e-02 | 1.728 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.877840e-02 | 1.726 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 1.897360e-02 | 1.722 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.933685e-02 | 1.714 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.933685e-02 | 1.714 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.933685e-02 | 1.714 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.933685e-02 | 1.714 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.933685e-02 | 1.714 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 2.045862e-02 | 1.689 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 2.061614e-02 | 1.686 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 2.072254e-02 | 1.684 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 2.072254e-02 | 1.684 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 2.074754e-02 | 1.683 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 2.074754e-02 | 1.683 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 2.074754e-02 | 1.683 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 2.085233e-02 | 1.681 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 2.206958e-02 | 1.656 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 2.246968e-02 | 1.648 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 2.246968e-02 | 1.648 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 2.246968e-02 | 1.648 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 2.262640e-02 | 1.645 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 2.293070e-02 | 1.640 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 2.307295e-02 | 1.637 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 2.327503e-02 | 1.633 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 2.426385e-02 | 1.615 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 2.474484e-02 | 1.607 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 2.643921e-02 | 1.578 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 2.643921e-02 | 1.578 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 3.034437e-02 | 1.518 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 2.873248e-02 | 1.542 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 2.873248e-02 | 1.542 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 2.873248e-02 | 1.542 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 2.840818e-02 | 1.547 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 2.846647e-02 | 1.546 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 2.846647e-02 | 1.546 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 2.939783e-02 | 1.532 | 0 | 0 |
| Protein folding | R-HSA-391251 | 2.635671e-02 | 1.579 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 2.551180e-02 | 1.593 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 2.643921e-02 | 1.578 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 2.873248e-02 | 1.542 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 2.873248e-02 | 1.542 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 3.005271e-02 | 1.522 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 2.653562e-02 | 1.576 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 3.034437e-02 | 1.518 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 3.099919e-02 | 1.509 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 3.095295e-02 | 1.509 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 2.582896e-02 | 1.588 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 3.104303e-02 | 1.508 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 3.104303e-02 | 1.508 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 3.104303e-02 | 1.508 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 3.146449e-02 | 1.502 | 1 | 0 |
| Mitophagy | R-HSA-5205647 | 3.243592e-02 | 1.489 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 3.277538e-02 | 1.484 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 3.388696e-02 | 1.470 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 3.487305e-02 | 1.458 | 1 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 3.578948e-02 | 1.446 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 3.578948e-02 | 1.446 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 3.684276e-02 | 1.434 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 3.684276e-02 | 1.434 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 3.710029e-02 | 1.431 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 3.710029e-02 | 1.431 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 3.710029e-02 | 1.431 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 3.710029e-02 | 1.431 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 3.710029e-02 | 1.431 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 3.890751e-02 | 1.410 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 3.890751e-02 | 1.410 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 3.890882e-02 | 1.410 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 3.965484e-02 | 1.402 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 3.965484e-02 | 1.402 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 3.972639e-02 | 1.401 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 4.017598e-02 | 1.396 | 0 | 0 |
| Defective Base Excision Repair Associated with OGG1 | R-HSA-9656249 | 4.062111e-02 | 1.391 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 4.062111e-02 | 1.391 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 4.062111e-02 | 1.391 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 4.062111e-02 | 1.391 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 4.062111e-02 | 1.391 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 4.062111e-02 | 1.391 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 4.092402e-02 | 1.388 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 4.164200e-02 | 1.380 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 4.187124e-02 | 1.378 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 4.212059e-02 | 1.376 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 4.227333e-02 | 1.374 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 4.227333e-02 | 1.374 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 4.255374e-02 | 1.371 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 4.327959e-02 | 1.364 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 4.342280e-02 | 1.362 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 4.367622e-02 | 1.360 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 4.382645e-02 | 1.358 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 4.528819e-02 | 1.344 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 4.528819e-02 | 1.344 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 4.553585e-02 | 1.342 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 4.653590e-02 | 1.332 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 4.684546e-02 | 1.329 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 5.027661e-02 | 1.299 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 5.041554e-02 | 1.297 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 5.041554e-02 | 1.297 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 5.133727e-02 | 1.290 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 5.160083e-02 | 1.287 | 0 | 0 |
| S Phase | R-HSA-69242 | 5.236273e-02 | 1.281 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 5.236273e-02 | 1.281 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 5.246335e-02 | 1.280 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 5.286062e-02 | 1.277 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 5.286062e-02 | 1.277 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 6.746677e-02 | 1.171 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 6.746677e-02 | 1.171 | 0 | 0 |
| Diseases of Cellular Senescence | R-HSA-9630747 | 6.746677e-02 | 1.171 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 6.746677e-02 | 1.171 | 0 | 0 |
| Diseases of cellular response to stress | R-HSA-9675132 | 6.746677e-02 | 1.171 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 6.746677e-02 | 1.171 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 6.746677e-02 | 1.171 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 6.746677e-02 | 1.171 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 6.746677e-02 | 1.171 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 6.746677e-02 | 1.171 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 6.746677e-02 | 1.171 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 6.746677e-02 | 1.171 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 6.746677e-02 | 1.171 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 6.746677e-02 | 1.171 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 5.384618e-02 | 1.269 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 5.384618e-02 | 1.269 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 7.111521e-02 | 1.148 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 7.111521e-02 | 1.148 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 7.111521e-02 | 1.148 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 6.289765e-02 | 1.201 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 6.912588e-02 | 1.160 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 6.353978e-02 | 1.197 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 6.493473e-02 | 1.188 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 6.457558e-02 | 1.190 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 5.384618e-02 | 1.269 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 6.289765e-02 | 1.201 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 6.140608e-02 | 1.212 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 5.384618e-02 | 1.269 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 5.845695e-02 | 1.233 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 6.164631e-02 | 1.210 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 6.832929e-02 | 1.165 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 5.819751e-02 | 1.235 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 6.493473e-02 | 1.188 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 6.353978e-02 | 1.197 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 5.727745e-02 | 1.242 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 5.998218e-02 | 1.222 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 7.184569e-02 | 1.144 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 7.204753e-02 | 1.142 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 7.213066e-02 | 1.142 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 7.622087e-02 | 1.118 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 7.903047e-02 | 1.102 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 7.922282e-02 | 1.101 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 8.076482e-02 | 1.093 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 8.076482e-02 | 1.093 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 8.122667e-02 | 1.090 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 8.244714e-02 | 1.084 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 8.313712e-02 | 1.080 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 8.335841e-02 | 1.079 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 8.428257e-02 | 1.074 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 8.536797e-02 | 1.069 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 8.572113e-02 | 1.067 | 1 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 8.594795e-02 | 1.066 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 8.656112e-02 | 1.063 | 1 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 8.700460e-02 | 1.060 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 9.052998e-02 | 1.043 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 9.052998e-02 | 1.043 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 9.052998e-02 | 1.043 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 9.055697e-02 | 1.043 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 9.117840e-02 | 1.040 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 9.117840e-02 | 1.040 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 9.117840e-02 | 1.040 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 9.527463e-02 | 1.021 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 9.854878e-02 | 1.006 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 9.854878e-02 | 1.006 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 9.891975e-02 | 1.005 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 9.891975e-02 | 1.005 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.900450e-02 | 1.004 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 1.000801e-01 | 1.000 | 0 | 0 |
| Defective OGG1 Substrate Binding | R-HSA-9656255 | 1.000801e-01 | 1.000 | 0 | 0 |
| Defective OGG1 Localization | R-HSA-9657050 | 1.000801e-01 | 1.000 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p14ARF Defects | R-HSA-9646303 | 1.000801e-01 | 1.000 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 1.000801e-01 | 1.000 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 1.000801e-01 | 1.000 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p14ARF Defects | R-HSA-9646304 | 1.000801e-01 | 1.000 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.003465e-01 | 0.998 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.010868e-01 | 0.995 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.010868e-01 | 0.995 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 1.038802e-01 | 0.983 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.038802e-01 | 0.983 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 1.063752e-01 | 0.973 | 1 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 1.063752e-01 | 0.973 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 1.074180e-01 | 0.969 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 1.074180e-01 | 0.969 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.074180e-01 | 0.969 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 1.078513e-01 | 0.967 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.105960e-01 | 0.956 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 1.109943e-01 | 0.955 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.118764e-01 | 0.951 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 1.118764e-01 | 0.951 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 1.128132e-01 | 0.948 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 1.129670e-01 | 0.947 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.129670e-01 | 0.947 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 1.132068e-01 | 0.946 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.140372e-01 | 0.943 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 1.179314e-01 | 0.928 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 1.187828e-01 | 0.925 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 1.224598e-01 | 0.912 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 1.224598e-01 | 0.912 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 1.224598e-01 | 0.912 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 1.224598e-01 | 0.912 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 1.224598e-01 | 0.912 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 1.224598e-01 | 0.912 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 1.262772e-01 | 0.899 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 1.273013e-01 | 0.895 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 1.275862e-01 | 0.894 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 1.275862e-01 | 0.894 | 0 | 0 |
| Defective OGG1 Substrate Processing | R-HSA-9656256 | 1.901494e-01 | 0.721 | 0 | 0 |
| Drug-mediated inhibition of MET activation | R-HSA-9734091 | 1.901494e-01 | 0.721 | 0 | 0 |
| Defective ACTH causes obesity and POMCD | R-HSA-5579031 | 1.901494e-01 | 0.721 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 1.901494e-01 | 0.721 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function | R-HSA-9645722 | 1.901494e-01 | 0.721 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9632697 | 1.901494e-01 | 0.721 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9630791 | 1.901494e-01 | 0.721 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 1.327513e-01 | 0.877 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 1.327513e-01 | 0.877 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 1.327513e-01 | 0.877 | 0 | 0 |
| FBXW7 Mutants and NOTCH1 in Cancer | R-HSA-2644605 | 1.327513e-01 | 0.877 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 1.327513e-01 | 0.877 | 0 | 0 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | R-HSA-2644607 | 1.327513e-01 | 0.877 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.691393e-01 | 0.772 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 1.691393e-01 | 0.772 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 1.691393e-01 | 0.772 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 1.349229e-01 | 0.870 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 1.349229e-01 | 0.870 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 1.594301e-01 | 0.797 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 1.594301e-01 | 0.797 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.594301e-01 | 0.797 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.851579e-01 | 0.732 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 1.433982e-01 | 0.843 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 1.433982e-01 | 0.843 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 1.629420e-01 | 0.788 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 1.629420e-01 | 0.788 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 1.629420e-01 | 0.788 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 1.395139e-01 | 0.855 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 1.395139e-01 | 0.855 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 1.536408e-01 | 0.813 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 1.536408e-01 | 0.813 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 1.343287e-01 | 0.872 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 1.836636e-01 | 0.736 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 1.348132e-01 | 0.870 | 1 | 1 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 1.431901e-01 | 0.844 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 1.453123e-01 | 0.838 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 1.534759e-01 | 0.814 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 1.804029e-01 | 0.744 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 1.467406e-01 | 0.833 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.594301e-01 | 0.797 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 1.431901e-01 | 0.844 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 1.766676e-01 | 0.753 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 1.547919e-01 | 0.810 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 1.802415e-01 | 0.744 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 1.343287e-01 | 0.872 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 1.944191e-01 | 0.711 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 1.448894e-01 | 0.839 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 1.349229e-01 | 0.870 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 1.602441e-01 | 0.795 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 1.327513e-01 | 0.877 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 1.749542e-01 | 0.757 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 1.846694e-01 | 0.734 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 1.757282e-01 | 0.755 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 1.534759e-01 | 0.814 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 1.534759e-01 | 0.814 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 1.691393e-01 | 0.772 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 1.833792e-01 | 0.737 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 1.836636e-01 | 0.736 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 1.361464e-01 | 0.866 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 1.545916e-01 | 0.811 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 1.448894e-01 | 0.839 | 0 | 0 |
| Translation | R-HSA-72766 | 1.498522e-01 | 0.824 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 1.901494e-01 | 0.721 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 1.327513e-01 | 0.877 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 1.327513e-01 | 0.877 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 1.691393e-01 | 0.772 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 1.349229e-01 | 0.870 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 1.629420e-01 | 0.788 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 1.753741e-01 | 0.756 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 1.361464e-01 | 0.866 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 1.665976e-01 | 0.778 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 1.893191e-01 | 0.723 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 1.944191e-01 | 0.711 | 1 | 1 |
| Protein methylation | R-HSA-8876725 | 1.433982e-01 | 0.843 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 1.630061e-01 | 0.788 | 1 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 1.349229e-01 | 0.870 | 1 | 1 |
| PECAM1 interactions | R-HSA-210990 | 1.851579e-01 | 0.732 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 1.850289e-01 | 0.733 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 1.867774e-01 | 0.729 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 1.630061e-01 | 0.788 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 1.731000e-01 | 0.762 | 1 | 1 |
| CaM pathway | R-HSA-111997 | 1.731000e-01 | 0.762 | 1 | 0 |
| Immune System | R-HSA-168256 | 1.527973e-01 | 0.816 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in invasion | R-HSA-9854909 | 1.691393e-01 | 0.772 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 1.395549e-01 | 0.855 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.360132e-01 | 0.866 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.594301e-01 | 0.797 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 1.691393e-01 | 0.772 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 1.691393e-01 | 0.772 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 1.595702e-01 | 0.797 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 1.944191e-01 | 0.711 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 1.433982e-01 | 0.843 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 1.349229e-01 | 0.870 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 1.994793e-01 | 0.700 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 1.996019e-01 | 0.700 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 2.000889e-01 | 0.699 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 2.012940e-01 | 0.696 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 2.012940e-01 | 0.696 | 1 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 2.014268e-01 | 0.696 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 2.023091e-01 | 0.694 | 1 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 2.058622e-01 | 0.686 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 2.069334e-01 | 0.684 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 2.069334e-01 | 0.684 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 2.069334e-01 | 0.684 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 2.069334e-01 | 0.684 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 2.069334e-01 | 0.684 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 2.069334e-01 | 0.684 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 2.069334e-01 | 0.684 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 2.069334e-01 | 0.684 | 0 | 0 |
| Diseases of Base Excision Repair | R-HSA-9605308 | 2.069334e-01 | 0.684 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 2.069334e-01 | 0.684 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 2.118713e-01 | 0.674 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 2.118713e-01 | 0.674 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 2.118713e-01 | 0.674 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 2.118713e-01 | 0.674 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 2.127593e-01 | 0.672 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 2.127593e-01 | 0.672 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 2.127593e-01 | 0.672 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 2.136530e-01 | 0.670 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 2.148009e-01 | 0.668 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 2.148009e-01 | 0.668 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 2.150002e-01 | 0.668 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.264872e-01 | 0.645 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 2.264872e-01 | 0.645 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 2.264872e-01 | 0.645 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 2.264872e-01 | 0.645 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 2.264872e-01 | 0.645 | 0 | 0 |
| PKA activation | R-HSA-163615 | 2.264872e-01 | 0.645 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 2.316206e-01 | 0.635 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 2.325019e-01 | 0.634 | 0 | 0 |
| PI and PC transport between ER and Golgi membranes | R-HSA-1483196 | 2.712088e-01 | 0.567 | 0 | 0 |
| Abasic sugar-phosphate removal via the single-nucleotide replacement pathway | R-HSA-73930 | 2.712088e-01 | 0.567 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects | R-HSA-9632693 | 2.712088e-01 | 0.567 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p16INK4A Defects | R-HSA-9630750 | 2.712088e-01 | 0.567 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 2.712088e-01 | 0.567 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 2.712088e-01 | 0.567 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9632700 | 2.712088e-01 | 0.567 | 0 | 0 |
| IKBKB deficiency causes SCID | R-HSA-5602636 | 2.712088e-01 | 0.567 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 2.712088e-01 | 0.567 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.712088e-01 | 0.567 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9630794 | 2.712088e-01 | 0.567 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 2.712088e-01 | 0.567 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 2.712088e-01 | 0.567 | 0 | 0 |
| Defective GFPT1 causes CMSTA1 | R-HSA-4085023 | 2.712088e-01 | 0.567 | 0 | 0 |
| Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3 | R-HSA-5083628 | 2.712088e-01 | 0.567 | 0 | 0 |
| MPS IIID - Sanfilippo syndrome D | R-HSA-2206305 | 2.712088e-01 | 0.567 | 0 | 0 |
| IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | R-HSA-5603027 | 2.712088e-01 | 0.567 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 3.441592e-01 | 0.463 | 0 | 0 |
| Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2 | R-HSA-5083629 | 3.441592e-01 | 0.463 | 0 | 0 |
| Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1 | R-HSA-5083633 | 3.441592e-01 | 0.463 | 0 | 0 |
| Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum) | R-HSA-5655799 | 3.441592e-01 | 0.463 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 3.441592e-01 | 0.463 | 0 | 0 |
| TGFBR2 Kinase Domain Mutants in Cancer | R-HSA-3645790 | 3.441592e-01 | 0.463 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 3.441592e-01 | 0.463 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 3.441592e-01 | 0.463 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 3.441592e-01 | 0.463 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 2.454881e-01 | 0.610 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 2.454881e-01 | 0.610 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 2.454881e-01 | 0.610 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 2.454881e-01 | 0.610 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 2.842731e-01 | 0.546 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 2.842731e-01 | 0.546 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 2.842731e-01 | 0.546 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 4.098112e-01 | 0.387 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of other transcription factors | R-HSA-8866906 | 4.098112e-01 | 0.387 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 4.098112e-01 | 0.387 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 4.098112e-01 | 0.387 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 4.098112e-01 | 0.387 | 0 | 0 |
| Classical Kir channels | R-HSA-1296053 | 4.098112e-01 | 0.387 | 0 | 0 |
| Adrenaline signalling through Alpha-2 adrenergic receptor | R-HSA-392023 | 4.098112e-01 | 0.387 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 4.098112e-01 | 0.387 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 2.393447e-01 | 0.621 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 2.393447e-01 | 0.621 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 2.393447e-01 | 0.621 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 2.393447e-01 | 0.621 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 2.393447e-01 | 0.621 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 2.393447e-01 | 0.621 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 3.228563e-01 | 0.491 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 3.228563e-01 | 0.491 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 2.673648e-01 | 0.573 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 2.673648e-01 | 0.573 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 2.673648e-01 | 0.573 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 2.673648e-01 | 0.573 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 2.489326e-01 | 0.604 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 3.608898e-01 | 0.443 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 3.608898e-01 | 0.443 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 3.608898e-01 | 0.443 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 4.688947e-01 | 0.329 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 4.688947e-01 | 0.329 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 4.688947e-01 | 0.329 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 4.688947e-01 | 0.329 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 4.688947e-01 | 0.329 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 4.688947e-01 | 0.329 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 3.242654e-01 | 0.489 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 3.242654e-01 | 0.489 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 3.980973e-01 | 0.400 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 3.980973e-01 | 0.400 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 3.980973e-01 | 0.400 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 3.980973e-01 | 0.400 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 3.527959e-01 | 0.452 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 3.185172e-01 | 0.497 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 3.185172e-01 | 0.497 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 2.906444e-01 | 0.537 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 2.670726e-01 | 0.573 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 3.109047e-01 | 0.507 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 3.811743e-01 | 0.419 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 3.811743e-01 | 0.419 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 4.342631e-01 | 0.362 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 4.342631e-01 | 0.362 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 4.342631e-01 | 0.362 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 4.342631e-01 | 0.362 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 3.313468e-01 | 0.480 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 3.657582e-01 | 0.437 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 3.210040e-01 | 0.493 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 4.092670e-01 | 0.388 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 3.519069e-01 | 0.454 | 1 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 3.893545e-01 | 0.410 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 3.577936e-01 | 0.446 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 4.369564e-01 | 0.360 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 3.931377e-01 | 0.405 | 1 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 3.763028e-01 | 0.424 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 3.048712e-01 | 0.516 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 4.360929e-01 | 0.360 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 4.641405e-01 | 0.333 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 4.341399e-01 | 0.362 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 4.461301e-01 | 0.351 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 4.461301e-01 | 0.351 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 4.629048e-01 | 0.335 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 4.629048e-01 | 0.335 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 2.670726e-01 | 0.573 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 3.385094e-01 | 0.470 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 2.489326e-01 | 0.604 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 2.466436e-01 | 0.608 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 3.763028e-01 | 0.424 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 2.718239e-01 | 0.566 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 4.423940e-01 | 0.354 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 2.509344e-01 | 0.600 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 2.466436e-01 | 0.608 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 3.608898e-01 | 0.443 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 3.763028e-01 | 0.424 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 2.952883e-01 | 0.530 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 2.658100e-01 | 0.575 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 2.454881e-01 | 0.610 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 3.811743e-01 | 0.419 | 1 | 1 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 3.893545e-01 | 0.410 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 4.590923e-01 | 0.338 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 3.980973e-01 | 0.400 | 1 | 1 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 3.953758e-01 | 0.403 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 4.123366e-01 | 0.385 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 4.545580e-01 | 0.342 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 4.535610e-01 | 0.343 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 4.535610e-01 | 0.343 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 3.111954e-01 | 0.507 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 3.111954e-01 | 0.507 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 2.489326e-01 | 0.604 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 2.842731e-01 | 0.546 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 2.950533e-01 | 0.530 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 3.980973e-01 | 0.400 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 3.980973e-01 | 0.400 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 4.342631e-01 | 0.362 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 4.092670e-01 | 0.388 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 3.577936e-01 | 0.446 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 3.113911e-01 | 0.507 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 3.522245e-01 | 0.453 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 2.670726e-01 | 0.573 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 3.798740e-01 | 0.420 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 3.424679e-01 | 0.465 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 4.342631e-01 | 0.362 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 3.060504e-01 | 0.514 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 4.501241e-01 | 0.347 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 2.842731e-01 | 0.546 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 2.489326e-01 | 0.604 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 3.811743e-01 | 0.419 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 2.784457e-01 | 0.555 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 3.313468e-01 | 0.480 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 4.641405e-01 | 0.333 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 2.421316e-01 | 0.616 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 3.948307e-01 | 0.404 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 3.421167e-01 | 0.466 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 2.509344e-01 | 0.600 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 4.590923e-01 | 0.338 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 4.119977e-01 | 0.385 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 4.388753e-01 | 0.358 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 4.092670e-01 | 0.388 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 4.641405e-01 | 0.333 | 1 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 2.947198e-01 | 0.531 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 4.369564e-01 | 0.360 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 4.400164e-01 | 0.357 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 4.342631e-01 | 0.362 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 2.957328e-01 | 0.529 | 1 | 1 |
| Opioid Signalling | R-HSA-111885 | 3.315315e-01 | 0.479 | 1 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 3.228563e-01 | 0.491 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 4.688947e-01 | 0.329 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 3.242654e-01 | 0.489 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 4.092670e-01 | 0.388 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 3.725234e-01 | 0.429 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 3.931377e-01 | 0.405 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 4.641405e-01 | 0.333 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 2.947198e-01 | 0.531 | 1 | 1 |
| G-protein mediated events | R-HSA-112040 | 3.946476e-01 | 0.404 | 1 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 3.893545e-01 | 0.410 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 4.182736e-01 | 0.379 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 2.844343e-01 | 0.546 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 4.473201e-01 | 0.349 | 1 | 0 |
| Neuronal System | R-HSA-112316 | 2.389659e-01 | 0.622 | 1 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 4.545580e-01 | 0.342 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 4.369564e-01 | 0.360 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 3.360484e-01 | 0.474 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 3.360484e-01 | 0.474 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 2.848205e-01 | 0.545 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 3.278373e-01 | 0.484 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 3.937716e-01 | 0.405 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 2.712088e-01 | 0.567 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 2.712088e-01 | 0.567 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 3.441592e-01 | 0.463 | 0 | 0 |
| Loss of Function of TGFBR2 in Cancer | R-HSA-3642278 | 3.441592e-01 | 0.463 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 3.441592e-01 | 0.463 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 4.098112e-01 | 0.387 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 3.228563e-01 | 0.491 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 3.608898e-01 | 0.443 | 0 | 0 |
| Electric Transmission Across Gap Junctions | R-HSA-112303 | 4.688947e-01 | 0.329 | 0 | 0 |
| Transmission across Electrical Synapses | R-HSA-112307 | 4.688947e-01 | 0.329 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 3.242654e-01 | 0.489 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 3.242654e-01 | 0.489 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 3.527959e-01 | 0.452 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 3.811743e-01 | 0.419 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 3.811743e-01 | 0.419 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 4.342631e-01 | 0.362 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 4.342631e-01 | 0.362 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 3.657582e-01 | 0.437 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 3.134308e-01 | 0.504 | 1 | 1 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 4.681861e-01 | 0.330 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 3.028133e-01 | 0.519 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 3.784130e-01 | 0.422 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 3.763028e-01 | 0.424 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 3.072978e-01 | 0.512 | 1 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 3.106673e-01 | 0.508 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 3.784130e-01 | 0.422 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 2.906444e-01 | 0.537 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 3.106673e-01 | 0.508 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 3.542447e-01 | 0.451 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 4.423940e-01 | 0.354 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 3.722998e-01 | 0.429 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 3.608898e-01 | 0.443 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 3.931377e-01 | 0.405 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 3.481701e-01 | 0.458 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 3.661375e-01 | 0.436 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 3.661375e-01 | 0.436 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 3.661375e-01 | 0.436 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 3.185172e-01 | 0.497 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 4.128243e-01 | 0.384 | 1 | 1 |
| Hedgehog 'off' state | R-HSA-5610787 | 3.901665e-01 | 0.409 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 2.842731e-01 | 0.546 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 2.842731e-01 | 0.546 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 3.228563e-01 | 0.491 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 3.608898e-01 | 0.443 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 4.688947e-01 | 0.329 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 3.527959e-01 | 0.452 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 3.811743e-01 | 0.419 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 4.342631e-01 | 0.362 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 2.906444e-01 | 0.537 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 4.128243e-01 | 0.384 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 2.718239e-01 | 0.566 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 3.242654e-01 | 0.489 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 3.313468e-01 | 0.480 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 3.216088e-01 | 0.493 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 3.328832e-01 | 0.478 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 3.651658e-01 | 0.438 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 3.481701e-01 | 0.458 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 2.526311e-01 | 0.598 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 3.441592e-01 | 0.463 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 2.842731e-01 | 0.546 | 0 | 0 |
| Intracellular oxygen transport | R-HSA-8981607 | 4.098112e-01 | 0.387 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 4.098112e-01 | 0.387 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 3.228563e-01 | 0.491 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 2.957328e-01 | 0.529 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 3.608898e-01 | 0.443 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 3.608898e-01 | 0.443 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 4.688947e-01 | 0.329 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 4.688947e-01 | 0.329 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 4.688947e-01 | 0.329 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 3.980973e-01 | 0.400 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 3.811743e-01 | 0.419 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 4.342631e-01 | 0.362 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 3.328823e-01 | 0.478 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 2.489326e-01 | 0.604 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 3.519069e-01 | 0.454 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 3.980973e-01 | 0.400 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 3.145398e-01 | 0.502 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 3.185172e-01 | 0.497 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 4.098112e-01 | 0.387 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 4.342631e-01 | 0.362 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 4.683340e-01 | 0.329 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 2.393447e-01 | 0.621 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 2.496173e-01 | 0.603 | 0 | 0 |
| Prostanoid ligand receptors | R-HSA-391908 | 4.342631e-01 | 0.362 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 4.109747e-01 | 0.386 | 0 | 0 |
| FasL/ CD95L signaling | R-HSA-75157 | 4.098112e-01 | 0.387 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 2.957328e-01 | 0.529 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 2.494727e-01 | 0.603 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 3.577936e-01 | 0.446 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 4.590923e-01 | 0.338 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 3.322120e-01 | 0.479 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 3.028133e-01 | 0.519 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 3.980973e-01 | 0.400 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 4.342631e-01 | 0.362 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 4.648641e-01 | 0.333 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 4.128243e-01 | 0.384 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 2.957328e-01 | 0.529 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 4.590923e-01 | 0.338 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 3.577936e-01 | 0.446 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 4.692232e-01 | 0.329 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 4.692232e-01 | 0.329 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 4.692232e-01 | 0.329 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 4.692232e-01 | 0.329 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 4.692232e-01 | 0.329 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 4.692232e-01 | 0.329 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 4.692232e-01 | 0.329 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 4.692232e-01 | 0.329 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 4.692232e-01 | 0.329 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 4.692232e-01 | 0.329 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 4.692232e-01 | 0.329 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 4.692232e-01 | 0.329 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 4.745077e-01 | 0.324 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 4.745077e-01 | 0.324 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 4.745077e-01 | 0.324 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 4.745077e-01 | 0.324 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 4.796481e-01 | 0.319 | 1 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 4.816544e-01 | 0.317 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 4.817609e-01 | 0.317 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 4.817609e-01 | 0.317 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 4.846416e-01 | 0.315 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 4.863762e-01 | 0.313 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 4.866942e-01 | 0.313 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 4.890057e-01 | 0.311 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 4.943418e-01 | 0.306 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 4.971821e-01 | 0.303 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 4.986244e-01 | 0.302 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 4.995987e-01 | 0.301 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 5.028564e-01 | 0.299 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 5.028564e-01 | 0.299 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 5.028564e-01 | 0.299 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 5.028564e-01 | 0.299 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 5.028564e-01 | 0.299 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 5.028564e-01 | 0.299 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 5.028564e-01 | 0.299 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 5.028564e-01 | 0.299 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 5.028564e-01 | 0.299 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 5.040436e-01 | 0.298 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 5.040436e-01 | 0.298 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 5.040436e-01 | 0.298 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 5.040436e-01 | 0.298 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 5.040436e-01 | 0.298 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 5.040436e-01 | 0.298 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 5.040436e-01 | 0.298 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 5.040436e-01 | 0.298 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 5.040436e-01 | 0.298 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 5.042197e-01 | 0.297 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 5.056000e-01 | 0.296 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 5.056000e-01 | 0.296 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 5.104900e-01 | 0.292 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 5.124219e-01 | 0.290 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 5.124219e-01 | 0.290 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 5.124219e-01 | 0.290 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 5.138904e-01 | 0.289 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 5.166559e-01 | 0.287 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 5.166559e-01 | 0.287 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 5.166559e-01 | 0.287 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 5.166559e-01 | 0.287 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 5.218357e-01 | 0.282 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 5.218357e-01 | 0.282 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 5.220666e-01 | 0.282 | 0 | 0 |
| Activation of AMPA receptors | R-HSA-399710 | 5.220666e-01 | 0.282 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 5.220666e-01 | 0.282 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 5.220666e-01 | 0.282 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 5.220666e-01 | 0.282 | 0 | 0 |
| Defective F9 activation | R-HSA-9673221 | 5.220666e-01 | 0.282 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 5.220666e-01 | 0.282 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 5.220666e-01 | 0.282 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 5.220666e-01 | 0.282 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 5.220666e-01 | 0.282 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 5.220666e-01 | 0.282 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 5.220666e-01 | 0.282 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 5.220666e-01 | 0.282 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 5.220666e-01 | 0.282 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 5.220666e-01 | 0.282 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 5.220666e-01 | 0.282 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 5.258917e-01 | 0.279 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 5.285786e-01 | 0.277 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 5.290674e-01 | 0.276 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 5.333745e-01 | 0.273 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 5.350783e-01 | 0.272 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 5.350783e-01 | 0.272 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 5.350783e-01 | 0.272 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 5.350783e-01 | 0.272 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 5.350783e-01 | 0.272 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 5.350783e-01 | 0.272 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 5.350783e-01 | 0.272 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 5.350783e-01 | 0.272 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 5.391979e-01 | 0.268 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 5.418522e-01 | 0.266 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 5.418522e-01 | 0.266 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 5.418522e-01 | 0.266 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 5.472626e-01 | 0.262 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 5.519947e-01 | 0.258 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 5.519947e-01 | 0.258 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 5.519947e-01 | 0.258 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 5.532268e-01 | 0.257 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 5.571230e-01 | 0.254 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 5.658342e-01 | 0.247 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 5.658342e-01 | 0.247 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 5.658342e-01 | 0.247 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 5.658342e-01 | 0.247 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 5.658342e-01 | 0.247 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 5.658342e-01 | 0.247 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 5.658342e-01 | 0.247 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 5.658342e-01 | 0.247 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 5.658342e-01 | 0.247 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 5.662712e-01 | 0.247 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 5.662712e-01 | 0.247 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 5.662712e-01 | 0.247 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 5.662712e-01 | 0.247 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 5.681195e-01 | 0.246 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 5.681195e-01 | 0.246 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 5.699179e-01 | 0.244 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 5.699179e-01 | 0.244 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 5.699179e-01 | 0.244 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 5.699179e-01 | 0.244 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 5.699179e-01 | 0.244 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 5.699179e-01 | 0.244 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 5.699179e-01 | 0.244 | 0 | 0 |
| NGF-independant TRKA activation | R-HSA-187024 | 5.699179e-01 | 0.244 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 5.699179e-01 | 0.244 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 5.699179e-01 | 0.244 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 5.699179e-01 | 0.244 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 5.699179e-01 | 0.244 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 5.699179e-01 | 0.244 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 5.699179e-01 | 0.244 | 0 | 0 |
| TRAIL signaling | R-HSA-75158 | 5.699179e-01 | 0.244 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 5.699179e-01 | 0.244 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 5.757089e-01 | 0.240 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 5.757089e-01 | 0.240 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 5.757089e-01 | 0.240 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 5.757089e-01 | 0.240 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 5.757089e-01 | 0.240 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 5.801888e-01 | 0.236 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 5.826226e-01 | 0.235 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 5.834614e-01 | 0.234 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 5.884313e-01 | 0.230 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 5.884313e-01 | 0.230 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 5.884313e-01 | 0.230 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 5.884313e-01 | 0.230 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 5.885829e-01 | 0.230 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 5.885829e-01 | 0.230 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 5.898741e-01 | 0.229 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 5.909131e-01 | 0.228 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 5.929596e-01 | 0.227 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 5.950947e-01 | 0.225 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 5.950947e-01 | 0.225 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 5.950947e-01 | 0.225 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 5.950947e-01 | 0.225 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 5.950947e-01 | 0.225 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 5.950947e-01 | 0.225 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 6.056568e-01 | 0.218 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 6.058386e-01 | 0.218 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 6.058386e-01 | 0.218 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 6.081720e-01 | 0.216 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 6.126319e-01 | 0.213 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 6.126319e-01 | 0.213 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 6.126319e-01 | 0.213 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 6.129808e-01 | 0.213 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 6.129808e-01 | 0.213 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 6.129808e-01 | 0.213 | 0 | 0 |
| Highly sodium permeable postsynaptic acetylcholine nicotinic receptors | R-HSA-629587 | 6.129808e-01 | 0.213 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 6.129808e-01 | 0.213 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 6.129808e-01 | 0.213 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 6.129808e-01 | 0.213 | 0 | 0 |
| MET Receptor Activation | R-HSA-6806942 | 6.129808e-01 | 0.213 | 0 | 0 |
| Abacavir transmembrane transport | R-HSA-2161517 | 6.129808e-01 | 0.213 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 6.129808e-01 | 0.213 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 6.129808e-01 | 0.213 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 6.129808e-01 | 0.213 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 6.129808e-01 | 0.213 | 0 | 0 |
| Lipid particle organization | R-HSA-8964572 | 6.129808e-01 | 0.213 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 6.129808e-01 | 0.213 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 6.192802e-01 | 0.208 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 6.228509e-01 | 0.206 | 1 | 1 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 6.228509e-01 | 0.206 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 6.228509e-01 | 0.206 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 6.228509e-01 | 0.206 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 6.228509e-01 | 0.206 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 6.273207e-01 | 0.203 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 6.273207e-01 | 0.203 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 6.330098e-01 | 0.199 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 6.336542e-01 | 0.198 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 6.345242e-01 | 0.198 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 6.345242e-01 | 0.198 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 6.345242e-01 | 0.198 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 6.348021e-01 | 0.197 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 6.447572e-01 | 0.191 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 6.447572e-01 | 0.191 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 6.458611e-01 | 0.190 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 6.458611e-01 | 0.190 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 6.458611e-01 | 0.190 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 6.491107e-01 | 0.188 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 6.491107e-01 | 0.188 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 6.491107e-01 | 0.188 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 6.491107e-01 | 0.188 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 6.491107e-01 | 0.188 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 6.491107e-01 | 0.188 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 6.491107e-01 | 0.188 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 6.491107e-01 | 0.188 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 6.517343e-01 | 0.186 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 6.517343e-01 | 0.186 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 6.517343e-01 | 0.186 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 6.517343e-01 | 0.186 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 6.517343e-01 | 0.186 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 6.517343e-01 | 0.186 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 6.517343e-01 | 0.186 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 6.517343e-01 | 0.186 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 6.517343e-01 | 0.186 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 6.517343e-01 | 0.186 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 6.517343e-01 | 0.186 | 1 | 1 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 6.517343e-01 | 0.186 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 6.517343e-01 | 0.186 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 6.517343e-01 | 0.186 | 0 | 0 |
| DAG1 core M1 glycosylations | R-HSA-8932506 | 6.517343e-01 | 0.186 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 6.517343e-01 | 0.186 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 6.517343e-01 | 0.186 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 6.517343e-01 | 0.186 | 0 | 0 |
| Activation of TRKA receptors | R-HSA-187015 | 6.517343e-01 | 0.186 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 6.517343e-01 | 0.186 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 6.517343e-01 | 0.186 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 6.518677e-01 | 0.186 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 6.553082e-01 | 0.184 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 6.555386e-01 | 0.183 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 6.555386e-01 | 0.183 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 6.555386e-01 | 0.183 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 6.555386e-01 | 0.183 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 6.555386e-01 | 0.183 | 0 | 0 |
| Disease | R-HSA-1643685 | 6.568058e-01 | 0.183 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 6.637811e-01 | 0.178 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 6.637811e-01 | 0.178 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 6.647810e-01 | 0.177 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 6.648533e-01 | 0.177 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 6.665099e-01 | 0.176 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 6.679618e-01 | 0.175 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 6.698048e-01 | 0.174 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 6.723348e-01 | 0.172 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 6.723348e-01 | 0.172 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 6.738955e-01 | 0.171 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 6.738955e-01 | 0.171 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 6.738955e-01 | 0.171 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 6.738955e-01 | 0.171 | 0 | 0 |
| Sulfide oxidation to sulfate | R-HSA-1614517 | 6.738955e-01 | 0.171 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 6.738955e-01 | 0.171 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 6.738955e-01 | 0.171 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 6.751583e-01 | 0.171 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 6.751583e-01 | 0.171 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 6.756695e-01 | 0.170 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 6.756695e-01 | 0.170 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 6.756695e-01 | 0.170 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 6.756695e-01 | 0.170 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 6.756695e-01 | 0.170 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 6.756695e-01 | 0.170 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 6.758749e-01 | 0.170 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 6.810726e-01 | 0.167 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 6.815524e-01 | 0.167 | 1 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 6.832945e-01 | 0.165 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 6.832945e-01 | 0.165 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 6.832945e-01 | 0.165 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 6.866092e-01 | 0.163 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 6.866092e-01 | 0.163 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 6.866092e-01 | 0.163 | 0 | 0 |
| DAG1 core M2 glycosylations | R-HSA-8932504 | 6.866092e-01 | 0.163 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 6.866092e-01 | 0.163 | 0 | 0 |
| Highly calcium permeable nicotinic acetylcholine receptors | R-HSA-629597 | 6.866092e-01 | 0.163 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 6.866092e-01 | 0.163 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 6.866092e-01 | 0.163 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 6.866092e-01 | 0.163 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 6.866092e-01 | 0.163 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 6.866092e-01 | 0.163 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 6.866092e-01 | 0.163 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 6.866092e-01 | 0.163 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 6.866092e-01 | 0.163 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 6.866092e-01 | 0.163 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 6.876556e-01 | 0.163 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 6.889017e-01 | 0.162 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 6.933064e-01 | 0.159 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 6.946026e-01 | 0.158 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 6.946026e-01 | 0.158 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 6.949174e-01 | 0.158 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 6.949174e-01 | 0.158 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 6.949174e-01 | 0.158 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 6.949174e-01 | 0.158 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 6.949174e-01 | 0.158 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 6.949174e-01 | 0.158 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 6.972372e-01 | 0.157 | 1 | 1 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 6.972372e-01 | 0.157 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 6.972372e-01 | 0.157 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 6.972372e-01 | 0.157 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 6.972372e-01 | 0.157 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 6.972372e-01 | 0.157 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 6.977312e-01 | 0.156 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 7.059235e-01 | 0.151 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 7.080425e-01 | 0.150 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 7.084660e-01 | 0.150 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 7.137555e-01 | 0.146 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 7.139272e-01 | 0.146 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 7.151750e-01 | 0.146 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 7.179937e-01 | 0.144 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 7.179937e-01 | 0.144 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 7.179937e-01 | 0.144 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 7.179937e-01 | 0.144 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 7.179937e-01 | 0.144 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 7.179937e-01 | 0.144 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 7.179937e-01 | 0.144 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 7.179937e-01 | 0.144 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 7.179937e-01 | 0.144 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 7.179937e-01 | 0.144 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 7.179937e-01 | 0.144 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 7.179937e-01 | 0.144 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 7.191764e-01 | 0.143 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 7.191764e-01 | 0.143 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 7.191764e-01 | 0.143 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 7.191764e-01 | 0.143 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 7.191764e-01 | 0.143 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 7.191764e-01 | 0.143 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 7.256654e-01 | 0.139 | 1 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 7.259195e-01 | 0.139 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 7.291474e-01 | 0.137 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 7.291474e-01 | 0.137 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 7.291474e-01 | 0.137 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 7.291474e-01 | 0.137 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 7.306460e-01 | 0.136 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 7.307920e-01 | 0.136 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 7.307920e-01 | 0.136 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 7.307920e-01 | 0.136 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 7.397597e-01 | 0.131 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 7.397597e-01 | 0.131 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 7.397597e-01 | 0.131 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 7.397597e-01 | 0.131 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 7.397597e-01 | 0.131 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 7.397597e-01 | 0.131 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 7.397597e-01 | 0.131 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 7.397597e-01 | 0.131 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 7.397597e-01 | 0.131 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 7.397597e-01 | 0.131 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 7.397597e-01 | 0.131 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 7.397597e-01 | 0.131 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 7.430610e-01 | 0.129 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 7.439826e-01 | 0.128 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 7.459056e-01 | 0.127 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 7.459056e-01 | 0.127 | 0 | 0 |
| Highly calcium permeable postsynaptic nicotinic acetylcholine receptors | R-HSA-629594 | 7.462369e-01 | 0.127 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 7.462369e-01 | 0.127 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 7.462369e-01 | 0.127 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 7.462369e-01 | 0.127 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 7.462369e-01 | 0.127 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 7.462369e-01 | 0.127 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 7.462369e-01 | 0.127 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 7.462369e-01 | 0.127 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 7.462369e-01 | 0.127 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 7.462369e-01 | 0.127 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 7.462369e-01 | 0.127 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 7.462369e-01 | 0.127 | 0 | 0 |
| Defective factor IX causes hemophilia B | R-HSA-9668250 | 7.462369e-01 | 0.127 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 7.462369e-01 | 0.127 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 7.462369e-01 | 0.127 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 7.462369e-01 | 0.127 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 7.474435e-01 | 0.126 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 7.474435e-01 | 0.126 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 7.474435e-01 | 0.126 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 7.568255e-01 | 0.121 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 7.580533e-01 | 0.120 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 7.580533e-01 | 0.120 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 7.580533e-01 | 0.120 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 7.590387e-01 | 0.120 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 7.590387e-01 | 0.120 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 7.590387e-01 | 0.120 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 7.590387e-01 | 0.120 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 7.590387e-01 | 0.120 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 7.590387e-01 | 0.120 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 7.590387e-01 | 0.120 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 7.590387e-01 | 0.120 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 7.626156e-01 | 0.118 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 7.632601e-01 | 0.117 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 7.632601e-01 | 0.117 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 7.632601e-01 | 0.117 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 7.691790e-01 | 0.114 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 7.691790e-01 | 0.114 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 7.691790e-01 | 0.114 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 7.703924e-01 | 0.113 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 7.715830e-01 | 0.113 | 0 | 0 |
| DAG1 core M3 glycosylations | R-HSA-8932505 | 7.716530e-01 | 0.113 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 7.716530e-01 | 0.113 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 7.716530e-01 | 0.113 | 0 | 0 |
| FGFR2b ligand binding and activation | R-HSA-190377 | 7.716530e-01 | 0.113 | 0 | 0 |
| FGFRL1 modulation of FGFR1 signaling | R-HSA-5658623 | 7.716530e-01 | 0.113 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 7.716530e-01 | 0.113 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 7.716530e-01 | 0.113 | 0 | 0 |
| Cholesterol biosynthesis via desmosterol | R-HSA-6807047 | 7.716530e-01 | 0.113 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 7.716530e-01 | 0.113 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 7.716530e-01 | 0.113 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 7.716530e-01 | 0.113 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 7.770680e-01 | 0.110 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 7.770680e-01 | 0.110 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 7.770680e-01 | 0.110 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 7.770680e-01 | 0.110 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 7.770680e-01 | 0.110 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 7.782624e-01 | 0.109 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 7.782624e-01 | 0.109 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 7.782624e-01 | 0.109 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 7.782624e-01 | 0.109 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 7.810487e-01 | 0.107 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 7.813002e-01 | 0.107 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 7.845106e-01 | 0.105 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 7.905440e-01 | 0.102 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 7.924728e-01 | 0.101 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 7.924728e-01 | 0.101 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 7.924728e-01 | 0.101 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 7.939046e-01 | 0.100 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 7.939046e-01 | 0.100 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 7.939046e-01 | 0.100 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 7.939046e-01 | 0.100 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 7.939046e-01 | 0.100 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 7.939046e-01 | 0.100 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 7.939046e-01 | 0.100 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 7.939046e-01 | 0.100 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 7.945248e-01 | 0.100 | 0 | 0 |
| Presynaptic nicotinic acetylcholine receptors | R-HSA-622323 | 7.945248e-01 | 0.100 | 0 | 0 |
| Endosomal/Vacuolar pathway | R-HSA-1236977 | 7.945248e-01 | 0.100 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 7.945248e-01 | 0.100 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 7.945248e-01 | 0.100 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 7.945248e-01 | 0.100 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 7.945248e-01 | 0.100 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 7.945248e-01 | 0.100 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 7.945248e-01 | 0.100 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 7.945248e-01 | 0.100 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 7.945248e-01 | 0.100 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 7.968483e-01 | 0.099 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 7.975317e-01 | 0.098 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 8.033647e-01 | 0.095 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 8.050252e-01 | 0.094 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 8.059159e-01 | 0.094 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 8.059159e-01 | 0.094 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 8.086098e-01 | 0.092 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 8.086098e-01 | 0.092 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 8.096065e-01 | 0.092 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 8.096065e-01 | 0.092 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 8.096065e-01 | 0.092 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 8.096065e-01 | 0.092 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 8.096065e-01 | 0.092 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 8.106842e-01 | 0.091 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 8.127096e-01 | 0.090 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 8.151070e-01 | 0.089 | 0 | 0 |
| Defective EXT2 causes exostoses 2 | R-HSA-3656237 | 8.151070e-01 | 0.089 | 0 | 0 |
| Defective EXT1 causes exostoses 1, TRPS2 and CHDS | R-HSA-3656253 | 8.151070e-01 | 0.089 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 8.151070e-01 | 0.089 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 8.151070e-01 | 0.089 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 8.151070e-01 | 0.089 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 8.151070e-01 | 0.089 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 8.151070e-01 | 0.089 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 8.151070e-01 | 0.089 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 8.151070e-01 | 0.089 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 8.151070e-01 | 0.089 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 8.151070e-01 | 0.089 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 8.151070e-01 | 0.089 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 8.151070e-01 | 0.089 | 0 | 0 |
| Estrogen biosynthesis | R-HSA-193144 | 8.151070e-01 | 0.089 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 8.151070e-01 | 0.089 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 8.186175e-01 | 0.087 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 8.198095e-01 | 0.086 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 8.198095e-01 | 0.086 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 8.201085e-01 | 0.086 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 8.238406e-01 | 0.084 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 8.242320e-01 | 0.084 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 8.242320e-01 | 0.084 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 8.242320e-01 | 0.084 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 8.267989e-01 | 0.083 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 8.291576e-01 | 0.081 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 8.304632e-01 | 0.081 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 8.306045e-01 | 0.081 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 8.330491e-01 | 0.079 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 8.334130e-01 | 0.079 | 0 | 0 |
| Acetylcholine binding and downstream events | R-HSA-181431 | 8.336285e-01 | 0.079 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 8.336285e-01 | 0.079 | 0 | 0 |
| Postsynaptic nicotinic acetylcholine receptors | R-HSA-622327 | 8.336285e-01 | 0.079 | 0 | 0 |
| FGFR2c ligand binding and activation | R-HSA-190375 | 8.336285e-01 | 0.079 | 0 | 0 |
| FGFR4 ligand binding and activation | R-HSA-190322 | 8.336285e-01 | 0.079 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 8.336285e-01 | 0.079 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 8.336285e-01 | 0.079 | 0 | 0 |
| Signaling by activated point mutants of FGFR3 | R-HSA-1839130 | 8.336285e-01 | 0.079 | 0 | 0 |
| Mtb iron assimilation by chelation | R-HSA-1222449 | 8.336285e-01 | 0.079 | 0 | 0 |
| FGFR3 mutant receptor activation | R-HSA-2033514 | 8.336285e-01 | 0.079 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 8.336285e-01 | 0.079 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 8.336285e-01 | 0.079 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 8.336285e-01 | 0.079 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 8.336285e-01 | 0.079 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 8.336285e-01 | 0.079 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 8.340026e-01 | 0.079 | 1 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 8.378391e-01 | 0.077 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 8.378391e-01 | 0.077 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 8.378391e-01 | 0.077 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 8.378391e-01 | 0.077 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 8.378391e-01 | 0.077 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 8.378391e-01 | 0.077 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 8.378391e-01 | 0.077 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 8.378391e-01 | 0.077 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 8.405871e-01 | 0.075 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 8.419045e-01 | 0.075 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 8.425563e-01 | 0.074 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 8.427505e-01 | 0.074 | 1 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 8.461607e-01 | 0.073 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 8.484405e-01 | 0.071 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 8.501981e-01 | 0.070 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 8.502957e-01 | 0.070 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 8.502957e-01 | 0.070 | 0 | 0 |
| FGFR3c ligand binding and activation | R-HSA-190372 | 8.502957e-01 | 0.070 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 8.502957e-01 | 0.070 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 8.502957e-01 | 0.070 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 8.502957e-01 | 0.070 | 0 | 0 |
| Biosynthesis of protectins | R-HSA-9018681 | 8.502957e-01 | 0.070 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 8.502957e-01 | 0.070 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 8.502957e-01 | 0.070 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 8.502957e-01 | 0.070 | 0 | 0 |
| Biosynthesis of E-series 18(R)-resolvins | R-HSA-9023661 | 8.502957e-01 | 0.070 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 8.502957e-01 | 0.070 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 8.502957e-01 | 0.070 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 8.504851e-01 | 0.070 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 8.504851e-01 | 0.070 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 8.504851e-01 | 0.070 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 8.525455e-01 | 0.069 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 8.596020e-01 | 0.066 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 8.617603e-01 | 0.065 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 8.622258e-01 | 0.064 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 8.622258e-01 | 0.064 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 8.622258e-01 | 0.064 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 8.622258e-01 | 0.064 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 8.625558e-01 | 0.064 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 8.652940e-01 | 0.063 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 8.652940e-01 | 0.063 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 8.652940e-01 | 0.063 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 8.652940e-01 | 0.063 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 8.652940e-01 | 0.063 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 8.652940e-01 | 0.063 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 8.652940e-01 | 0.063 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 8.652940e-01 | 0.063 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 8.652940e-01 | 0.063 | 0 | 0 |
| FGFR3 ligand binding and activation | R-HSA-190239 | 8.652940e-01 | 0.063 | 0 | 0 |
| Synthesis of 12-eicosatetraenoic acid derivatives | R-HSA-2142712 | 8.652940e-01 | 0.063 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 8.652940e-01 | 0.063 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 8.652940e-01 | 0.063 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 8.652940e-01 | 0.063 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 8.652940e-01 | 0.063 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 8.679513e-01 | 0.062 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 8.719636e-01 | 0.060 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 8.719636e-01 | 0.060 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 8.719636e-01 | 0.060 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 8.731158e-01 | 0.059 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 8.731158e-01 | 0.059 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 8.731158e-01 | 0.059 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 8.740080e-01 | 0.058 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 8.749758e-01 | 0.058 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 8.787905e-01 | 0.056 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 8.787905e-01 | 0.056 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 8.787905e-01 | 0.056 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 8.787905e-01 | 0.056 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 8.787905e-01 | 0.056 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 8.787905e-01 | 0.056 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 8.787905e-01 | 0.056 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 8.787905e-01 | 0.056 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 8.787905e-01 | 0.056 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 8.807970e-01 | 0.055 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 8.822512e-01 | 0.054 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 8.832075e-01 | 0.054 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 8.832075e-01 | 0.054 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 8.832075e-01 | 0.054 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 8.832075e-01 | 0.054 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 8.867413e-01 | 0.052 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 8.890835e-01 | 0.051 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 8.890835e-01 | 0.051 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 8.890835e-01 | 0.051 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 8.909354e-01 | 0.050 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 8.909354e-01 | 0.050 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 8.909354e-01 | 0.050 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 8.909354e-01 | 0.050 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 8.909354e-01 | 0.050 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 8.909354e-01 | 0.050 | 0 | 0 |
| Vitamin B6 activation to pyridoxal phosphate | R-HSA-964975 | 8.909354e-01 | 0.050 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 8.909354e-01 | 0.050 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 8.909354e-01 | 0.050 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 8.909354e-01 | 0.050 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 8.909354e-01 | 0.050 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 8.925517e-01 | 0.049 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 8.968505e-01 | 0.047 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 8.968505e-01 | 0.047 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 8.968505e-01 | 0.047 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.011966e-01 | 0.045 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 9.011966e-01 | 0.045 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 9.018641e-01 | 0.045 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 9.018641e-01 | 0.045 | 0 | 0 |
| Synthesis of 15-eicosatetraenoic acid derivatives | R-HSA-2142770 | 9.018641e-01 | 0.045 | 0 | 0 |
| Biosynthesis of aspirin-triggered D-series resolvins | R-HSA-9020265 | 9.018641e-01 | 0.045 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 9.018641e-01 | 0.045 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 9.018641e-01 | 0.045 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 9.018641e-01 | 0.045 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.045959e-01 | 0.044 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.091887e-01 | 0.041 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.107399e-01 | 0.041 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.109312e-01 | 0.041 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 9.116983e-01 | 0.040 | 0 | 0 |
| Activated point mutants of FGFR2 | R-HSA-2033519 | 9.116983e-01 | 0.040 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 9.116983e-01 | 0.040 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 9.116983e-01 | 0.040 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 9.116983e-01 | 0.040 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 9.116983e-01 | 0.040 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 9.130580e-01 | 0.040 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.172960e-01 | 0.037 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 9.172960e-01 | 0.037 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.176844e-01 | 0.037 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.205212e-01 | 0.036 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 9.205475e-01 | 0.036 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 9.205475e-01 | 0.036 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 9.205475e-01 | 0.036 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 9.205475e-01 | 0.036 | 0 | 0 |
| Synthesis of 5-eicosatetraenoic acids | R-HSA-2142688 | 9.205475e-01 | 0.036 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 9.205475e-01 | 0.036 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 9.205475e-01 | 0.036 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 9.205475e-01 | 0.036 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.232433e-01 | 0.035 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 9.232433e-01 | 0.035 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 9.233878e-01 | 0.035 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.271096e-01 | 0.033 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.271096e-01 | 0.033 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 9.279318e-01 | 0.032 | 1 | 1 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 9.285104e-01 | 0.032 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 9.285104e-01 | 0.032 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 9.285104e-01 | 0.032 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.285104e-01 | 0.032 | 0 | 0 |
| Keratan sulfate degradation | R-HSA-2022857 | 9.285104e-01 | 0.032 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.287963e-01 | 0.032 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 9.296761e-01 | 0.032 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 9.296761e-01 | 0.032 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.303690e-01 | 0.031 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.339779e-01 | 0.030 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 9.356756e-01 | 0.029 | 0 | 0 |
| FGFR2 ligand binding and activation | R-HSA-190241 | 9.356756e-01 | 0.029 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 9.356756e-01 | 0.029 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 9.356756e-01 | 0.029 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 9.356756e-01 | 0.029 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 9.356756e-01 | 0.029 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 9.356756e-01 | 0.029 | 0 | 0 |
| Biosynthesis of E-series 18(S)-resolvins | R-HSA-9018896 | 9.356756e-01 | 0.029 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.356756e-01 | 0.029 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 9.356756e-01 | 0.029 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.357580e-01 | 0.029 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.361026e-01 | 0.029 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.379641e-01 | 0.028 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 9.386834e-01 | 0.027 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 9.407222e-01 | 0.027 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 9.408167e-01 | 0.026 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.408167e-01 | 0.026 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.413279e-01 | 0.026 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.413279e-01 | 0.026 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 9.421231e-01 | 0.026 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 9.421231e-01 | 0.026 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.421231e-01 | 0.026 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.450509e-01 | 0.025 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 9.456085e-01 | 0.024 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.457370e-01 | 0.024 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.461621e-01 | 0.024 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.477392e-01 | 0.023 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 9.479246e-01 | 0.023 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 9.479246e-01 | 0.023 | 0 | 0 |
| Biosynthesis of D-series resolvins | R-HSA-9018676 | 9.479246e-01 | 0.023 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 9.479246e-01 | 0.023 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.483149e-01 | 0.023 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.502660e-01 | 0.022 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.502660e-01 | 0.022 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 9.502660e-01 | 0.022 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.514086e-01 | 0.022 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 9.514086e-01 | 0.022 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.531449e-01 | 0.021 | 0 | 0 |
| Synthesis of UDP-N-acetyl-glucosamine | R-HSA-446210 | 9.531449e-01 | 0.021 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 9.531449e-01 | 0.021 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 9.531449e-01 | 0.021 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.531449e-01 | 0.021 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 9.531449e-01 | 0.021 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.544326e-01 | 0.020 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.550988e-01 | 0.020 | 0 | 0 |
| CYP2E1 reactions | R-HSA-211999 | 9.578422e-01 | 0.019 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 9.578422e-01 | 0.019 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.578422e-01 | 0.019 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 9.578422e-01 | 0.019 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 9.582640e-01 | 0.019 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.582640e-01 | 0.019 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.602603e-01 | 0.018 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.605674e-01 | 0.017 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.617854e-01 | 0.017 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.617854e-01 | 0.017 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 9.620688e-01 | 0.017 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.620688e-01 | 0.017 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.620688e-01 | 0.017 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 9.650206e-01 | 0.015 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 9.650206e-01 | 0.015 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 9.650206e-01 | 0.015 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.650206e-01 | 0.015 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 9.658719e-01 | 0.015 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.658719e-01 | 0.015 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 9.658719e-01 | 0.015 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 9.658719e-01 | 0.015 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.688163e-01 | 0.014 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 9.692939e-01 | 0.014 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.692939e-01 | 0.014 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.693805e-01 | 0.014 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 9.707185e-01 | 0.013 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.707185e-01 | 0.013 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.707185e-01 | 0.013 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.713812e-01 | 0.013 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.720050e-01 | 0.012 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.723730e-01 | 0.012 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.730749e-01 | 0.012 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.732206e-01 | 0.012 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.732206e-01 | 0.012 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.751434e-01 | 0.011 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 9.751434e-01 | 0.011 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.751434e-01 | 0.011 | 0 | 0 |
| Biosynthesis of EPA-derived SPMs | R-HSA-9018679 | 9.751434e-01 | 0.011 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 9.755156e-01 | 0.011 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.755156e-01 | 0.011 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 9.755156e-01 | 0.011 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.755156e-01 | 0.011 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 9.755156e-01 | 0.011 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.761604e-01 | 0.010 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 9.761604e-01 | 0.010 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.776198e-01 | 0.010 | 1 | 1 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 9.776362e-01 | 0.010 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.776362e-01 | 0.010 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.776362e-01 | 0.010 | 0 | 0 |
| Mucopolysaccharidoses | R-HSA-2206281 | 9.776362e-01 | 0.010 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 9.795484e-01 | 0.009 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 9.798791e-01 | 0.009 | 0 | 0 |
| Aspartate and asparagine metabolism | R-HSA-8963693 | 9.798791e-01 | 0.009 | 0 | 0 |
| Synthesis of glycosylphosphatidylinositol (GPI) | R-HSA-162710 | 9.798791e-01 | 0.009 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 9.800074e-01 | 0.009 | 1 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.809608e-01 | 0.008 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.813104e-01 | 0.008 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 9.814562e-01 | 0.008 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 9.818972e-01 | 0.008 | 0 | 0 |
| HS-GAG degradation | R-HSA-2024096 | 9.818972e-01 | 0.008 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.824549e-01 | 0.008 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.829338e-01 | 0.007 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.829338e-01 | 0.007 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.837130e-01 | 0.007 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.844157e-01 | 0.007 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.852686e-01 | 0.006 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.853468e-01 | 0.006 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 9.853468e-01 | 0.006 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.853468e-01 | 0.006 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.853468e-01 | 0.006 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.855750e-01 | 0.006 | 1 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.857721e-01 | 0.006 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.857721e-01 | 0.006 | 1 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.861772e-01 | 0.006 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.863164e-01 | 0.006 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.868167e-01 | 0.006 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.868167e-01 | 0.006 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.868167e-01 | 0.006 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.868167e-01 | 0.006 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.868167e-01 | 0.006 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 9.868167e-01 | 0.006 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.874023e-01 | 0.006 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 9.879467e-01 | 0.005 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 9.881393e-01 | 0.005 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 9.881393e-01 | 0.005 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.881393e-01 | 0.005 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 9.881393e-01 | 0.005 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.881393e-01 | 0.005 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.881487e-01 | 0.005 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.881487e-01 | 0.005 | 0 | 0 |
| HS-GAG biosynthesis | R-HSA-2022928 | 9.893293e-01 | 0.005 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.893293e-01 | 0.005 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.895142e-01 | 0.005 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 9.895142e-01 | 0.005 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.897560e-01 | 0.004 | 1 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.901107e-01 | 0.004 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.903999e-01 | 0.004 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 9.903999e-01 | 0.004 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.903999e-01 | 0.004 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.903999e-01 | 0.004 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.903999e-01 | 0.004 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.908374e-01 | 0.004 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.909759e-01 | 0.004 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.910011e-01 | 0.004 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 9.910096e-01 | 0.004 | 1 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.913632e-01 | 0.004 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.922299e-01 | 0.003 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.922299e-01 | 0.003 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 9.922299e-01 | 0.003 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.925063e-01 | 0.003 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.928545e-01 | 0.003 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.929461e-01 | 0.003 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.930096e-01 | 0.003 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.936740e-01 | 0.003 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.937111e-01 | 0.003 | 0 | 0 |
| Aflatoxin activation and detoxification | R-HSA-5423646 | 9.937111e-01 | 0.003 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.937111e-01 | 0.003 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.937882e-01 | 0.003 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.938791e-01 | 0.003 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.940855e-01 | 0.003 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.941897e-01 | 0.003 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.941897e-01 | 0.003 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.943399e-01 | 0.002 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.943399e-01 | 0.002 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.943423e-01 | 0.002 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.943423e-01 | 0.002 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.947918e-01 | 0.002 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.949102e-01 | 0.002 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.949385e-01 | 0.002 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.950553e-01 | 0.002 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.950553e-01 | 0.002 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.953030e-01 | 0.002 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.955039e-01 | 0.002 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.957223e-01 | 0.002 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.958639e-01 | 0.002 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.958807e-01 | 0.002 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.962714e-01 | 0.002 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.962942e-01 | 0.002 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.964536e-01 | 0.002 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.967717e-01 | 0.001 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.967717e-01 | 0.001 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.970616e-01 | 0.001 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.973021e-01 | 0.001 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.973225e-01 | 0.001 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.973225e-01 | 0.001 | 0 | 0 |
| Keratan sulfate/keratin metabolism | R-HSA-1638074 | 9.975730e-01 | 0.001 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.975730e-01 | 0.001 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.976347e-01 | 0.001 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.976507e-01 | 0.001 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.977863e-01 | 0.001 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.977863e-01 | 0.001 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.978167e-01 | 0.001 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.980360e-01 | 0.001 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.981118e-01 | 0.001 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.981684e-01 | 0.001 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 9.982332e-01 | 0.001 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.985307e-01 | 0.001 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.985497e-01 | 0.001 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.987139e-01 | 0.001 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.988431e-01 | 0.001 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.988620e-01 | 0.000 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.989593e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.990686e-01 | 0.000 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 9.991579e-01 | 0.000 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.991579e-01 | 0.000 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.991579e-01 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.991772e-01 | 0.000 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.992950e-01 | 0.000 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.993186e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.993923e-01 | 0.000 | 0 | 0 |
| Latent infection - Other responses of Mtb to phagocytosis | R-HSA-1222499 | 9.995539e-01 | 0.000 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.996045e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.996257e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.996391e-01 | 0.000 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.996391e-01 | 0.000 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.997374e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.997374e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.997638e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.997638e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.997789e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.997875e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.997906e-01 | 0.000 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.997988e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.998089e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.998454e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.998635e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.998772e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.998882e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.998920e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999125e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.999182e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999656e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999825e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999835e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999864e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999917e-01 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 9.999936e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999936e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.999941e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999946e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999953e-01 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 9.999955e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999956e-01 | 0.000 | 1 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.999978e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.999989e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999991e-01 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 9.999994e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999995e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 9.999995e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999996e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999998e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999998e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999998e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999999e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 1 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 1 | 0 |